Enroll in Vital Psychedelic Training, starting September 17!
Master the art of psychedelic practice

Learn More

Category: Podcast

Posted on

PT413 – Queering Psychedelics, The Dark History of Conversion Therapy, and The EMBARK Approach

In this episode, David interviews Alex Belser, Ph.D.: clinical scientist; author; licensed psychologist; Co-Investigator for a psilocybin and OCD study at Yale University; and co-creator of the EMBARK approach, a new model of psychedelic-assisted therapy that focuses on six clinical domains that typically arise during psychedelic experiences.

He is also one of the editors of Queering Psychedelics: From Oppression to Liberation in Psychedelic Medicine, the new anthology from Chacruna featuring 38 essays from queer authors and allies looking at the heteronormative aspects of psychedelic culture and psychedelic-assisted psychotherapy, self-acceptance, psychedelics and pleasure, and ways the queer community can become allies with other groups. As they serendipitously recorded this episode on June 1, it only made sense to celebrate Pride Month by releasing it now, as well as launching a giveaway, where you can win one of five copies of Queering Psychedelics. 

Belser talks about the concurrent emergence of the psychedelic and queer communities; the need to research the effects of transphobia and homophobia in psychedelic work (as well as the internalized phobias often realized during an experience); why it’s more important than ever to talk about the psychedelic space’s dark past with conversion therapy; why the Mystical Experiences Questionnaire needs to be updated; the idea of queer people being boundary walkers; recreating the Good Friday Experiment, the immense importance of long-form interviews and other forms of qualitative research, the power of love and community, and the question: how does anyone not want to change after a powerful psychedelic experience?

Notable Quotes

“When we talk about MK-Ultra and we talk about the abuses of boundary transgressions and sexual transgressions, we also need to be talking about how psychedelics have been used to harm people through conversion therapy and how they have repeatedly been used in this way. If we don’t look to our past and what’s happening currently, then I don’t think we’re ever going to have a truly integral reckoning with how we carry these medicines in ethical ways.”

“I spoke with an Orthodox Priest who said, ‘Before, I used to give sermons to my congregation and I would talk about God’s justice: the justice of the lord.’ And now, after taking psychedelics (he had a really powerful experience), he says, ‘All I want to talk about is God’s love.’”

“[The EMBARK model is] open architecture. It’s multidimensional, but it allows for the therapist to bring in their existing skill sets, and it allows for a patient-centered approach to what might actually emerge or arise, because I don’t think there’s one path for psychedelic healing. What we see are multiple trajectories, and we needed to build a comprehensive theoretical framework for psychotherapy that allows for different expressions of that for different people.”

“I don’t think psychedelics are a panacea or cure-all, but I think that they help us experiment with different ways of being together, and it doesn’t have to be one way. That’s what I’ve learned; it really does not have to be one way, and it does not have to be the old way.”

Links

Winy a Copy of Queering Psychedelics!

Alexbelser.com

Centerforbreakthroughs.com

Embarkapproach.com

Psychedelics Today: Dr. Alexander Belser – How Privilege Affects Gender Inclusivity in Psychotherapy

Plasticbrainblog.com: The shameful history of psychedelic gay conversion therapy

Lgbtmap.org: U.S. Map of Conversion Therapy Laws

Archive.org: Full text of 1960 Playboy interview with Tim Leary

Maps.org: LSD and Sexuality: Review of a case of homosexuality treated therapeutically with LSD and description of a male-female psychedelic session program, by Richard Alpert

The Varieties of Psychedelic Experience: The Classic Guide to the Effects of LSD on the Human Psyche, by Jean Houston, Ph.D. & Robert Masters, Ph.D.

Far from the Tree: Parents, Children, and the Search for Identity, by Andrew Solomon

Queering Psychedelics: From Oppression to Liberation in Psychedelic Medicine, edited by Alex Belser, Clancy Cavnar, and Beatriz C. Labate

Psychedelics Today: PT269 – Adam Strauss – Comedy, OCD, and The Mushroom Cure

Yalemedicine.org: Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.

Psychedelics Today: PT229 – Dr. Matthew Johnson – What is Consciousness?

Wikipedia.org: Marsh Chapel Experiment

Cybin.com

Washington.edu: A Study of Psilocybin-assisted Psychotherapy for Clinicians With Symptoms of Depression and Burnout Related to Frontline Work in the COVID Pandemic

Posted on

Psychedelics Weekly – Drug Testing and Harm Reduction, Ketamine vs. ECT, and Does Therapy Really Work?

In this episode of Psychedelics Weekly, Joe and Kyle are once again able to take advantage of Kyle’s temporary Colorado residency and record together in Joe’s office.

While last week focused on the numerous challenges facing a rapidly growing industry of psychedelic therapists, facilitators, and guides, the topic of therapy itself is put under the microscope this week, as they dissect a New York Times article titled, “Does Therapy Really Work? Let’s Unpack That.” They discuss whether or not therapy is right for everyone, the efficacy of different types of therapy, the role of the therapeutic alliance in treatment outcomes, and how (if it’s even possible) to measure all of these factors.

They also discuss:

-a study showing that ketamine was more effective than ECT (electroconvulsive therapy) for patients with treatment-resistant depression;

-the potential benefits of the LSD analog, Br-LSD, in treating people with major depressive disorders, cluster headaches, and more;

-Ireland’s Health Service Executive launching the Safer Nightlife program, which will partner with music festivals this summer to establish on-site drug testing;

-the U.S. slowly beginning to legalize fentanyl test strips, which, for some reason, are illegal in many parts of the country;

and much more!

See you next week, and if you’re in the NYC area, make sure to check out “Tales of Transformation,” an in-person event Thursday, June 8 at the Athenæum, moderated by David, and featuring Ifetayo Harvey, Juliana Mulligan, and Raad Seraj.

Links

(bolded links are the discussed articles)

Navigating Psychedelics For Clinicians and Wellness Practitioners (the next edition begins July 12 and 13)

Psychedelicscience.org (use code PT15 for 15% off tickets)

Joe’s IG live with Global Psychedelic Society

Globalpsychedelic.org

California Psychedelic Conference: June 3-4 in Los Angeles

Nytimes.com: Does Therapy Really Work? Let’s Unpack That.

Besselvanderkolk.com

Wiley.com: The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta-analytic evaluation of recent meta-analyses

Psychiatryonline.org: Effect of a Layperson-Delivered Telephone Program for People With Depressive Symptoms

The Cato Institute: Jeffrey A. Singer

Forbes.com: New York City’s Psychedelic Athenæum: A Place To Find The Others

Psychedelics Today – Tales of Transformation: Thursday, June 8, at the Athenæum, 7:00 – 9:30pm EST

Thealchemistskitchen.com

Gizmodo.com: Ketamine Might Be on Par With the Gold Standard for Treatment-Resistant Depression, Study Finds

Psychologytoday.com: A Beneficial Psychedelic That Does Not Cause Hallucinations

Psychedelics Today: PT369 – Chronic Pain and Phantom Limb Pain: Could Psilocybin Be the Answer?, featuring: Timothy Furnish, MD & Joel Castellanos, MD

Psychedelics Today: PT245 – Robin Carhart-Harris – Psychedelics, Entropy, and Plasticity

Neurosciencenews.com: How Neurons That Wire Together Fire Together

Psychedelics Today: PT409 – Pathology, The DSM, and The Ontological Shock of Psychedelic Experiences, featuring: Erica Rex & Mona Sobhani, Ph.D.

Irishmirror.ie: Drug testing to be rolled out at music festivals in Ireland this summer

Everydayhealth.com: Fentanyl Testing Strips Are Illegal in Many States — but That’s Changing

Time.com: How Conservatives Are Changing Their Mind on Legalizing Fentanyl Test Strips

Alchemically Stoned: The Psychedelic Secret of Freemasonry, by P. D. Newman

Posted on

PT412 – Psychedelics and Virtual Reality: Where Novel Experience, Technology, and Altered States of Consciousness Meet

In this episode, Joe interviews the Co-Founders of Enosis Therapeutics: researcher and scientist, Agnieszka Sekula; and psychiatrist, clinical advisor to the Australian Psychedelic Society, and leading Australian advocate for psychedelic-assisted psychotherapy, Dr. Prash P. 

Enosis Therapeutics is a medtech startup that began with the question: how can we use VR – with or without psychedelics – to improve mental health outcomes? They feel that the biggest problem with powerful psychedelic experiences is that, once you’re back in reality, it’s oddly difficult to remember the insights and new ideas that were so clear during the experience, and even harder to make connections that lead to concrete change. They believe that the immersive nature of VR and the novelty of unique VR environments creates a sense of presence that can’t be recreated otherwise – a liminal, in-between state that’s just different enough to allow the patient to feel like they’re back in that non-ordinary state, and therefore more able to anchor their experience and begin to find connections and more clearly understand newfound insights. 

This all happens by the user essentially creating nonlinear, abstract, multi-sensory VR paintings while describing what they remembered; allowing them to revisit these worlds later, bring in therapists (or anyone else) to work inside these environments, and hear their own voice describing what happened, thereby creating a mental map that can be worked with in completely unique ways. 

They talk about the conflict between new technologies and traditionalists; the problems with moving away from psychoanalysis and not treating psychotherapy as a process; how VR could improve the efficacy of therapy (and improve therapists’ lives); how it could replace models of repeated dosage; how VR could generate analytics to actually quantify success in mental health treatment; and how (whether psychedelics are used or not) culture needs to bring the psychedelic way of thinking to mental health.

Notable Quotes

“Imagine that you build out that network, that you make it physically visible and tangible, and you can actually have someone that comes into that space and visits that network. So you can share your mental model with anyone that you want: it can be a therapist, it can be a guide, it can be a shaman, it can be a well-being specialist, it can be your partner, it can be your parent, it can be your child. It can be anyone that you wish had a better understanding of you, but they don’t. It’s hard to understand ourselves, [much less] understand each other based on those linear narratives. But if we actually see how people connect things [and] how they see those links, I feel like we have a much better chance to actually connect to each other and have a better understanding of consciousness.” -Agnieszka

“So much of the focus in psychedelic therapy has been on the dosing session, whereas a lot of us would like to think that it really should be on the psychotherapy, and the psychedelic is purely that stimulus that ignites the insights which you then take through psychotherapy. If that stimulus can be the stimulus which ignites a process of psychotherapy, and therefore the power of psychotherapy to produce change, and in that way, brings psychotherapy further to the forefront of mental health treatment (in a way, it’s completely disappeared and been replaced by biological methods), then I think we have won – just by that.” -Prash

“We can induce a similar psycho-emotional state with the use of VR during the integration sessions to help patients remember, at their psychological and at an emotional level, what the experience has been like. …A lot of studies (especially earlier studies) would report that within the first two weeks after the psychedelic experience [is] the most potent time for integration because patients are still in that emotional state that was evoked with psychedelics. So maintaining that for longer by repeat application of VR might give us more access to those emotions, and might enable patients to process things a little bit more deeply.” -Agnieszka

Links

Enosistherapeutics.com

Frontiersin.org: Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy

Trans4mind.com: COEX Systems

Goodreads.com: Mozart’s “The music is not in the notes” quote

Ovid-clinics.com

Mind-foundation.org

Insight-conference.eu

Psychedelicmedicinecoalition.org

Psychedelics Today: PT321 – Lyle Maxson – Virtual Reality, Biofeedback, and Digital Therapeutics: The Future of Mental Health

Posted on

Psychedelics Weekly – New LSD Research and The Challenges Facing a Rapidly Growing Psychedelic Guide Industry

In this episode of Psychedelics Weekly, Kyle and David meet up to talk news, but end up mostly having a discussion about the numerous challenges facing the rapidly growing industry of psychedelic therapists, guides, and facilitators.

That discussion comes from the article, “Psychedelic workers of the world, unite!”, which breaks down the shortcomings and risks of an industry many are flocking to without realizing what they’ll likely have to deal with: unprecedented legal and financial risks, burnout, misalignment with management, transference and countertransference, and what happens when one finds themselves in the middle of a genuine emergency? While these issues could be found in any industry, a big reason why they seem so prevalent and dangerous in the psychedelic world is our lack of elders and passed-down experience – and the faster this all grows, the more we need that guidance. 

And for news, they talk about Ohio State making history as the first U.S. University to receive a license to grow psilocybin mushrooms; a new study showing that LSD enhanced learning, exploratory thinking, and sensitivity to feedback; and the National Institute on Drug Abuse (NIDA) funding $1.5 million to research the efficacy of psychedelics for substance use disorder – which spurs a conversation about research, funding, and the idea that maybe we’re spending too much time and money on neuroscience.

Links

(bolded links are the discussed articles)

Navigating Psychedelics For Clinicians and Therapists – Live Sessions (the next round launches in July)

Ecstaticintegration.org: Psychedelic workers of the world, unite!

Theguardian.com: Alternative reality: two kambo deaths spark soul-searching in Australia’s counter-culture capital

Thelantern.com: Ohio State Becomes First American University to be Granted DEA License for Psychedelic Mushroom Growth

​​Arizonaphysician.com: Challenging Medicine’s Status Quo: Sue Sisley, MD

Thedebrief.org: New Research Reveals LSD’s Mind-Altering Power to Enhance Learning and Exploratory Thinking

Psychedelics Today: PT245 – Robin Carhart-Harris – Psychedelics, Entropy, and Plasticity

Neurosciencenews.com: How Neurons That Wire Together Fire Together

Marijuanamoment.net: Federal Agency Announces $1.5 Million In Funding For Research On Psychedelics To Treat Drug Addiction

Mindmatters.ai: Why Pioneer Neurosurgeon Wilder Penfield Said the Mind is More Than the Brain

Beyond the Brain: Birth, Death, and Transcendence in Psychotherapy, by Stanislav Grof

Posted on

PT411 – The Humanity of Healthcare Professionals, Ancient Psychedelic Use, and Breaking the Cycle of Colonialism

In this episode, Joe interviews Priyanka Wali, MD: board-certified practicing physician in Internal Medicine, MAPS-trained psychedelic facilitator, comedian, and co-host (with Sean Hayes of “Will & Grace” fame) of the HypochondriActor podcast, where they discuss interesting medical issues in a funny (and hopefully uplifting) way. 

She talks about recognizing and protecting the humanity of healthcare professionals, and how medical school is creating a cycle of hurt people trying to help other hurt people. She believes we need to become more holistic, especially in embracing Indigenous ways of thinking, as their frameworks may be the only way to explain phenomena with which Western science can’t yet come to terms.  

They talk a lot about ancient psychedelic use: the use of a soma described in the Rigveda; Egyptian culture and mushrooms observed in statues; Plato; the work of Brian Muraresku and Graham Hancock; and Vedic chants, Kashmiri Bhajans, and how singing (especially in a group) can be especially healing to the nervous system. And as Wali experienced first-hand the Kashmiri Pandit genocide of 1990, she discusses how much colonialism has changed cultures, and how much our cycles of oppression relate to our collective inability to experience pain and fear.  

They discuss the psychological impact of living through major catastrophes; the special and hard-to-describe feeling of returning to your home (especially in a world changed by colonization and constant conflict); the sad case of Ignaz Semmelweis and hand washing; ghosts of Japan’s 2011 tsunami, the concept of ‘future primitive,’ and more.

Notable Quotes

“We’re only thinking about it from a certain perspective. And this is where you think about principles of colonization come in: looking at things only from one perspective. If you start to bring in Indigenous systems [and] Indigenous ways of looking at data, then suddenly, we do actually have ways to account for these other phenomenon that can’t be objectively tabulated.”

“In traditional Kashmiri culture, it was routine to gather together and sing together. We humans: we’re supposed to gather around the fire and dance and chant. There’s actually something very healing for our bodies. And let’s not forget how our nervous systems regulate with each other, so being physically together as a group, as a collective, singing, using our bodies: it’s actually very healing for the nervous system. We need more of that.”

“I think the next shift in consciousness is recognizing that we experience fear as part of the human experience, but we can choose not to give into it. We can be with it, we can allow it to be there, we can even honor it, but we don’t have to act on it. And we can, instead, choose the path of peace or love, or not even choose those paths, but just choose not to do anything with the fear; choose not to oppress someone, judge someone, lash it out, [or] numb it. …Unless we, in the present day, begin to start being with our fear, we will continue to perpetuate these cycles of oppression.”

Links

Priyankawali.com

Apple podcasts: The HypochondriActor podcast

Wikipedia.org: Kashmiri Pandits

Ripleys.com: The Hallucinatory Voices That Saved a Woman’s Life

When the Impossible Happens: Adventures in Non-Ordinary, by Stanislav Grof Ph.D.

Cosmic Trigger I: Final Secret of the Illuminati, by Robert Anton Wilson

Researchgate.net: Evolution of ephedra as the Soma of Rigveda

Tripsavvy.com: Philae Temple Complex, Egypt: The Complete Guide

Sciencedirect.com: The entheomycological origin of Egyptian crowns and the esoteric underpinnings of Egyptian religion (Stephen R. Berlant)

Libcom.org: What is anarcho-syndicalism?

Psychedelics Today: PTSF 35 (with Brian Muraresku)

Psychedelics Today: Lost Civilizations, DMT Entities, & Altered States of Consciousness and Early Religion, featuring: Graham Hancock

Netflix.com: Ancient Apocalypse

Psychologytoday.com: Kirtan: The Easy Meditation That Can Improve Your Brain

Paannyaar.com: Kashmiri Bhajans – List Of Most Popular Bhajans In Kashmiri

Wikipedia.org: Sankofa

Psychedelicmedicinecoalition.org

The Structure of Scientific Revolutions, by Thomas S. Kuhn

Npr.org: The Doctor Who Championed Hand-Washing And Briefly Saved Lives

My Grandmother’s Hands: Racialized Trauma and the Pathway to Mending Our Hearts and Bodies, by Resmaa Menakem

Historicalindia.org: Genocide of Kashmiri Pandits

Allthatsinteresting.com: Inside The Disturbing Legend Of The ‘Tsunami Spirits’ That Have Haunted Japan Ever Since Its 2011 Disaster

Confronting Collapse: The Crisis of Energy and Money in a Post Peak Oil World: A 25-Point Program for Action, by Michael C. Ruppert

Apple podcasts: SmartLess

HempLucid‘s function-based mushroom/cannabinoid gummies are a great option for those seeking targeted solutions for sleep, stress, and focus. Save 10% off by using the code PSYCHEDELICS10 at checkout.
Posted on

Psychedelics Weekly – Challenging the ‘Gifting’ Part of Prop 122, Public Perception in Oregon, and The Medicine of Music

In this episode of Psychedelics Weekly, Joe and Kyle are both on the road, so David and Alexa take the helm.

They cover news stories about:

-a man in Colorado facing a Class 3 drug felony for giving people psilocybin mushrooms in exchange for monetary donations – pointing out the bold (or stupid?) stances some are taking to highlight the absurdity of legislation that allows possession and donation as long as no money changes hands;

-a study showing what many of us have felt ourselves: that the day after psilocybin-assisted therapy, depressed patients had a stronger brain response to music and saw improvements in the ability to find pleasure in previously empty activities;

-a trip report from a psychedelically-naive 50-year old, showing the power and beauty of MDMA-assisted therapy;

-the New Hampshire state Senate continuing to be behind the times and voting down House Bill 639, which would have created a legal recreational cannabis framework for the state;

-a video where people on the street in Oregon were asked how much they thought psilocybin therapy would cost, showing a drastic misalignment between public perception and reality;

and a local TV news feature touring Rose City Laboratories, the first licensed psilocybin testing lab in Oregon.

And in conversation, they talk about some of the lesser-discussed (and often dismissed) tools like CBD, THC patches, and very low-dose edibles; the problem with drug dealers and harm reduction; the power of music in guiding a psychedelic experience (and in living a pleasurable life); and the importance of dosing and listening to your body to know what’s right for you.

Links

(bolded links are the discussed articles)

Myjewishlearning.com: Why Cheesecake on Shavuot?

Tales of Transformation: A panel on how psychedelic experiences can evolve into collective transformation and new life callings, featuring Ifetayo Harvey, Juliana Mulligan, Raad Seraj

Hemplucid.com (Use PSYCHEDELICS10 for 10% off)

YouTube: “Moms on Mushrooms”: A Growing Trend? (Tracey Tee on Dr. Phil)

Our IG live with Tracey Tee, hosted by Victoria

Entheoventures substack: Balancing the Psychedelic Narrative: A Call for Accuracy and Responsibility from All Sides

Summitdaily.com: Dillon man accused of selling psychedelic ‘magic mushrooms’ claims he was gifting them under Colorado’s new proposition

Psypost.org: Psilocybin therapy for depression appears to have a curious effect on the brain’s response to music

Sciencedirect.com: Increased low-frequency brain responses to music after psilocybin therapy for depression

Journal of Psychopharmacology: Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression

Alexa Jesse (with Host Bodies)- “Hourglass”

Psychedelicscene.com: The Healing Beauty of Ecstasy

Erowid.org

Hightimes.com: New Hampshire Senate Votes Down Cannabis Legalization Bill

Marysmedicinals.com

Wweek.com: How Much Would You Expect to Pay for Psilocybin Mushroom Therapy?

Epichealingeugene.com

Kgw.com: Touring the first Oregon lab licensed to test the strength of legal psilocybin

Psycon.org

Psychedelicscience.org (use code PT15 for 15% off)

Posted on

PT410 – Manufacturing MDMA and Why Creating MDMA Analogs Is So Important

In this episode, Joe interviews Nick Kadysh: Founder and CEO of PharmAla Biotech and member of the board of directors for The Canadian Psychedelic Businesses Association. 

PharmAla Biotech is a Toronto-based Life Sciences company with two focuses: contracting with manufacturers to provide researchers with GMP MDMA (created under Good Manufacturing Practice regulations), and creating and researching novel analogs of MDMA. And just today, they announced that Health Canada has authorized them (and their distribution partner, Shaman Pharma) to supply their LaNeo™ MDMA for the treatment of a patient under Canada’s Special Access Program – the first time this has happened in Canada. 

He discusses the creation of PharmAla and why their model changed from primarily researching analogs to manufacturing; why they’re operating out of Canada and using manufacturers instead of running the lab themselves; the excitement around Australia’s recent about-face on MDMA and psilocybin-assisted therapy; the bureaucracy of U.S. drug policy and how much a broken supply chain affects the whole industry; bad IP and companies filing rapid fire patents; why creating new analogs of MDMA is so important; and why the psychedelic space needs to bring culture along with us.

He also talks about Spravato, cannabis and risks of cancer, THC nasal sprays, and research he’s most excited about: that MDMA seems to alleviate dyskinesia caused from Parkinson’s disease, and that MDMA could improve social anxiety in people with autism. He’s aiming to run a clinical trial and believes they have developed a safe MDMA analog that the autistic community will respond to very well.

Notable Quotes

“I don’t want to give the impression that we think that MDMA is unsafe. In the case of PTSD-assisted psychotherapy the way that it’s being presented by MAPS, I think it’s remarkably safe. But, you know, better is still possible.” 

“If you told me that you have a brand new drug that was developed in a lab that nobody has ever seen or tried or tested before, and let’s call it drug A. And then you have drug B, which is derived from a mushroom, that people have been consuming regularly for the past 5,000 years and no one’s died. And you’re asking me which one is safer? It’s the mushroom, man. It’s not even a question.”

“We owe it to ourselves in this industry to take the population along for the ride. This is why I think safety is so important, because if you’re working on safety, people like that. People trust that. That’s what happened last time: there was the counterculture and the culture, and the culture won, and we’re still paying for it today. So let’s bring the culture along.”

Links

Pharmala.ca

News.bbc.co.uk: Ecstasy ‘not worse than riding’

Revivethera.com

Tga.gov.au: Change to classification of psilocybin and MDMA to enable prescribing by authorised psychiatrists

Psychedelics Today: Canada’s SAP Expansion Signals a Step Forward for Psychedelics

The Canadian Psychedelic Businesses Association

Uams.edu: William E. Fantegrossi, Ph.D.

YouTube: Researchers look at Ecstacy to ease Parkinsons Agony

Maps.org: MDMA-Assisted Therapy Shows Promise for Reducing Social Anxiety in Autistic Adults, New Study Shows

Psychedelics Today: Can Psychedelics Provide Relief for Autistic Individuals?

Autisticpsychedelic.com

Psychedelics Today: PT233 – JR Rahn of MindMed – LSD, ADHD, and Decriminalization

Pharmaphorum.com: J&J builds case for antidepressant Spravato with head-to-head trial

National Library of Medicine: The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research.

Feather.com: THC and CBD Rapid Sprays

Thecse.com: Pharmala Biotech Holdings Inc.

Posted on

Psychedelics Weekly – Multi-Stakeholder Capitalism, Psilocybin Service Centers Begin Opening in Oregon, and Vancouver’s ‘The Drugs Store’

In this episode of Psychedelics Weekly, Joe and temporary-Colorado-resident Kyle once again record in-person, discussing how psychedelics could change business, the drug war and safe supply, and more. 

They cover: 

-a Rolling Stone profile on David Bronner, who makes the case for multi-stakeholder capitalism; where businesses are accountable to their workers, customers, the environment, and surrounding Indigenous communities instead of just investors – an idea more people would likely align with after a psychedelic experience; 

-The first psilocybin service center in Oregon (EPIC Healing Eugene) finally receiving their license via the Oregon Health Authority;

-A man who saw his color blindness improve for four months after a 5g mushroom experience;

-Delaware officially legalizing recreational cannabis; 

-The opening of ‘The Drugs Store’ in Vancouver, British Columbia: a mobile store selling drugs illegally as a response to the opioid epidemic and constant influx of untested and laced drugs – the “inevitable result of the government doing nothing” towards offering a safe supply; 

-and a survey from the CDC showing that cannabis use among teenagers has declined since legal dispensaries began opening, disproving one of the most common prohibitionist arguments that legalization would only increase use. 

And of course, these topics bring on a lot of conversation: how businesses need to be more reflective on how they’re operating; concern over if too much regulation is nerfing the world; the human cost of the drug war and the ever-escalating amount of ODs and drug poisoning cases; HPPD and the need for research around psychedelics and vision/perception; why we will always need both clinical access and the recreational underground, and more.

Links

(bolded links are the discussed articles)

Rollingstone.com: ‘It’s Ripped the World Apart’: David Bronner on How Psychedelics Could Be a Cure for Capitalism

Psychedelics Today: PT367 – Colorado Proposition 122 and the Decriminalization of Natural Medicines

Marijuanamoment.net: Oregon Approves Nation’s First Psilocybin Service Center For Adults To Receive Psychedelic Treatment

Epichealingeugene.com

Imdb.com: Wall-E

Goodreads.com: Janis Joplin quote

Saving Normal: An Insider’s Revolt Against Out-Of-Control Psychiatric Diagnosis, DSM-5, Big Pharma, and the Medicalization of Ordinary Life, by Allen Frances

Technologynetworks.com: Consuming Psychedelics Temporarily Improves Man’s Color Blindness

Louisville.edu: UofL researchers discover procedure to regenerate dormant cone cells, potentially to improve vision in retinitis pigmentosa

Psychedelics Today: PT229 – Dr. Matthew Johnson – What is Consciousness?

Psychedelics Today: HPPD and Flashbacks: Everything You Need To Know – And What We Don’t Know, Too, by Ed Prideaux

Futureconevents.com

Cato.org: Jeffrey Singer

Victorialitmanlaw.com

Lhthehealingground.com (Veronica Lightning Horse)

The Myth of Mental Illness: Foundations of a Theory of Personal Conduct, by Thomas S. Szasz, M.D.

Studentsforliberty.org

Vice.com: A Store Selling Heroin, Meth, and Cocaine Just Opened in Canada

Dancesafe.org

Teen Marijuana Use Has Been Declining Since Legal Dispensaries Started Opening, Federal CDC Study Shows

Posted on

PT409 – Pathology, The DSM, and The Ontological Shock of Psychedelic Experiences

In this episode, Joe interviews Erica Rex: award-winning journalist, past guest and writer, and participant in one of the first ever clinical trials using psilocybin to treat cancer-related depression; and Mona Sobhani, Ph.D.: cognitive neuroscientist and the author of Proof of Spiritual Phenomena: A Neuroscientist’s Discovery of the Ineffable Mysteries of the Universe.

As Rex discovered the power of psychedelics through a clinical trial, she discusses a huge problem she discovered: that researchers are not preparing participants enough for the ontological shock they may go through in trying to match unexplainable happenings to a rigid framework (or match the normal to a framework that has suddenly shifted) – that while patients have support at the clinic, it all disappears when they return to normal life. She believes that all too often, researchers are doing only what is necessary to be able to continue to receive funding, push drugs through the FDA, and prescribe a pill. 

And as psychedelics changed Sobhani from very constrained scientific thinking to being very open to new ideas about consciousness and spirituality, she learned that many scientists had similar stories, and that coming out of the psychedelic closet is sometimes the best thing to do to normalize these ways of healing. 

They discuss the challenges of newcomers trying to explain their experience without having the necessary language; how we still don’t truly understand mental illness; how the DSM just clusters symptoms to fit ‘disorders’ into a box; how society has started pathologizing anything we find unpleasant (which of course, is a part of being human); Gary Fisher’s research on using LSD and psilocybin for schizophrenic children, why science needs to combine consciousness research and psychedelics research, and more.

Notable Quotes

“I think most people (neuroscientists, a lot of psychologists): we don’t like labels. We don’t like the DSM (especially neuroscientists). It doesn’t make any sense; all you’re doing is clustering symptoms and calling it a disorder. It’s useful, but it’s not explanatory. …Everyone’s so focused on ‘What are the brain mechanisms?’ but we do need to pull out and [ask]: ‘What are the societal mechanisms? How is our society not supporting [us]? Why do we see such an increase in some of these disorders? It’s a really big question.” -Mona

“There was a big move to get grief made into a pathology that was defined in the DSM so it could be treated with a pill. Grief. This was during COVID. So now grief is a pathology and you can be diagnosed with ‘grieving disorder’ and treated for it. …Anything that does not serve the machine is now considered a disease and disorder and has to be fixed, which is unfortunate because it takes us away from every piece of authentic experience that we could ever possibly have. And that is dehumanizing, profoundly.” -Erica

“Our whole society’s not built around humanity, even though we talk a lot about humanity. But there’s no humane principles in business or in society. Nothing is built around what the human needs, and that’s why, even in psychiatry, you see [that] grief or these normal human needs are pathologized. …We’re just cutting off parts of ourselves and not catering to being a human because we hate being human so much, apparently. We hate the things that are inconvenient about it, that it’s like we just have to cut it off and block it off and go forward. But you can’t do that; then you have all these coping mechanisms that emerge and then all these disorders, because you’re not functioning in an environment that supports you being what you are.” -Mona

Links

Psychedelics Today: PT273 – Erica Rex – Clinical Trials and Spontaneous Mystical Experiences

Madinamerica.com: Psychedelic Therapy Will Not Save Us, by Erica Rex

Madinamerica.com: The Culture Is the Poison: Why Psychedelics Are Dangerous Medicine in a Neoliberal Society, by Erica Rex

Scientificamerican.com: The Power of Psychedelics: They worked for my depression. Could they be the future of psychiatry? By Erica Rex

Scientificamerican.com: Hallucinogens Could Ease Existential Terror, by Erica Rex

Psychedelics Today: Could the Sonoran Desert Toad Cure Narcissism? by Erica Rex

Her NIH/NCI talk, “A Breast Cancer Patient’s Perspectives on the Uses of Psychedelics in Medicine” (begins at 1:04:41)

Npr.org: The ’60s Are Gone, But Psychedelic Research Trip Continues

Monasobhaniphd.com

Proof of Spiritual Phenomena: A Neuroscientist’s Discovery of the Ineffable Mysteries of the Universe, by Mona Sobhani, Ph.D.

Brave New World of Psychedelic Science substack

Exploring Consciousness: A community of curious (neuro)scientists

Globenewswire.com: COMPASS Pathways presents largest ever study of psilocybin therapy, at American Psychiatric Association annual meeting

Treatment of Childhood Schizophrenia Utilizing LSD and Psilocybin, by Gary Fisher, Ph.D.

The Center Cannot Hold: My Journey Through Madness, by Elyn R. Saks

The Myth of Normal: Trauma, Illness, and Healing in a Toxic Culture, by Gabor Maté with Daniel Maté

The Myth of Mental Illness: Foundations of a Theory of Personal Conduct, by Thomas S Szasz

Saving Normal: An Insider’s Revolt Against Out-Of-Control Psychiatric Diagnosis, Dsm-5, Big Pharma, and the Medicalization of Ordinary Life, by Allen Frances

Jamanetwork.com: Association of Religious and Spiritual Factors With Patient-Reported Outcomes of Anxiety, Depressive Symptoms, Fatigue, and Pain Interference Among Adolescents and Young Adults With Cancer

Ecotopia, by Ernest Callenbach

Posted on

Psychedelics Weekly – Psychedelics and Sports, The Risks of Over-Regulation, and What Makes Music Psychedelic?

In this episode of Psychedelics Weekly, Joe and Kyle record in-person again, discussing psychedelics and parenthood, sports, music, and more. 

They cover: 

-an Elle (!) article about how mushrooms are becoming the new ‘Cali sober,’ with more and more people starting to microdose – including parents; 

-ESPN’s documentary, “Peace of Mind,” highlighting the rise of psychedelic use among athletes, including retired NHL player, Riley Cote;

-An article discussing how interest in psychedelics has skyrocketed in Oregon since the passing of Measure 109, and how over-regulation and the glacial speed of the government is only driving the growth of the black market; 

-An essay attempting to define what it is that leads people to describe music as psychedelic (with several recommendations from Joe); 

-DMT aficionados using AI to create and catalog depictions of the entities they’ve seen;

and more!

And they have larger discussions about the drug war, how famous athletes are opening people’s minds to psychedelics, how strict regulation in psychedelic legislation can create more harm, how we need to collaborate more in the psychedelic space, the concept of a DMT ‘hyper-slap,’ and the problem of psychedelic exceptionalism and thinking your drug is good while others are bad.

Links

(bolded links are the discussed articles)

Psychedelic Neuroscience Demystified: How Psychedelics Alter Consciousness and Produce Therapeutic Effects

PT403 – Understanding the Brain: Psychedelic Neuroscience Demystified, featuring: Melanie Pincus, Ph.D. & Manesh Girn

Trailblazerspresents.com

Psychedelics Weekly – Breaking Convention, Decolonizing the Psychedelic Space, and How Colorado’s Senate Bill 23-290 Will Affect Prop 122 (Kyle and David break down SB23-290)

Psychedelics Today: PT217 – Erika Dyck – Canadian Psychedelic History

Elle.com: Shrooms Are the New Cali Sober

Psychedelics Today: Psychedelics Weekly – Roland Griffiths Faces the End, The NBA Lifts Its Cannabis Ban, and The Rising Popularity of Mushrooms for Moms

Espnpressroom.com: New ESPN E60 Examines Use of Psychedelics in Mental Health Treatment of Athletes

Wweek.com: Oregon’s Appetite for Psilocybin Is Being Fed Outside the Law in the Mushroom Underground

Cnn.com: High Profits (available to purchase on Amazon)

Psilotemple.org

Wikipedia.org: Fugio Cent

The Politics of Experience, by R.D. Laing

Psychedelicmedicinepac.com

Mapsbcorp.com: American Medical Association to Issue First New Code for Psychedelic Therapies

Psychedelicscene.com: What Makes Psychedelic Music Psychedelic?

YouTube: Shpongle – Hammock Therapy

Spotify: The Mars Volta – The Bedlam in Goliath (not their most acclaimed, but it’s this show notes writer’s favorite, and I think, most psychedelic)

The Beach Boys – Pet Sounds (Joe called it “Animal Sounds”…)

YouTube: The Beatles – Revolution 9 (Remastered 2009)

Spotify: LSDREAM

YouTube: Paul McCartney flipping people off

YouTube: Grateful Dead – Drums/Space – 12/28/1980 – Oakland Auditorium (Official)

Vice.com: DMT Users Are Using AI to Draw the Strange Beings They Meet While Tripping

Women of Visionary Art, by David Jay Brown & Rebecca Ann Hill

Psychedelics Today: Daniel McQueen – DMTx and Future Psychedelic Technologies

Reddit.com: Ever been hyperslapped? What happened?

Joe’s tweet about psychedelic exceptionalism

Drug Use for Grown-Ups: Chasing Liberty in the Land of Fear, by Carl L. Hart

Psychedelics Today: PT236 – Drugs: Honesty, Responsibility, and Logic, featuring: Dr. Carl Hart

Posted on

PT408 – Fireside Project: Harm Reduction Through Free Peer Support

In this episode, David interviews two of the founding members of Fireside Project: activist, healing justice practitioner, musician, and Chief Ambassador, Hanifa Nayo Washington; and lawyer, aspiring researcher, and Executive Director, Joshua White, Esq.

Fireside Project was created after White volunteered for a help line for years and realized a few things: that follow-up calls made a big difference; that the state of mental health in the U.S. was a disaster (he was talking to some of the same people for years); and that while psychedelics were becoming popular, they would likely only be accessible to the wealthy. Alongside Washington, they realized the most effective thing they could do would be creating a free help line where people could call for peer support during a psychedelic experience, and receive support in integrating that experience afterward. They’ve focused on finding volunteers who may be marginalized or who have been persecuted from the war on drugs, but most importantly, have real experience and true compassion (rather than letters after their name proving their credentials). They are on track to receive 10,000 calls over their first two years.

They discuss Fireside’s Burning Man origin story; the serendipity they’ve seen in the organization’s beginnings and so many calls; where the name came from; how they prepare volunteers; what true equity looks like; and how, while it’s a common challenge for therapists and facilitators to hold back and not try to fix a problem, that may be even more important here.

Fireside Project takes calls every day from 11am – 11pm PST, and while there is an app you can download, they recommend saving their number in your phone for when you need it (62-FIRESIDE). And to destroy the notion of being afraid to ask for help, they encourage everyone to share their stories on social media: the times that you’ve used Fireside Project or the times you had a challenging experience and wish you had known about them. Many newcomers have no idea this support exists, and it could truly be life-changing for them.

Notable Quotes

“What’s revolutionary about what we’re doing in this idea of democratizing care is that these are volunteers, and they come as peers. They come to the experiences having had their own experiences, and desiring to hold space for others as they navigate their experiences and navigate their processing afterwards. …They’re not doing therapy. They’re not diagnosing. They’re really with the person (the caller, the texter) as somebody who gets it.” -Hanifa

“I think some of the most powerful moments on the line come when we say absolutely nothing at all, when we just allow the silence to become almost palpable, to really feel that ember. I think silence has led to so many of the most beautiful moments that I’ve been lucky enough to see on the line.” -Josh

“By being able to create a safe and non-judgmental space for people by phone, then yes, that absolutely can reduce the risks of their psychedelic experiences. And I think there’s kind of a yin and yang here, which is that when a person is in a space of non-judgment, and when they do feel deeply seen and heard and listened to, then that not only reduces the risks, but it also allows someone to really turn towards their psychedelic experience and to unwrap the gift that’s before them.” -Josh

Links

Firesideproject.org

Handsofhanifa.com

​​Year of Yes, by Shonda Rhimes

Safe and Sound: TALK Line

Good Chemistry: The Science of Connection from Soul to Psychedelics, by Julie Holland (*Josh called it The Chemistry of Connection, but that’s a different book)

Onevillagehealing.org

Check out Odyssey, a sparking mushroom beverage providing holistic support for the body and mind, supporting energy, endurance, focus, immunity, and mood. Use code PSYCHEDELICS for 20% off at odysseyelixir.com.
Posted on

Psychedelics Weekly – Breaking Convention, Decolonizing the Psychedelic Space, and How Colorado’s Senate Bill 23-290 Will Affect Prop 122

In this episode of Psychedelics Weekly, David speaks with Kyle, who recorded at Joe’s place while he was away at Trailblazers in NYC. 

They talk about David’s trip to the UK last week for Breaking Convention, then discuss a recent Vice article about looking outside the binary and confined thinking of Western medicine and embracing the underground – that there are cheaper and more accessible peer support models and affinity groups for everyone, but in going underground, we need to be careful that more accessible models aren’t dangerous or re-traumatizing. While businesses are competing to make headway in the psychedelic space, nobody is controlling all of it, which leads to both possibility and risk. 

They cover SB23-290, the bill Senate President Steve Fenberg created to establish a regulatory framework for psilocybin access and administration in Colorado in lieu of the advisory board that should have been put in place as part of Prop 122. They break down the positives and negatives of this framework, and ask: how much do these committees who are passing legislation really know about psilocybin? 

And they briefly discuss an article on what MDMA therapy may look like when MAPS hopefully gets approval via the FDA early next year, Rick Doblin’s speech at Breaking Convention, and his concept of society eventually having “net zero trauma.”

Links

(bolded links are the discussed articles)

Breakingconvention.co.uk

Philosophy and Psychedelics: Frameworks for Exceptional Experience, edited by Christine Hauskeller & Peter Sjostedt-Hughes

Breaking Convention: Celia Morgan

Breaking Convention: Leor Roseman

The Botany of Desire: A Plant’s-Eye View of the World, by Michael Pollan

Vice.com: Inside the Quest to Decolonise Psychedelics

Marijuanamoment.net: Colorado Senate Passes Psychedelics Regulation Bill

Senate Bill 23-290

The Spirit Catches You and You Fall Down: A Hmong Child, Her American Doctors, and the Collision of Two Cultures, by Anne Fadiman

Nature.com: US could soon approve MDMA therapy — opening an era of psychedelic medicine

YouTube: PSYCH Interview: Rick Doblin – Net Zero Trauma by 2050

Posted on

PT407 – The Planet, Psychedelics, and Psyche: Optimism in Ecology

In this episode, Joe interviews Deborah Parrish Snyder: ecologist, Director and VP of the Institute of Ecotechnics, and Co-owner and CEO of Synergetic Press, which has published over 40 books on ethnobotany, psychedelics, biospherics, and social and ecological justice. 

Straddling the line between ecology, psychedelics, and psyche, she discusses the many projects of the Institute: Biosphere 2, the large-scale closed ecological system she helped design in 1986; London’s “October Gallery,” a man-made city biome project that could be a model for other cities; their “Eden in Iraq” wastewater project; and the Heraclitus, an 82-foot ship which has sailed 270k miles around the earth, studying different cultures, mapping coral reefs, and more, and will soon be setting sail again after being rebuilt for the last decade.  

She talks about where we’re at as a society in regards to the environment: how we’re in a period of consequences and it’s easy to feel hopeless, but much of the youth are “solutionists” who don’t want to hear apologies, and instead, want to do something about it. She believes that while schools don’t teach ecology, it’s never too late to learn, and non-ordinary states of consciousness could help people remember our connection to nature, care about our planet, and find the others who feel the same way. Consider pairing your self-exploration with improving the world around you: what can you do to turn your perfect, overly fertilized lawn into a regenerative landscape instead?

Notable Quotes

“We are nature. It’s not like we are part of nature, we are actually nature. This is an Indigenous concept that Western culture has abandoned (or never had to begin with, I’m not sure). Whenever our industrial, technological revolution gave us ways that we could start to live without nature as our main support system, that’s when we started to lose the plot, because there wasn’t closed loop thinking, there wasn’t [understanding of] what would be the long term effects of these things. So we’re starting to see that now. I don’t think humanity went into this intentionally, but at the same time, as we start to recognize the science, we should not be in denial; we should be activated to right the course of the ship.”

“I think that economics continues to drive that complex, but the more people that are awake and connected, the better. And as the war on drugs begins to become rational, and decriminalization of these tools becomes more accessible, we can start to build a society, I think, that is a bit more connected with nature and a bit more connected to each other, because these things don’t just give you an ‘Aha!’ connection with nature, they also give them connection with yourself and they can give you connection with others. …So keep your eyes open. If you’re not happy in your community, look for the others. Find the others; they’re out there.”

“The Western mindset of ‘we are going to conquer nature’: hopefully that worldview is starting to crack. It’s better that we become more like gardeners of the Earth, instead of plundering and pillaging.”

Links

Synergeticpress.com

Ecotechnics.edu

Psychedelics Today: PT312 – Deborah Snyder – Ecology, Synergy, and the Biosphere

Psychedelics Today: T228 – Deborah Snyder from Synergetic Press

Ecotechnics.edu: Research Vessel Heraclitus

Heraclitus video

Operating Manual for Spaceship Earth, by R. Buckminster Fuller

Synergia Ranch

Social Forestry: Tending the Land as People of Place, by Tomi Hazel Vaarde

Ecotechnics.edu: Las Casas de la Selva

Ecotechnics.edu: October Gallery

Ecotechnics.edu: Birdwood Downs

Ecotechnics.edu: Bioshphere 2

Dutch government ordered to cut carbon emissions in landmark ruling

Confessions of a Hope Fiend Paperback, by Timothy Leary

Openfuturecoalition.org

Seaclifforganics.nz: DIY – Johnson Su Bioreactor

Ecotechnics.edu: Eden in Iraq

Brotherhood of the Screaming Abyss: My Life with Terence McKenna, by Dennis McKenna, Ph.D.

Psychedelics Today: Wade Davis – Ayahuasca and a New Hope for Colombia

The Amazon Conservation Team

Oryx and Crake, by Margaret Atwood

Posted on

Psychedelics Weekly – The Church of Psilomethoxin Controversy, Psychedelics for Long COVID, and The Growth of Bicycle Day

In this episode of Psychedelics Weekly, Joe and Kyle once again record in person, diving into novel compounds, changing opinions, Bicycle Day, and more. 

They start by dissecting a very recent controversy around The Church of Psilomethoxin and whether the sacrament they label as psilomethoxin – supposedly created by adding 5-MeO-DMT to the substrate of cultivated Psilocybe mushrooms – actually contains any psilomethoxin in it. Usona Institute published a paper last week reporting on their analysis of a sample they allegedly collected from the Church, which only showed what we’d see in a sample of a typical psilocybin-containing mushroom. While the Church has issues with Usona’s data collection, analytical methods, and motives, they also reiterate a main component of the church: that their “claims to the existence of Psilomethoxin, at this time, are solely based on faith,” and bolstered by their “own direct experiences with the Sacrament.” It’s a very interesting story that touches on faith, consent, personal safety, and the harms of the drug war, which Joe covered extensively in a Twitter Space last night with Andrew Gallimore and the writer of a very critical article, Mario de la Fuente. 

They also discuss: 

-a Time magazine article about the mystery of Long COVID, and how many believe the anti-inflammatory and neuroplastic benefits of psychedelics could be the answer; 

-how Bicycle Day may soon become more popular than 4/20, likely due to society’s warmer reception to the life-changing effects of psychedelics (as opposed to their propagandized and unmoving beliefs about cannabis); 

-how some analysts believe that seven in 10 ketamine companies will likely face financial challenges as the industry grows too quickly; 

and why Snoop Dogg apparently microwaves blunts before smoking them (and does that actually do anything?).

Links

(bolded links are for the discussed articles)

Andrew Gallimore’s twitter thread about psilomethoxin

Chemrxiv.org: Fungi Fiction: Analytical Investigation into the Church Of Psilomethoxin’s Alleged Novel Compound Using UPLC-HRMS

Psychedelicalpha.com: Opinions | The Church of Psilomethoxin: Fantasy Chemistry Gets Fact Checked

Psilomethoxin.com: Psychedelic Capitalism, Scientific Integrity, and a Wider Look Into Current Events; Response to USONA Article

Psychedelics Today: PT393 – Religious Freedom and the Church of Psilomethoxin, featuring: Greg Lake, Esq.

You Have the Right to Remain Innocent, by James Duane

Time.com: The Latest Promising Long COVID Treatment? Psychedelic Drugs

Psychedelics Today: PT369 – Chronic Pain and Phantom Limb Pain: Could Psilocybin Be the Answer? featuring: Timothy Furnish, MD & Joel Castellanos, MD

Marijuanamoment.net: Top Colorado Senator Files Psychedelics Regulations Bill, Drawing Mixed Reactions

Marijuanamoment.net: Majority Of Americans Back Legalizing Psychedelics Therapy And Federally Decriminalizing Substances Like Psilocybin, Poll Finds

Breakthroughbulletin.com: New Poll Shows Strong Support For Psychedelic Medicine

Theatlantic.com: The Pandemic Did Not Affect Mental Health the Way You Think

Forbes.com: Bicycle Day May Soon Overtake Cannabis Holiday 4/20

Dosed 2

Psychedelics Today: PT271 – Jeremy Narby, Ph.D. – Anthropology, Ayahuasca, and Plant Teachers

Psychedelics Today: PT406 – Alex & Allyson Grey – Bicycle Day, Unveiling Entheon, & the Mystical Experience Through Art

PT’s Bicycle Day Instagram post showcasing submitted art

PT’s 2nd Bicycle Day Instagram post showcasing submitted art

Theguardian.com: Ketamine clinics have emerged across the US. They’re already going bust

Benzinga.com: Snoop Dogg Microwaves His Blunts Before Smoking And For Good Reason, Here’s Why

Posted on

PT406 – Bicycle Day, Unveiling Entheon, and The Mystical Experience Through Art

In this episode, on the eve of Bicycle Day, Victoria and Kyle interview two long-standing icons of visionary psychedelic art: Alex and Allyson Grey.

They talk about the LSD trip that saved Alex’s life, connected him to Allyson, inspired his art, and even made him change his name; his decades-in-the-making “Sacred Mirrors” project of 21 7-foot tall pieces depicting the complex layers of human existence; the interconnectedness of life; the history of psychedelic art; how imagination and non-ordinary states help us connect with the divine; and the value of art in conveying the mystical experience.

Alex and Allyson are the Co-Founders of the Chapel of Sacred Mirrors, an interspiritual church/retreat center in upstate New York that, after years of work, is debuting Entheon: an art sanctuary and psychedelic reliquary featuring much of their art and work from favorite artists, a shrine to Tool (who Alex has worked with for most of their career), and a collection of relics from psychedelic legends that includes Albert Hofmann’s glasses, art signed by Stan Grof and the Shulgins, and even Timothy Leary’s ashes. Entheon opens on June 3, on the anniversary of the first acid trip the Greys took together, which gave them a framework for understanding life and an inspiration for art they still follow to this day.

And in honor of Bicycle Day, Alex talks about two pieces dedicated to Albert Hofmann, and continues his Bicycle Day tradition of reading a statement Hofmann made a year before he passed about psychedelics being the “absolute highest importance to consciousness change.” In celebration of Albert Hofmann and the gift he gave us, and with inspiration from the incredibly complex and beautiful art Alex and Allyson create, have a happy, safe, and creative Bicycle Day!

“St. Albert and the LSD Revelation Revolution” by Alex Grey

Notable Quotes

“I hadn’t had any insight that would prove to me any kind of spiritual reality was really there, even though I was making art. And I think from my perspective now: hey, if you’re being creative, you’re evidence. The creative spirit is what birthed the universe, and you’re an expression here and now of it. You’re evolving on that wavefront of reality that is binding time together and our beings together.” -Alex

“We could see the vast vista of fountains and drains of everyone, and every being and thing in the universe was interconnected and made of light, and in that, I think we felt connected rather than disconnected. We felt like we were individual and independent, but also interconnected with all beings and things. [It] makes you feel like there’s some importance to yourself, that you really are necessary in the web of the eternal.” -Allyson

“You’re making love with the divine in the mystical experience, in the divine imagination. That’s where the small self meets the larger self and becomes no self. So I think that the mystical experience is the cornerstone of the sacred traditions, and the artistic sacred traditions as well.” -Alex

“It took me right outside of my miserable psychodrama self and immediately, I got a psychic swirlie to show me the way. So that was a confirmation, and all my prayers basically were answered in that, and I got to meet the love of my life, really, because of it. So we’re very thankful, and it’s one of the reasons why we’ve always loved celebrating Bicycle Day.” -Alex

Links

Alexgrey.com

Allysongrey.com

Cosm.org (the Chapel of Sacred Mirrors)

Entheon

Be Here Now, by Ram Dass

Alexgrey.com: Sacred Mirrors

Alexgrey.com: Life Energy

Learnreligions.com: Indra’s Jewel Net

Mushroomstone.com: Breaking the Mushroom Code

Psychedelicreview.com: Early Inhabitants of Algeria Create Cave Art that Shows Mushrooms

Mythology.net: Sekhmet

Dr. Albert Hofmann’s quote from 2007 that they read every Bicycle Day

Wikipedia.org: Paracelsus

Toolband.com

Alexgrey.com: “Net of Being”

Alexgrey.com: “Theologue”

Allysongrey.com: “Jewel Net of Indra”

Alexgrey.com: “Transfiguration”

Alexgrey.com: “The Great Turn”

“Albert Hofmann and the New Eleusis” by Alex Grey
Posted on

PT405 – The Psychedelic Medicine PAC: The Push for Federal Funding and Politicians Who Will Fight for Us

In this episode, Joe interviews Melissa Lavasani: CEO of Washington, DC-based Psychedelic Medicine Coalition, and now, President of the brand new Psychedelic Medicine PAC.

She discusses her path to psychedelics, how she ended up running the Initiative 81 campaign (the Entheogenic Plant and Fungus Policy Act of 2020), and how she came to realize that decriminalization efforts can’t be the only option we go for – that, like it or not, we live in a system where politics and money are major factors behind any systematic change, and if we want to make any headway, we have to play the game. The Psychedelic Medicine PAC (Political Action Committee) was created to open up federal funding for psychedelic research, as nearly all research today (of which there still isn’t enough) is being funded by private companies. They will use donations to support politicians who are on our side and can advance psychedelic progress, who will push for federal funding to get the new and necessary data people who aren’t bought in yet need to see. 

They talk about speaking with people from the other side of the aisle at a recent education campaign in DC; how federal funding is neutral money; what she learned from DC’s deprioritization of cannabis policing; how personal stories and one-on-one human connection can change minds better than traditional confrontational activism; and the need to get ahead of the inevitable wave of big pharma propaganda they’ll bring when they officially step up to the table. She believes the path to helping the most people is advancing science and data through federal funding, and that begins with education and getting more politicians on our side. If you agree, follow them for details about their upcoming event in May, visit their table at Psychedelic Science this June (use PT15 for 15% off tickets), and donate to the PAC or the coalition. 

Also, as a bonus, this episode begins with a mini version of Psychedelics Weekly. Joe and Kyle didn’t have enough time to record a full episode, but still wanted to check in and review a few notable stories and highlight our recent Vital graduation ceremony. See you next week!

Notable Quotes

“I dipped my toes with the microdosing [and] I found immediate effects of that. I engaged with my children for the first time in many years, and with my son for, really, the first time since he was born. So that was a really mind-blowing experience of taking something for only a few days and feeling my humanity come back again.”

“I think when you take the media out of it and you isolate them in a place they feel very safe (in their office) and there’s no cameras around and they don’t feel the need to get their talking points across, and you have a human-to-human conversation with them about this issue, the result is that much better because you isolate all of these external influences that they’re constantly under and you say, ‘Listen, I am talking to you as a human being. This was my experience. This is what I did to heal myself.’ …Watching them have their epiphany about this is so fun.”

“When these campaigns win with very small margins (like 1%, 3%, 5%), that means half of the state voted against it, and that means half the state wasn’t being spoken to in these campaigns in the right way. …The U.S. is extremely diverse, and not just racially, but within perspectives that exist in this country, and we cannot just be speaking to one side of this issue. We have to really engage with the public in a meaningful way, and that is speaking to the half of the country that doesn’t understand this.”

“We forget that the traditional pharmaceutical industry has yet to step in on this issue. I think that they’re very closely watching what’s going to happen with psychedelics, but they have yet to stick their lobbyists on the hill. And that is the day that I am not looking forward to, because they have one of the most powerful lobbies in the country and they have budgets for this kind of work in the billions of dollars, really. So how is the psychedelic industry going to compete with that? How you counter that is: you educate members of congress, you educate those influential people before the pharmaceutical industry gets there so they can’t fill their heads with misinformation.”

Links

Psychedelic Neuroscience Demystified: How Psychedelics Alter Consciousness and Produce Therapeutic Effects

Maps.org: Zendo Project Celebrates a Decade at Burning Man and a New Beginning for the Organization

BBC.com: People were taking drugs in Spain 3,000 years ago, study finds

Telegraph.co.uk: Rory Lamont: ‘My rugby injuries made me suicidal – psychedelic drugs saved me’

Benzinga.com: Bipartisan Letter Calls For Including Active Service Members In Psychedelic-Assisted Therapy Research

Benzinga.com: This South American Country Wants To Legalize Natural Psychedelics: What’s Going On In Uruguay?

———————————————

Psychedelicmedicinecoalition.org

Psychedelicmedicinepac.com

Psychedelics Today: PT338 – Melissa Lavasani – The Power of Storytelling, The Preservation of Peyote, and “How to Change Your Mind”

NBCnews.com: Candidates who support psychedelics as medicine get a political action committee

Psychedelics Today: PT327 – Rick Doblin, Ph.D. – Confronting Abuse in Clinical Trials and the Future of Psychedelic Medicine

Psychedelics Today: PT229 – Dr. Matthew Johnson – What is Consciousness?

Governing.com: What Can Communities Do to Prevent Psychedelic Healing Centers?

Arpa-h.gov

Posted on

PT404 – Clusterbusters: The Horrors of Cluster Headaches and the Miracle of Psilocybin

In this episode, Joe lets Court Wing take lead in interviewing two of the leaders behind Clusterbusters: Founder and Executive Director, Bob Wold; and President, Eileen Brewer.

A long-time friend of the show, Court Wing has become our resident expert on chronic pain, writing articles about how psilocybin relieved his chronic pain, and hosting Timothy Furnish, MD & Joel Castellanos, MD in their episode about phantom limb pain. Now he speaks with Clusterbusters, a non-profit dedicated to educating people about the horrors of cluster headaches, funding ongoing research into new treatments, and normalizing the miracle that psilocybin has been to so many sufferers in alleviating their headaches. 

Wold and Brewer discuss their past struggles (Wold is a cluster sufferer and Brewer has migraine disease) and discovering the amazing intervention of psychedelics; the battles they’ve gone through in spreading this knowledge; how using psychedelics is also helping people work through PTSD; the barriers that legal psilocybin is creating; the concept of schools having a drug education program; the research looking at cluster headaches and other headache diseases; their creation of the Pain And Psychedelics Association, and more. While cluster headache sufferers have a lot to be frustrated about; as psilocybin becomes more mainstream and more and more research is funded, they now have a lot of hope.

Notable Quotes

“A couple of people started growing their own mushrooms and self-treating themselves just to try it to see if it might actually help, and the results were incredible. It was better than anything that any of them had tried in the past. It wasn’t really an abortive (it wasn’t treating one headache) and it wasn’t really a preventive, where you would take it and you would prevent some of your cluster attacks. It was something that was actually doing both of those things, and people were getting long-lasting results by one or two doses of magic mushrooms.” -Bob

“It makes sense that that would happen within a disease community, it happens outside of disease communities too. Some people just use psychedelics occasionally just to get that perspective back and to work within themselves (and without themselves) to sort it all out, [and] get themselves back together. And I think there’s a real division there between people who do that and people who don’t.” -Eileen

“The two or three years before my first dose of psilocybin, my medical bills were like $20,000 a year trying to treat my clusters. That included hospital stays and specialists and travel. …The first time I grew my own mushrooms, it cost me a hundred dollars to grow a year’s supply and I didn’t have to go to Walgreens to pick up my medicine. So my medical treatment for the following year for my cluster headaches was $100 versus $20,000 and I was able to take as much as I needed when I needed it. And at this point, that’s what most people with headache disorders are doing; they’re growing their own because the system is going to take years and years to be built into something that’s actually accessible to everybody – and affordable.” -Bob

“People are dying while we’re waiting for these policies to happen, and I’m really struggling with the fact that we are setting up more barriers. I know that all the intentions are good, but we are hurting people.” -Eileen

Links

Clusterbusters.org

Remaptherapeutics.com

Psychedelics Today: Surprising Results: Psilocybin Trial for Depression Alleviates Chronic Pain

Psychedelics Today: Why Did Psychedelics Relieve My Chronic Pain?

Psychedelics Today: PT391 – MDMA-Assisted Psychotherapy For Fibromyalgia and Other Central Sensitization Syndromes, featuring: Dr. Devon Christie & Dr. Pamela Kryskow, MD

Psychedelics Today: PT306 – Dr. Devon Christie – Vital Psychedelic Conversations

Psychedelics Today: PT315 – Dr. Dominique Morisano – From Research to Reality: Planning a Global Psychedelic Summit

Psychedelics Today: PT369 – Chronic Pain and Phantom Limb Pain: Could Psilocybin Be the Answer?, featuring: Timothy Furnish, MD & Joel Castellanos, MD

UC San Diego Psychedelics and Health Research Initiative

Newswire.ca: Apex Labs Granted Approval for 294 Patient Take Home Psilocybin Clinical Trial

FDA.gov: Risk Evaluation and Mitigation Strategies | REMS

Yalemedicine.org: Emmanuelle Schindler, MD, Ph.D.

Maastrichtuniversity.nl: Dr. Jan Ramaekers

Clinicaltrials.gov: Psilocybin in Patients With Fibromyalgia: EEG-measured Brain Biomarkers of Action (Psilopain)

Posted on

Psychedelics Weekly – Roland Griffiths Faces the End, The NBA Lifts Its Cannabis Ban, and The Rising Popularity of Mushrooms for Moms

In this episode of Psychedelics Weekly, Kyle is back in Colorado and in-person with Joe, and they discuss what stood out to them in the news this week:

-A New York Times interview with Roland Griffths, where he talks about his cancer diagnosis and how meditation and psychedelics have helped him prepare for the inevitable end;

-An article on the rising popularity of psychedelics among mothers, and the benefits and risks of moms rejecting alcohol culture in favor of something new (and largely illegal);

-The NBA removing cannabis from its list of banned substances and allowing players to invest in cannabis companies, which follows years of other sports slowly accepting that cannabis is a part of our culture and there’s no need to play the part of “big brother” anymore;

and an article looking at legalization from the perspectives of people who were against recent measures like Prop 122, and how some towns in Colorado and Oregon are looking for ways to prevent the creation of psilocybin service centers from being built in their backyards.

They also go further into the Psychedelic Medicine Coalition’s recently created Political Action Committee and the work they’re doing to educate lawmakers; Harvard Law School hosting webinars comparing psychedelic legislation and the role of psychedelics in Indigenous groups in Europe, Australia, and North America; Arizona’s HB-2486, which would give $30 million in grants to universities and non-profit organizations to conduct psilocybin research; and Rick Doblin’s recent appearance on The Joe Rogan Experience.

They also discuss the many events we’ll be at in the coming months, and the excitement and often overwhelming aspects of psychedelic conferences, which are outlined in this week’s blog from Dennis Walker. If you’re attending any, come say hi! And for discounts: use code PSYCTODAY for 30% off tickets to DiscoveryCon, use PSYCHTODAYBC10 for 10% off tickets to Breaking Convention, and use code PT15 for 15% off tickets for MAPS’ Psychedelic Science 2023.

Links

(bolded links are the articles they discussed)

Psychedelics Today: Expanding Your Horizons: The Ultimate Guide to Attending a Psychedelic Conference

The Joe Rogan Experience: #1964 – Rick Doblin

Psychedelics Today: PT403 – Understanding the Brain: Psychedelic Neuroscience Demystified, featuring: Melanie Pincus, Ph.D. & Manesh Girn

Ssdp.org: 30 Under 30 Women in Psychedelics

NYtimes.com: A Psychedelics Pioneer Takes the Ultimate Trip

Griffithsfund.org

Romper.com: The Rise Of The Mushroom Moms

Psychedelics Today: PT396 – Moms on Mushrooms: Motherhood and Psychedelics Inside a Broken Culture, featuring: Tracey Tee

The ‘Housewife Syndrome’: An Indicator of Madness or Oppression?

Psychedelicspotlight.com: Indiana Nurse Faces Ten Years in Prison for Microdosing Psilocybin Mushrooms

Psychedelics Today: PT319 – Kole – Activism and Trust: A Cautionary Tale From Someone Who Got Caught

The Lancet: Development of a rational scale to assess the harm of drugs of potential misuse

Madinamerica.com: JAMA Psychiatry: We Must Look at the Harms of Psychedelic-Assisted Therapy

Plantph.com

Momsonmushrooms.com

Marijuanamoment.net: The NBA Is Lifting Its Ban On Marijuana In New Deal With Players Union, According To Report

Politico.com: Psychedelics coalition grows its advocacy footprint

Psychedelicmedicinecoalition.org: Donate

12news.com: There’s a push to legalize a specific psychedelic for medical research out of the Arizona legislature

Governing.com: What Can Communities Do to Prevent Psychedelic Healing Centers?

Thecrimson.com: Experts Discuss Psychedelics Policy in the Global North at Harvard Law School Webinar

Cnn.com: High Profits

Posted on

PT403 – Understanding the Brain: Psychedelic Neuroscience Demystified

In this episode, David interviews neuroscientist, artist, and educator, Melanie Pincus, Ph.D.; and Ph.D. candidate in Neuroscience, lead or co-author on over a dozen scientific publications, and regular contributor to PT, Manesh Girn. 

They tell their stories of how they became interested in neuroscience, and stress the importance of staying radically open-minded (or “epistemically naive”) when it comes to how much we can claim we understand about the brain, the mind-body connection, and consciousness itself – that while fMRI and other advances have brought us a long way, there are still a ton of “unknown unknowns,” especially around creativity, decision making, and imagination. They discuss the misconception that we only use 10% of our brains; comparisons between the brain and the universe; society’s misunderstanding of “happy hormones” (dopamine, serotonin, etc.); how chronic stress takes a toll on all parts of the body; how MDMA works with memory processing; and how stacking modalities with the psychedelic experience (like play or activities focused on emotion regulation) can really help with personal goals and growth. 

They have taken their understanding and fascination with neuroscience and applied it to a new course in our Psychedelic Education Center: “Psychedelic Neuroscience Demystified: How Psychedelics Alter Consciousness and Produce Therapeutic Effects“: an 8-week live course with 10 hours of prerecorded material and a built-in community. It was designed with practitioners and clinicians in mind, but with the goal of still being as accessible as possible for anyone who is curious about the neuroscience of psychedelics, and how that knowledge can help with preparation, the journey, integration, and working with a heightened window of neuroplasticity. 

Class begins on May 17, and if you sign up before April 12, you can get $100 off!

Notable Quotes

“There’s so much good science now, and good neuroscience that can inform how people work with their clients in terms of helping them set up for and make sense of their psychedelic experience and ways to optimize the preparation before going into a psychedelic journey, the actual psychedelic journey in terms of thinking about dosing and type of substance to work with, and then also in the integration period, where there’s this heightened window of neuroplasticity and how one could really work with a client to best take advantage of that window of opportunity to lead to lasting change.” -Melanie

“It’s just this blob, this squishy blob of matter. And you think: for that person, their entire life, experiences, memories, [and] hopes were all happening in this little blob that’s in my hand. And just seeing all the layers of blood vessels and how everything’s connected to each other, it’s just fascinating and it’s downright bizarre that somehow, this thing can give rise to experience and consciousness. It’s like, how the hell is that even possible?” -Manesh

“For people who are interested in stacking modalities, there’s other modalities that are really potent at promoting neuroplasticity. So if you want to synergize with the window of plasticity during the integration period, you could for sure partake in regular exercise, because that’s one of the most well-known plasticity promoters.” -Melanie

“How do we respond adaptively to times of change? How do we adjust ourselves? How do we create homeostasis in a changing environment, and how do we adapt to new circumstances? And this is also a whole brain/nervous system/body affair as well, on how to regulate your entire organism to deal with change and to be resilient and to be adaptable. It’s not just in the brain. It’s not just in the brain at all.” -Manesh

Links

Psychedelic Neuroscience Demystified: How Psychedelics Alter Consciousness and Produce Therapeutic Effects (Sign up before April 12 for $100 off)

Syncopydesignlab.com

YouTube: The Psychedelic Scientist

Psychedelics Today: Psychedelics Weekly – Research Explained: Ketamine and the Corticothalamic Network, Psilocybin and the Immune System, & Canalization and Plasticity, featuring Manesh Girn

Psychedelics Today: PT258 – Manesh Girn – Psychedelics and the Brain: Neuroplasticity and Creativity

Theguardian.com: Dreamachine, the psychedelic contraption hoping to blow British minds

Huffpost.com: What Exactly Are Sweetbreads, Anyway? A Guide For Anyone Who Doesn’t Already Know

Wikipedia.org: Jamais vu

Jannalevin.com

Britannica.com: Do We Really Use Only 10 Percent of Our Brain?

Sciencedaily.com: Massive study reveals few differences between men’s and women’s brains

Healthline.com: How to Hack Your Hormones for a Better Mood

The Fellowship of the River: A Medical Doctor’s Exploration into Traditional Amazonian Plant Medicine, by Joseph Tafur, MD

Psychologytoday.com: What Does ‘Allostatic Load’ Mean for Your Health?

Psychedelics Today: PT288 – Annie & Michael Mithoefer – Vital Psychedelic Conversations

Minoritytrip.com: s1e8 – Manesh Girn: Curiosity as Freedom from Circumstance, the Default Mode Network, and Nature of the Networked Mind

Attending Breaking Convention? Come see us and use code PSYCHTODAYBC10 for 10% off all purchases!
Posted on

Psychedelics Weekly – Investors Form REIT for Psychedelic Therapy, Diplo Runs a Marathon on LSD, and Is Cannabis a Psychedelic?

In this episode of Psychedelics Weekly, Joe calls in from Los Angeles to cover the week’s news with David. 

They review: 

-Dr. Julie Holland’s recent appearance on the The Cannabis Investing Podcast, where she discussed the concept of cannabis being a psychedelic;

-Vancouver Island University in British Columbia, Canada, planning to establish a Psychedelic Research Centre, with a focus on the historical and ethical context of psychedelic substances, using a “two eyed seeing” approach that combines Western-style science with Indigenous perspectives;

-A group of investors creating a Real Estate Investment Trust (REIT) to purchase real estate for the purposes of psychedelic therapy, which, if used as the collaborative model we imagine it could be, could solve a lot of problems;

-Diplo completing the Los Angeles Marathon in 3 hours and 35 minutes while under a reported 4-5 drops of LSD, and the dismissive spin mainstream media added to the story; 

and a Rolling Stone article focusing on (and somewhat oversimplifying) the conflicts between the medicalization and decriminalization/legalization camps (can we just do both?).

The articles of course lead to much larger discussions: how cannabis has helped David overcome OCD; the need for more transparency and a review system based on abusive behavior in the psychedelic space; the idea of collectivization in therapy models; the need to agree on ethical foundations; and our general misunderstanding of IP and IP law: was all the criticism of Compass Pathways unwarranted?

Links

“The Mushroom Cure” tickets

Psychedelic Neuroscience Demystified: How Psychedelics Alter Consciousness and Produce Therapeutic Effects

Mortlakeandcompany.com

Seekingalpha.com: Cannabis Is A Psychedelic – Dr. Julie Holland

Psychedelics Today: PT314 – Daniel McQueen, MA – Vital Psychedelic Conversations

Gaia.com: What is the Ayurvedic Perspective on Cannabis?

Psychedelics Today: PT398 – Lost Civilizations, DMT Entities, & Altered States of Consciousness and Early Religion, featuring: Graham Hancock

Imdb.com: “Orgasm Inc: The Story of OneTaste”

Firesideproject.org

CBC.ca: First Nations researcher exploring psychedelics as healing tool for intergenerational trauma

Rootstothrive.com: Shannon Dames, RN, MPH, EdD

Bisnow.com: ‘Nothing Short Of Incredible’: Investors Look To Form REIT To Buy Real Estate For Psychedelic Therapy

Usatoday.com: Diplo says he ran a marathon while on LSD. Experts say he’s tripping.

Concussionrepairmanual.com

Rollingstone.com: Market Battle Lines are Being Drawn in Psychedelics—But What are the Warring Camps Really Fighting About?

Drrosalindwatts.com

Psychedelics Today: PT233 – JR Rahn of MindMed – LSD, ADHD, and Decriminalization

Posted on

PT402 – Magic, Virtual Reality, and Ketamine & Internal Family Systems

In this episode, David interviews Sunny Strasburg, LMFT: Clinical Director at TRIPP PsyAssist; psychedelic trainer, consultant, therapist, and writer, specializing in EMDR and Internal Family Systems, and offering ketamine-assisted therapy as well as ketamine therapy retreats (often co-led by Dr. Richard Schwartz). 

She talks about her family history with magic, and how the act of calling energy in and out pairs with psychedelic work; how the human experience is made up of contrasts; why we need to embrace the recreational part of psychedelics; how art can be used more in therapy; and how post-experience group integration is the act of creating mythology, recreating the small-community-sitting-by-the-fire archetype – that community we so desperately need. And she discusses ketamine: different ways she uses it; how it pairs perfectly with Internal Family Systems; and how it’s autobiographical medicine, making us an observer and allowing us to separate ourselves from our story.

While passionate about the mystical, magic, and reconnecting to nature, she is also very involved with virtual reality, and she discusses how VR and meditation apps are easing people into non-ordinary states and familiarizing people with breathwork. With the help of pioneering psychedelic DJ, David Starfire, she created PsyAssist, an app with music playlists and voice integration for people to enhance ketamine experiences that don’t otherwise include therapy or integration work. PsyAssist was acquired by VR company, TRIPP, and they’re running a study on people using VR before a psychedelic experience to see if data proves that VR really does reduce the anxiety so many of us feel before taking that big journey. But she reminds us: as we become more connected to technology, VR, and AI, being connected to other human beings will become more and more important.

Notable Quotes

“I call ketamine the open source code of psychedelics because it doesn’t have a very strong signature or agenda in and of itself. Psychedelics like ayahuasca and psilocybin definitely have a presence. DMT has a presence of beings that live in that space, and it seems like you go to this place that’s informed by the beings that run that space. Ketamine is more open-ended. It feels like it takes autobiographical content and feeds it back to you in interesting ways. …It has this interesting signature of pulling us out of the experience and into ‘observer mind,’ and it also has a signature of traveling. That combination is super interesting for therapy.”

“I do not see VR as a replacement for therapists at all. In fact, I think the more we get into technology and AI, the more in-person experiences with another human being are going to become increasingly valuable to us. We have evolved for hundreds of thousands of years to be prosocial animals that connect with other beings like us, and that’s not going away anytime soon. …I actually think that as AI and technology takes a lot of jobs, I think there are certain sectors of human connection that are going to become more important than ever.” 

“I love [how] in holotropic breathwork, they have the mandalas with art materials and they encourage you to create a drawing or painting of what you experienced before you speak to anyone as part of that experience. And I really like that, because as soon as you start giving words to ineffable experience, it collapses it down to something that’s simplified beyond what it was. But you can keep it in that open-ended space when you make art …or you make music or dance around what you experienced. It holds that openness and that sublime energy of the ineffable.”

Links

Sunnystrasburgtherapy.com

Sunnystrasburgretreats.com

The Theradelic Approach: Psychedelic Therapy, Perspective, Preparation, and Practice, by Sunny Strasburg, LMFT, with foreword by Dr, Richard Schwartz, Ph.D.

PsyAssist.com

Wikipedia.org: Stregheria

LSD and the Mind of the Universe: Diamonds from Heaven, by Christopher M. Bache, Ph.D.

Psychedelics Today: Chris Bache – LSD and the Mind of the Universe: Diamonds from Heaven

Psychedelics Today: PT300 – Dr. Richard C. Schwartz – Vital Psychedelic Conversations

Psychedelics Today: PT288 – Annie & Michael Mithoefer – Vital Psychedelic Conversations

Survival of the Richest: Escape Fantasies of the Tech Billionaires, by Douglas Rushkoff

Davidstarfire.com

Imdb.com: Entheogen: Awakening the Divine Within

Melissawhippo.com

Thank You Life is a 501(c)(3) nonprofit organization on a mission to revolutionize mental healthcare and help the world heal by eliminating the financial barriers to psychedelic therapy. Click the link to donate!
Posted on

PT401 – The Self-Entropic Broadening Theory: Understanding The Psychedelic State and Psychosis

In this episode, Joe interviews Ph.D. student in the Drug Use and Behavior Lab at the University of Alabama Birmingham, Haley Maria Dourron.

She talks mostly about the paper she co-authored last year with Dr. Peter Hendricks and Camilla Strauss: “Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis,” which analyzes the long-standing comparisons between the psychedelic state and psychosis, and points out important distinctions between the two – that science should be looking more at the way one processes information and their level of self-focus rather than similarities in outward behavior. She discusses what she calls entropic processing, which is essentially how one’s brain creates novel ideas, relations, and insights based on very loosened mental schemas: with new information being considered in new ways (with no filter), do the connecting pathways that seem like eureka moments actually make sense? 

She discusses the broaden and build theory and the broadening of intentional scope; entropy; chronic LSD use and risk of psychosis; schizophrenia and psychedelics; why science needs to embrace naturalistic research, and more. As of this release date, there are still a few participatory spots left in her current study on the effect of psychedelic experiences on people who have a history of psychosis, so if you had an episode of psychosis at some point and have gone on to use psychedelics, she wants to hear your story.

Notable Quotes

“It’s such a wide open space where there’s still so much room to learn. And to me, it feels as if we’re opening a time capsule of all these different questions that have been kind of covered up, and we now have better technologies to probe what’s really going on.”

“A lot of work was actually done in the 1950s, giving people with schizophrenia LSD, psilocybin, [or] DMT, [and] oftentimes, apparently they had a reduced response. So that just shows how much more room we have to learn what really could be happening with these drugs, what populations necessarily should be excluded, [and] who is actually likely to experience adverse responses.” 

“The acute experience might kind of serve as a catalyst for people creating changes, but then it’s ultimately the changes that they make in their daily lives afterwards, and if they’re putting in the work of building those enduring resources, if you will. It might be [easier] to do so in the immediate afterglow of a psychedelic experience, but you’ve still got to try if you want those enduring effects.”

Links

Researchgate.net: Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis

Scientificamerican.com: LSD May Chip Away at the Brain’s “Sense of Self” Network

Verywellmind.com: An Overview of Broaden and Build Theory

Psychedelics Today: PT245 – Robin Carhart-Harris – Psychedelics, Entropy, and Plasticity

Wikipedia.org: Louis Sass

Iflscience.com: LSD, DNA, PCR: The Strange Origins Of A Biology Revolution

The Myth of Mental Illness: Foundations of a Theory of Personal Conduct, by Thomas S. Szasz, M.D.

Psychedelics Today: PTSF59 – Bipolar and Psychedelics, with Benjamin Mudge

Investigating the Phenomenology and Perceived Mental Health Impact of Classic Psychedelic Experiences in People with a History of Psychosis (her new study – only a few spots left for participation)

Check out Beckley Retreats here, and listen to CEO Neil Markey in episode PT400 here!
Posted on

Psychedelics Weekly – More Trouble For Field Trip Health, Ketamine Wellness Centers Abruptly Close, & The Creation of the Psychedelic Medicine PAC

In this episode of Psychedelics Weekly, Joe and Kyle are back at it, talking about news and what’s going on at Psychedelics Today (applications for Vital close this Sunday, March 26, and we’ve just announced a new neuroscience course!).

Following up on last week’s news that Field Trip Health had closed five clinics, they start with more unfortunate news: that Field Trip is laying off a lot of people, Ronan Levy has resigned as the CEO, trading has been suspended, and the company has obtained CCAA Protection (which, through the Companies’ Creditors Arrangement Act, essentially allows a struggling company a chance to restructure its finances to avoid bankruptcy, all through a formal Plan of Arrangement). And in similar news, all Ketamine Wellness Centers (an Arizona company recently acquired by Delic Holdings) would be closing immediately, with employees let go with little warning or explanation. These stories (and Synthesis Institute’s downfall) highlight the sad reality many of us in the psychedelic space forget: that just because a business is heart-centered and psychedelic-minded, it’s still a business, and businesses need to be profitable to survive. 

Next, they cover Melissa Lavasani and the Psychedelic Medicine Coalition creating the Psychedelic Medicine PAC (Political Action Committee) to get more government funding behind psychedelic research. Members of PMC went to D.C. last week, presenting a psychedelic briefing to begin the process of educating legislators about the realities of plant medicines and psychedelic-assisted therapy (and Joe was there). 

And they discuss more: concerns over Australia’s recent about-face on MDMA and psilocybin being used legally; a recent study where researchers used EEG and fMRI together to record what is happening in the brain while under the influence of DMT (and we should probably have Manesh Girn on again to explain it better than we could); and an interview with Eric Andre at SXSW where, in about 2 minutes, he brilliantly shines a light on drug exceptionalism, the lies of the drug war, and the need for more education on psychedelics – all to a bewildered reporter who didn’t seem prepared to talk to Eric Andre (we are- please come on the podcast!).

Links

Navigating Psychedelics/Beckley Retreats giveaway

Psychedelic Neuroscience Demystified: How Psychedelics Alter Consciousness and Produce Therapeutic Effects

Vitalpsychedelictraining.com

Psychedelicalpha.com: Field Trip Health & Wellness Obtains CCAA Protection

Meetfieldtrip.com: Field Trip Health & Wellness Obtains CCAA Protection

AZfamily.com: Ketamine Wellness Centers in Arizona and across county abruptly shut down

NBCnews.com: Candidates who support psychedelics as medicine get a political action committee

Psychedelicmedicinecoalition.org

Nofallenheroesfoundation.org

ABC.net.au: ‘Serious concerns’ over TGA’s decision making on landmark psilocybin, MDMA ruling

TGA.gov.au: Change to classification of psilocybin and MDMA to enable prescribing by authorised psychiatrists

Pharmala.ca

Interestingengineering.com: Scientists unlock effect of psychedelic drug DMT on the human brain

Pnas.org: Human brain effects of DMT assessed via EEG-fMRI

Vox.com: Wilder Penfield redrew the map of the brain — by opening the heads of living patients

Beyond the Brain, by Stanislav Grof

The Structure of Scientific Revolutions, by Thomas S. Kuhn

Fox26houston.com: Eric Andre talks his love of psychedelics at SXSW

Posted on

PT400 – Beckley Retreats: Combining Modern Science, Tradition, and Holistic Wellness

In this episode, Joe interviews the Co-Founder and CEO of Beckley Retreats, Neil Markey. 

Markey describes Beckley Retreats as comprehensive well-being programs, and talks about the importance of holistic wellness – that, while the retreats are centered around two group psilocybin experiences, the true benefits come from complementary factors: the four weeks of online prep and community building before the retreat, the six days in Jamaica surrounding the experiences, the six weeks of integration work after, and the depth of connections people find in the new community they may not have realized they needed so badly. He breaks down the details of the retreats and what they look for in facilitators, and tells a few success stories that really highlight how trauma, opposing ideas, and an infatuation with material objects and amassing wealth can all get in the way of real relationships and meaning. 

Beckley Retreats is currently working on two new projects: an observational study with Heroic Hearts and Imperial College London on using psilocybin for-traumatic brain injury, and a study with Bennet Zelner and the University of Maryland to bring executives through a retreat to see how it affects leadership and decision-making: can they prove that these types of experiences lead to more heart-centered leaders? 

We are currently running a giveaway where you can win a one-on-one meditation class with Neil and a custom Beckley Retreats tote, as well as many other prizes. Click here to enter!

Notable Quotes

“The problem, a lot of times with Western medicine, is if you can’t understand the mechanics of it, then we kind of discard it, or if you can’t isolate a single variable, then we discard it. It’s like: well, some things work in tandem. If you actually peel the physics back, it looks like everything’s connected to everything, so we’ve got to think about more comprehensive approaches. I think that you can learn a lot from looking at traditional practices and some of the Indigenous wisdom that’s out there; that there’s a method to how this work has been done for quite some time and we shouldn’t disregard it.”

“If we can help people in a clinic model, let’s do that. But [with a] clinic, again: when you take someone, you give them a mystical experience, and then they go right back home or right back to work and right back into life, are you creating enough space for there to be optimal change? I think we need to keep studying it and asking those questions.”

“[Amanda Feilding] never saw a rule that she didn’t want to break. She’s [this] lifelong badass that has just gone against the grain for her entire career. But it was never about money for her, it was all because she thought she could help people. It’s so inspiring. We need more of those stories; less stories about people that made a billion dollars or whatever and more material things, and [more of] these stories about folks that are just out there trying to help others. It fires me up.”

Links

Beckleyretreats.com

Upcoming Beckley Retreats

Beckleyfoundation.org

Psychedelics Today: Amanda Feilding – The Beckley Foundation: Changing Minds through Psychedelic Research

Vetsolutions.org

Heroicheartsproject.org

McKinsey & Company

Beckleywaves.com

Brainyquote.com: H.G. Wells quote (Joe said it was Mark Twain)

Pubmed: The gut microbiome and mental health: advances in research and emerging priorities

Psychedelics Today: PT372 – The Heroic Hearts Project: Veterans and The Impact of Storytelling, featuring: Jesse Gould & Zach Riggle

Psychedelicspotlight.com: Imperial College and Heroic Hearts Launch Psychedelic Research Retreat For Veterans With Head Trauma

Psychedelics Today: PT399 – Vital Psychedelic Conversations, featuring: Bennet Zelner, Ph.D. & Giles Hayward

Maps.org: The Pollination Approach to Delivering Psychedelic-Assisted Mental Healthcare

Synthesisretreat.com: Expansion: Leadership Edition (original leadership study through Bennet Zelner)

Nbcews.com: Candidates who support psychedelics as medicine get a political action committee

Markey with Amanda Feilding
Posted on

Psychedelics Weekly – Field Trip Health Closes Five Clinics, Legalization Bills Introduced in VT, and Ketamine Telehealth Uncertainty

In this episode of Psychedelics Weekly, Joe and Kyle join up once again to discuss the news and articles they found the most interesting this week. 

They start with the business news everyone is talking about: Field Trip Health & Wellness closing 5 of their clinics due to financial struggles (a deficit of $48.7 million since their inception and a net loss of $6.9 million reported for the last quarter), little confidence they’d be able to receive more funding, and the changing landscape of ketamine telehealth now that the Covid Public Health Emergency should finally come to an end in May. They also highlight an article dissecting the collapse of Synthesis Institute and the lessons to be learned, with both stories really showing just how new and unstable psychedelic business still is, and how the allure of first-mover advantage can be a dangerous gamble.

They also discuss four drug reform bills introduced in Vermont: two of which would decriminalize simple possession of all drugs, making a “personal use supply of drugs” a civil offense with a $50 fine; one removing penalties for using or selling psilocybin; and the last decriminalizing certain psychedelic plants and fungi. 

And they look at a research study aiming to learn more about people’s lives after they’ve been involved in a clinical trial, Time Magazine’s article about psychedelics and couples therapy, and a study that found that while 64% of survey respondents said at-home ketamine helped their symptoms, 55% (and 58% of Millennials) said they used more than the recommended dose – either by accident or on purpose.

Links

Investorsobserver.com: Field Trip Health to Close Ketamine Clinics as it Struggles to Find Profits

Meetfieldtrip.com: Field Trip Health & Wellness to Close Clinics in 5 Locations

Meetfieldtrip.com: Field Trip Health & Wellness Provides Business Update and Reports Fiscal Third Quarter 2023 Results

Harrisbricken.com: Good News for Ketamine Telehealth

Ecstaticintegration.substack.com: Synthesis and the shadow of psychedelic capitalism

Opb.org: Most students will continue with Oregon psilocybin program that ran out of money, new provider says

Twitter: @Eddietalksdrugs(Have you participated in a clinical trial involving #psilocybin-assisted psychotherapy? How has life been after the trial? Contact psychedelic.experiences@psych.ox.ac.uk for more information.)

Psychedelics Today: PT302 – Dr. Adele Lafrance – Vital Psychedelic Conversations

Boingboing.net: Oregonians work to make psychedelic psychiatric care a regulated, safe practice

Time.com: Psychedelics Could Revolutionize Couples Therapy

Psychedelicspotlight.com: Vermont Lawmakers File Bills To Legalize Psychedelics And Decriminalize All Drugs

Marijuanamoment.net: Vermont Lawmakers File Bills To Legalize Psychedelics And Decriminalize All Drugs

Legislature.vermont.gov: H.439

Legislature.vermont.gov: S.114

Dancesafe.org

Psychiatrictimes.com: Report Reveals More Than 50% of Americans Misuse At-Home Ketamine

Plusapn.com: 2023 Future of Mental Health: Ketamine Therapy Report

NYtimes.com: A Fraught New Frontier in Telehealth: Ketamine

Painnewsnetwork.org: New CDC Guideline: Too Little, Too Late for Chronic Pain Patients

The Stories of Vital 2022-2023 | Psychedelic Therapy Training

Posted on

PT399 – Vital Psychedelic Conversations

In this episode, David hosts another Vital Psychedelic Conversation, this time with Bennet Zelner, Ph.D.: Vital instructor who teaches economics at the University of Maryland Smith School of Business; and Giles Hayward: Vital student and Co-Founder of Woven Science (a company backing and building psychedelic and wellness tech companies) and El Puente, which focuses on Indigenous biocultural preservation.

Zelner believes that the traditional capitalist system we’ve grown accustomed to is an extractive and predatory one directly in opposition to a natural system we should be striving to emulate – one that circulates resources and exits largely in equilibrium with its different parts. His concept of the Pollination Approach (or regenerative economics) is about developing economic structures that are capable of balance: where communities are built to directly benefit each other and where businesses are structured to share resources and capital to all involved. In a hyper-individualistic system where loneliness and never feeling good enough are key drivers of depression, anxiety, and trauma, how could we not benefit from feeling more connected to each other, our communities, and the businesses that exist within them? 

They talk about different ways the pollination approach could be applied; how psychedelics disrupt these broken systems; how we can make these treatments affordable; and why we should be focusing on the delivery and integration of substances rather than creating new ones. And since Hayward is about to graduate from Vital’s inaugural run, he shares his feelings on the program and how it fell into this concept of regenerative economics. 

The application deadline for this year’s Vital has been extended to March 26, but this will be the last extension. So if you’re interested, now is the time to apply!

Applications are open until March 26 for the second edition of Vital, our 12-month training certificate program in psychedelic therapy and integration, beginning in April 2023. Head to Vitalpsychedelictraining.com for more info.

Notable Quotes

“Our connection to each other and to the natural world, I think, is undeniable. To argue that our individual well-being does not depend on the health of the natural systems that we depend on for food, for air, [and] for water is just folly. …I think that deep down, everybody actually knows that we’re connected, and we’ve just been taught to forget that by many cultural forces. I think psychedelics can help us remember this innate wisdom.” -Bennet

“If we go back thousands of years, our pagan ancestors believed in animism. We believed and saw that there was a spirit and an essence in everything. And yet today, through this reductionist mindset (ever since Descartes said, ‘I think, therefore I am’), we have gone on this odyssey which has fortified this belief that we live in a separate existence, a separate world where there’s no room to see the world around us as being alive [and] full of spirit. …If we’re able to see the world as alive, [and] we’re able to develop an intimate relationship with all things around us, one might think that these feelings of loneliness could dissipate somewhat.” -Giles

“The principles of nature are sacred. Whether we like it or not, we live in a world of natural systems, and if we’re unwilling to behave in a way according to the principles of natural systems, then the natural systems will survive. We’re the ones who will not.” -Bennet

Links

Maps.org: The Pollination Approach to Delivering Psychedelic-Assisted Mental Healthcare

DoubleBlind Magazine: Regenerative Patterning Psychedelic Pharma Has Arrived. Will It Be Able To Break Out Of An Outdated And Extractive Medical Model?

Psychedelics Today: PT221 – Bennet Zelner – The Pollination Approach

Woven.science

Foundationelpuente.org

Foundersfactory.com

NPR.org: Atomic Tune-Up: How the Body Rejuvenates Itself

Springer.com: The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world

Allpoetry.com: “Everything is waiting for you,” by David Whyte

Vanityfair.com: How PTSD Became a Problem Far Beyond the Battlefield

Bowling Alone: The Collapse and Revival of American Community, by Robert D. Putnam

Thealchemistskitchen.com

Posted on

PT398 – Lost Civilizations, DMT Entities, & Altered States of Consciousness and Early Religion

In this episode, Joe interviews Graham Hancock: legendary bestselling author and writer and presenter of the new Netflix docuseries, “Ancient Apocalypse,” where he travels the world looking for evidence of lost civilizations likely much more advanced than historians previously believed.

Hancock talks about his early books and how ayahuasca influenced his writing; the similarities in cave art and the common link of altered states of consciousness; how integral these states likely were toward the creation of early religion (especially Christianity); how much the annihilation of religious traditions has hidden history; why his and Rupert Sheldrake’s Tedx talks were originally taken offline; new understandings of Neanderthals’ intelligence and creativity; the Quetzalcóatl; and the concept of the Younger Dryas impact hypothesis: could there have been an advanced civilization 12,800 years ago that we’re just starting to comprehend? Could it have been Atlantis? 

He discusses the conflict with mystery and archaeology’s obsession with scientism and materialist reductionism – that we keep trying to force everything into little boxes of approved science and have lost our imaginations and openness to possibility, especially when you realize how often narratives are built based on interpretations of data rather than facts (since the farther back we go, evidence becomes harder to come by). He believes science needs humility, a willingness to listen to Indigenous history, and a much more open mind when it comes to altered states of consciousness: “I’m convinced we’re missing something important from our past, and if we don’t look for it, we won’t find it.

Hancock has just announced that he will be a speaker at UK’s Breaking Convention, April 20 – 22 at the University of Exeter, and some of the PT team will be there too! To save 10% off tickets, use code PSYCHTODAYBC10 at checkout.

Notable Quotes

“I think there’s a huge amount of genuine mystery in the past, and there’s an attempt by archaeologists to explain away that mystery, …to just drain the past of mystery and to leave nothing there except dry facts (supposed facts) as archaeologists claim, but which, when you dig deep enough, you find are actually interpretations of limited data sets. I don’t know why archaeologists just want the past to be so boring. …Of course there’s a need for rigor and discipline, but there’s also a need for imagination and openness of mind when it comes to interpreting our collective past.”

“Those paintings included the same geometric patterns and the same therianthropic entities construed in slightly different ways, but clearly the same kind of encounter is being documented in the cave art from 30 or 40 thousand years ago and is being documented by shamans in the Amazon rainforest today. And what’s the common factor? The common factor is altered states of consciousness.”

“With extended release DMT, volunteers are going into the DMT state for an hour and they’re making remarkably homogeneous reports about entity encounters and about the space in which they encounter those entities. One reasonable supposition has to be: there are many possibilities for this, but when people from all over the world see the same things [and] have the same encounters in the same sort of space, you have to consider the possibility that that space is real in some way that our science doesn’t recognize.”

“Psychedelics and experiences in altered states of consciousness have actually been foundational and fundamental to human culture, and by pretending that they’re not, as we’ve been doing for the last 50 years, we’re making a huge mistake. We have to change that outlook and welcome and embrace what these gifts of the universe have to give us.”

Links

Grahamhancock.com

Netflix: Ancient Apocalypse

Fingerprints of the Gods – Evidence of Earth’s Lost Civilization

Journey Through Pakistan

Ethiopia: The Challenge of Hunger

AIDS: The Deadly Epidemic

Lords of Poverty

African Ark: Peoples of the Horn

Supernatural: Meetings with the Ancient Teachers of Mankind

Visionary: The Mysterious Origins of Human Consciousness (The Definitive Edition of Supernatural)

Underworld: Flooded Kingdoms of the Ice Age

A-Z-animals.com: Denisovan vs Neanderthal: What’s the Difference?

The Mind in the Cave: Consciousness and the Origins of Art, by David Lewis-Williams

​​The Immortality Key: The Secret History of the Religion with No Name, by Brian C. Muraresku

Psychedelics Today: PTSF 35 (with Brian Muraresku)

Interestingengineering.com: Mysterious disappearance of megafauna: why humans may share the blame

Cometresearchgroup.org

YouTube: Graham Hancock – The War on Consciousness BANNED TED TALK

TEDBlog: Open for discussion: Graham Hancock and Rupert Sheldrake from TEDxWhitechapel

Psychedelics Today: PT381 – DMT, Hierarchies of Complexity, and Reality Switch Technologies, featuring: Dr. Andrew R. Gallimore

Reality Switch Technologies: Psychedelics as Tools for the Discovery and Exploration of New Worlds, by Andrew R. Gallimore

Britannica.com: Quetzalcóatl

The Structure of Scientific Revolutions, by Thomas S. Kuhn

Posted on

Psychedelics Weekly – Drug-Free Digital Trips, The Prevalence of Challenging Experiences, and the End of Synthesis Institute

In this episode of Psychedelics Weekly, David is joined by Kyle, who is finally home after a lot of traveling, to talk shop and dig into the articles they found the most interesting this week. 

They begin with the news that Paul Stamets now has a species of mushroom named after him (Psilocybe stametsii), then take a look at a recent self-report study called “Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics,” which aimed to collect data on just how many psychedelic users (in this study, anyone who had ever tried a psychedelic) felt that they had had a challenging or difficult experience. They discuss the results and highlight some interesting data: that LSD was the most commonly associated substance, that smoking cannabis was one of the most commonly reported interventions, and of course, the question of whether or not these experiences were beneficial. 

They then talk about Synthesis Institute closing its doors, the possible hope Synthesis could have, and the sadness in this – when businesses fail, it’s easy to look at numbers and profit margins and be dismissive, but we forget the people involved; not just at Synthesis, but the hundreds of would-be students. 

And lastly, they look at an article about a California-based startup called the Reality Center, which uses a combination of pulsing lights, sounds, and vibrations to create a drug-free but seemingly very psychedelic experience, reminding us yet again that you do not need a substance to achieve  non-ordinary states of consciousness.

Links

Forbes.com: There’s A New Species Of Magic Mushroom – Named After Paul Stamets

Graham Pechenik’s thread about the Stamets Stack becoming patented

Breakingconvention.co.uk

Fantasticfungi.com

Biomedcentral.com: Ketamine can be produced by Pochonia chlamydosporia: an old molecule and a new anthelmintic?

Mushroom.cat: Psilocybe Weilii: Good for Making Magic Mushrooms? Don’t Mistake It With Psilocybe Caerulescens

Psychedelics Today: PT377 – Integrative Medicine: Health, Wellness, and Psychedelics, featuring: Andrew Weil, M.D.

Sciencedirect.com: Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics

Psychedelics Today: PT314 – Daniel McQueen, MA – Vital Psychedelic Conversations

Psychedelicalpha.com: Inside Synthesis Institute’s Implosion

Retreat.guru

Oregon.gov: Higher Education Coordinating Commission

Stripes.com: A drug-free, digital psychedelic trip

Realitymgmt.com

Lucialightexperience.com

Psychedelics Today: Allison Pelissier – Lucia N°03 Light Experience

Psychedelics Today: PT394 – We Are The Medicine, featuring: Victor Alfonso Cabral, LSW

Pictureacolorfulworld.com

Posted on

PT397 – Vital Psychedelic Conversations

In this episode of Vital Psychedelic Conversations, David interviews Vital instructor, Dr. Devon Christie: Senior Lead of Psychedelic Programs at Numinus, MAPS-certified MDMA therapist, and now four-time guest; and Vital student, Emefa Boamah: coach, facilitator, and trauma-informed intuitive guide specializing in embodiment. 

We’ve all heard the trope, “It’s all in your mind,” but it’s also in your heart, soul, community, support system, and body – the focus of this episode. Christie and Boamah dive deep into the various aspects of the relationship between non-ordinary states and our bodies: ways to embody our bodies more; how the body is a fundamental source of truth; the benefit of checking in with one’s body after an experience (to validate or disprove what may have come up); the importance of movement and rest; the different bodies we inhabit (physical, emotional, energetic, mental, and spiritual); and ways to accept (and eventually love) our bodies in a society that’s always working to make us hate them – is self-love the ultimate act of defiance?

They also discuss the post-experience plasticity in everything, and the challenge of preparing an experiencer for something we can’t know; how facilitators and practitioners need to track their own subconscious feelings and reactions; the concept of embodied inquiry; the necessity of remaining curious and humble; and the idea of using integrative practices to find ways to become the person you want to be – the person you may have seen glimpses of in non-ordinary states. 

And as this year’s edition comes to an end, Boamah reflects on her experiences with Vital, particularly the communal aspects of the retreat and how healing it was to literally be lifted up by her companions. If you’re curious about whether Vital is right for you, please come to an upcoming Q+A. Applications close March 26!

Applications are open for the second edition of Vital, our 12-month training certificate program in psychedelic therapy and integration, beginning in April 2023. Head to Vitalpsychedelictraining.com for more info, or attend a Q+A to have your questions answered.

Notable Quotes

“Something happens with plant medicines (psychedelics (for me, with mushrooms)) that just takes you out of it and you see the inherent worth of who you are as a human, as a person. And integrating that process after coming out, I think, does a lot to help with self-love – not to say that cannot be attained without psychedelics, but it’s a different quality to it when you’re able to see yourself outside of yourself and see that you’re just valuable as you are.” -Emefa

“Not only are we fighting against us as human beings (like, whatever is happening internally), there’s also the societal expectations of how we ought to be. …There’s all these things where society is bent on making sure that we don’t feel comfortable in our bodies, so for me, from that lens, self-love is an act of reclamation. It’s like a defiant political act to reclaim who we are as people and spend that inherent worth without buying into what we’re being told to do, unapologetically – like, own it: ‘This is who we are and this is where we come from and we get to take space.’” -Emefa

“Those strongly reinforced habits: they restrict what we can attend to. They restrict our perception. So when they’re loosened under a psychedelic, we’ve got all these dimensions of experience that we can suddenly experience. That’s where, I think, not only in preparation, but in how we meet and attend to the emergent experience of people in psychedelic experiences, as practitioners, we need to be fluent ourselves in our own dimensions of experience of our being, so that we can meet and be curious and inquire and help that person to come to know themselves in all of that dimensionality, and then for their meaning to percolate up from that place.” -Devon

“The wisdom of ceremony, community ceremony, dance, music: that brings connection, that brings rhythm. And one nervous system by itself in the face of trauma is very vulnerable, many nervous systems together in the face of trauma: there’s resiliency. …Thankfully, in many ways, psychedelics help us to perceive this, and then in each person, perceive: ‘What’s the truth for me in this?’ and then we can try to live that.” -Devon

Links

Drdevonchristie.com

Numinus.com

Psychedelics Today: PT391 – MDMA-Assisted Psychotherapy For Fibromyalgia and Other Central Sensitization Syndromes, featuring: Dr. Devon Christie & Dr. Pamela Kryskow, MD

Psychedelics Today: PT306 – Dr. Devon Christie – Vital Psychedelic Conversations

Emefaboamah.com

Drdansiegel.com: An Introduction to Interpersonal Neurobiology

Pubmed: REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics

Psychedelics Today: PT328 – Courtney Watson, LMFT – Ancestral Veneration and Psychedelic-Assisted Therapy For (and By) QTBIPOC

Rest Is Resistance: A Manifesto, by Tricia Hersey

Methodspace.com: Embodied Inquiry as a Research Method

Imdb.com: Doctor Strange

Vitalpsychedelictraining.com

Posted on

PT396 – Moms on Mushrooms: Motherhood and Psychedelics Inside a Broken Culture

In this episode, in celebration of International Women’s Day, Victoria interviews Tracey Tee: co-founder and CEO of Band of Mothers Media, co-producer and co-host of the Band of Mothers podcast, and founder of Moms on Mushrooms, an online educational community for psychedelic-curious moms outside the prying eyes of social media.

With similar histories of womb trauma, self discovery, and body reconnection, Victoria and Tracey discuss the complications of motherhood, substance use and embracing psychedelics in a broken culture, in which engaging with small, approved coping mechanisms is fine – where the “wine mom” archetype and numbing yourself with medications is celebrated, but where we don’t often talk about how challenging motherhood can really be, and the lasting mental, physical, and spiritual impacts of birth, loss, and grief. Tracey’s goal with Moms on Mushrooms is to bring mothers together for personal growth, healing, and most of all, for the safe, supportive container that so many women considering plant medicine need.

She tells her story of creating and performing “The Pump and Dump Show” and the psychedelic journeys that led her to creating M.O.M., and discusses much more: how those large dose journeys reconnected her with her body; how microdosing has helped her feel more vulnerable, honest, and in tune with her daughter; how psychedelics can help parents realize where problematic core beliefs came from; how teaching children the ways of the world forces parents to confront and reaffirm what they truly believe; and the challenges mothers face in even talking about wanting to try psychedelics.

If you’re a mother and this episode resonates with you, check out Tee’s Microdosing 101 (for moms) course or join the Moms on Mushrooms community for $4.44 a month.

Notable Quotes

“Had I not had this divine intervention, I think I would have been pretty stubborn, which I can tend to be. I would have not wanted to be vulnerable with my daughter because I think I was raised to say that that wasn’t something that is good or that I should show – I’m a parent: ‘My way is the highway.’ Instead, I’m much softer. I ask for forgiveness, I tell her when I screw up, I admit my mistakes, [and] I ask her what she thinks. I always talk about Old Tracey and New Tracey (Old Tracey and ‘Shroom Tracey’): Old Tracey would have never been like that, and I think that’s a real gift, because in asking forgiveness [and] in admitting my mistakes, I’m changing.”

“What is the most upsetting to me is the fear, like this push/pull of hearing either my story or your story or reading How to Change Your Mind or watching a Netflix thing and saying: ‘My soul is telling me this makes sense, my soul is telling me to give this a shot. I might have a way out of this,’ and then my head is like: ‘You cannot do this. You’re a bad person, this is shameful, you might die (which is ridiculous) and at the very least, your children will be taken away from you.’ And that is why I’m talking to you, because that has to stop. It has to stop.”

“I don’t love rehashing the past. I don’t love carrying victimhood, but I am sad for what I lost. And when I work with the medicine (again, intentionally, safely; all the things that we’ve been talking about), I am shown, piece by piece, [that] I’m calling all those parts back. And it’s not easy, but it’s like I’m rebuilding. I’m like a Lego project right now, and I would never be able to do that without the shrooms.”

Links

Momsonmushrooms.com

Bandofmothers.com

Band of Mothers podcast

Thepumpanddumpshow.com

Psychedelics Today: Webinar – A Somatic Perspective on Sex & Psychedelics: Focusing on Consent and Repressed Sexual Trauma Memories

Psychedelics Today: Reclaiming Ownership of Your Body With Psychedelics, by Jessika Lagarde

Psychedelics Today: PT236 – Drugs: Honesty, Responsibility, and Logic, featuring: Dr. Carl Hart

Posted on

Psychedelics Weekly – Cannadelic, Concussions, Vital, and More PT News

In this episode, Psychedelics Weekly is back after a brief hiatus (everyone was either traveling or sick last week!), with the OG PT team: Joe and Kyle. 

With the exception of some commentary on John Oliver’s recent piece on psychedelics (which was excellent), they skip the psychedelic news this week in favor of Psychedelics Today news, as a lot has been going on!

In the last few weeks:

Joe sustained a traumatic brain injury and a broken arm;

Joe, Kyle, and Victoria attended PT’s first Cannadelic in Miami, where Joe and Kyle moderated or sat on several panels, Kyle and Victoria went and saw Afroman, and we won the Psychedelic Brand of the Year award(!);

Joe experienced a music festival in different ways (completely sober, and somewhat still in a concussion daze) and did some interesting research on psychedelics and post-concussion effects;

Despite Joe and Kyle both getting sick and not being able to attend all of it, the last Vital retreat was an amazing one, capping off a year of incredible content and connection that is only fueling the fire to make this year’s Vital even better;

And, due to issues beyond our control with the planned venue and the City of Los Angeles, we had to cancel Convergence.

Phew! As promised, lots going on! 

Links

Cannadelic.miami

Shoulderdoc.co.uk: Greater Tuberosity Fractures

Psychedelics Today: PT371 – The Trickster Archetype and the Need for Comic Relief, featuring: Dennis Walker

Drug Use for Grown-Ups: Chasing Liberty in the Land of Fear, by Dr. Carl L. Hart

Psychedelics Today: PT393 – Religious Freedom and the Church of Psilomethoxin, featuring: Greg Lake, Esq.

OGafroman.com

Evilbonewater.com

Bravenewweed.com: Ep115 – The Great Delta-8 Debate: Is it Safe, Legal, or an Interesting High?

Tigerfiberhemp.com

Everland.co

Woodbinecenter.org

YouTube: Psychedelic Assisted Therapy: Last Week Tonight with John Oliver

Vitalpsychedelictraining.com

Posted on

PT395 – Thank You Life: Accessibility, Fair Compensation, and Trusting Intuition

In this episode, David interviews Kevin Cannella, LPC: MAPS-trained psychedelic psychotherapist and Co-Founder and Executive Director of Thank You Life, a nonprofit organization working to provide access to psychedelic therapy by eliminating its financial barriers.

Co-Founded by Dr. Dan Engle, Thank You Life is very new and still in the process of officially launching, having just obtained 501(c)(3) status in December and recently gaining its first corporate sponsor in Dr. Bronner’s. The nonprofit came from the realization of just how expensive psychedelic-assisted therapy can be, and Cannella wondering: what if there was a fund practitioners could plug into when a patient couldn’t pay? While access for the patient is obvious, this model benefits the practitioner as well, which is something not often discussed in the psychedelic space – we focus a lot on how much these services will cost the patient, but rarely on the practitioner deserving to be paid fairly for their time and expertise. 

Cannella tells his story of immersion into a world of ayahuasca, yoga, and vipassana meditation; volunteering at the Temple of the Way of Light, living in Hawaii, then Brazil, and finally, landing at Naropa University, where his passions were finally validated. He discusses looking for signs and learning to trust intuition, ways to increase accessibility outside of a 501(c)(3) model, how it feels to be paid well for your work, and why he only wants to work with practitioners who offer therapy alongside their chosen substance.

Head to their website to donate to the Thank You Life fund, and follow them on socials for details on upcoming launch/fundraising events in April and May, including a public event at the also-new California Center for Psychedelic Therapy. For larger donations or partnership inquiries, email kevin@thankyoulife.org.

Notable Quotes

“If the client couldn’t pay, the financial burden was falling on the therapist or the clinic, although a lot of what was in my field was just therapists in private practice. Therapists can take some sliding scale people, maybe they even do some pro bono, but they still need to make a living and they can’t just be giving away their hours and their time. So this sort of Utopian thought was like: wouldn’t it be great if there was just a fund that we could all plug into, and then that fund could take the financial burden, and we could just be saying yes to the people that we want to be saying yes to?”

“What it feels like in my body when I would do a session for $70 compared to $150: it’s different. It’s different to get paid well. It’s a different energetic experience to get paid well. And I have so much more to give when I’m getting paid well, because I’m not burdened by feeling undervalued and feeling like I’m in this uphill battle with making a good financial living for myself and my family.”

“I think it can be one big shift in the whole way our culture looks at mental health if it becomes a standard that employers offer psychedelic-assisted psychotherapy for trauma healing. I mean, what a shift that that would bring, just on its own. …How different would it be if not only could you share with your boss that you got a ketamine treatment, but that the company was actually paying for it and saying, ‘Yes, go get your healing.’?”

Links

Thankyoulife.org

Pinchbeck.io

Templeofthewayoflight.org

Naropa.edu

Psychedelics Today: PT248 – Pierre Bouchard – Somatic Therapy, Trauma, and the Nervous System

Psychedelics Today: PT376 – Ketamine and Psychedelic-Assisted Therapy as Employee Benefits, featuring: Sherry Rais

Vital: Diversity, Equity & Inclusion Tuition Scholarship Access Fund

Psychedelics Today: PT367 – Colorado Proposition 122 and the Decriminalization of Natural Medicines, featuring: David Bronner

The Educational Foundation of America (EFA)

The California Center for Psychedelic Therapy

Psychedelics Today: PT224 – Dr. Dan Engle – The Concussion Repair Manual

Mayahealth.com

Donate to Thank You Life

Posted on

PT394 – We Are The Medicine

In this episode, David interviews Victor Alfonso Cabral, LSW: Director of Policy and Regulatory Affairs at Fluence Training and Licensed Social Worker and practicing psychotherapist in Pennsylvania.

Cabral is currently involved with the film, “We are the Medicine,” which aims to explore the reemergence of plant medicines from the perspective of people of color from all backgrounds and walks of life, with the added factor of a strong hip hop influence. Filmmakers Eric Blackerby and Esteban Serrano want the film to normalize the concept of psychedelics and healing for people of color, but also the notion of men being truly authentic with each other and building each other up with love and support – something that challenges society’s expectations on how men (and more specifically, Black and Brown men) should be in relationships with one another. Head to pictureacolorfulworld.com to donate and sign up for the mailing list for more info on future fundraisers and screenings. 

He begins the episode by reading a powerful poem he read at Horizons NYC, then tells his story: his childhood and his mother’s sacrifices; how trauma caught up to him in college and led to the low point of his life; his subsequent 120-pound weight loss journey and embracing of therapy, how his first psychedelic experience resulted in an awakening of possibility; how he became a social worker and why he felt instantly aligned with the work; how he ended up working for PA Governor Tom Wolf; and how he came to be interviewed by Sway Calloway (who is also an Executive Producer of the film). His story and all of the organizations and efforts he’s been involved with prove that being authentic, following your heart, and building relationships with the right people can lead to growth and positive change in whatever path you choose in this space. 

Notable Quotes

“Social work felt like I finally had language to describe the way in which I’d been living and being most of my life, and it felt validating to have this whole profession dedicated to the way in which I felt I was showing up in the world already.”

“After that experience, I felt like there [were] possibilities for me to be whatever I wanted to be, and that I wasn’t everything that had been prescribed to me through intergenerational trauma or systemic oppression or a capitalist society. And I was able to peel those things back one by one and see: okay, what’s under this? And what’s under this? And then when I got to the core of that, the message to me was: love is what matters. So that really made me feel like I do have everything that I need. I have my wife, I have my daughter, I have a family, I have good friends, I have my health. And I have ability to manifest, to do, to plan, to live. I’d been doing a lot up until that point to get my life on track, but that opened up the doors in a way that I didn’t think was possible for me, where I felt a kind of freedom that I’ve never felt before in my life.”

“When we talk about collective healing and about empowering our communities and about joy and freedom and liberation, I think it’s important for us, as men of color – for me and for the people that I love and the people around me – to be liberated, to just love each other and to be together, and to be able to be their authentic selves together without all of these other masks that we’re taught to wear. So I hope that if there’s anything that comes out of the film, [it’s] a message of what we can co-create when we can be our authentic selves with each other and hold each other up and love each other.”

Links

Pictureacolorfulworld.com

Fluencetraining.com

Tiss.edu: Tata Institute of Social Sciences

Indiafellow.org: Who Are The Katkari?

YouTube: Sway’s Universe: Can Psychedelics Help Black and Brown and Indigenous People Heal Trauma?

YouTube: “Symbol of Solidarity” Documentary Trailer

Resilientpa.org: 2022 Day of Racial Healing Recap

Ninawasi.com

Psychedelicsiceland.com

Imdb.com: “Down to Earth, with Zac Efron”

Marijuanamoment.net: GOP Pennsylvania Lawmaker Files Psilocybin Research Bill For Veterans And First Responders

Reason-for-hope.org

Centerforpsychedeliceducation.com: Press Release: PA Psychedelic Education Day

Philadose.com

Posted on

PT393 – Religious Freedom and the Church of Psilomethoxin

In this episode, Joe interviews Greg Lake, Esq.: Co-Founder of the Church of Psilomethoxin, author, and trial and appellate attorney specializing in working with entheogen-based religious practitioners in establishing their right to consume their sacraments under existing religious freedom laws.

Psilomethoxin (4-Hydroxy-5-methoxydimethyltryptamine or 4-Hydroxy-5-MeO-DMT) was first synthesized in 2021 by mixing 5-MeO-DMT with psilocybin substrate, and after initial tests and months of user reports, it was deemed safe to use.* Lake co-founded the Church of Psilomethoxin in 2022 with the goal of shifting the paradigm of religion to primary direct experiences and individual beliefs rather than a dogma everyone must follow, with a big focus on community and discussing the ultimate questions of life together – with Psilomethoxin as the sacrament of choice. While he prefers member-to-member referrals, there is an application on the site, and he hopes to grow the church through linking people up regionally, (eventually) training people to facilitate, and partnering with a data collection company to gather real-world data on both Psilomethoxin and on why people are seeking out psychedelic churches in the first place. 

He discusses several cases that brought us here and inspired his work; why he believes Psilomethoxin won’t be a target of the Federal Analogue Act; the Religious Freedom Restoration Act (RFRA) and the need for states to establish similar state legislation; the importance of new churches establishing evidence in the public record; how much courts take sincerity into consideration; and the concept that, while we’re quick to think of the law as the enemy, courts often don’t want to go after churches – religion is a sacred and intimate thing, so who is the victim if a court brings a church to court that hasn’t harmed anyone?

*Update, April 17, 2023: Results from analytical testing released on April 12, 2023, reveal that there is no evidence to suggest the compound psilomethoxin is present in the samples of sacrament material the Church of Psilomethoxin is offering to their members online. The report, prepared by Samuel Williamson and Alexander Sherwood of the Usona Institute, states, “Psilocybin, baeocystin, and psilocin, were, however, unambiguously identified in the sample, suggesting that the claims regarding the biosynthesis of psilomethoxin may be misguided. The implications of these findings should be critically considered within the context of public health and safety.”

We are following this story at Psychedelics Today and are working to update our community with commentary from the researchers. Stay tuned to our social media channels for more on this topic.

Notable Quotes

“I think eventually the courts will come around to realize that where medical and scientific and religious and spiritual begin or end within this space is not crystal clear, because as we’re all aware, in the research, people, even in clinical settings, are having mystical, religious experiences. And then they see that that really, at many times, translates to positive outcomes. If people, even in a medical setting, can have a religious experience, well then where does ‘This is a religious exercise, this is not’ come into play?”

“One of our core beliefs is that in the peak entheogenic experience like 5-MeO, where you experience unitive cosmic consciousness, that’s basically our moral code – that once you experience unity with all, that tells you pretty much everything that you’ll ever need to know about how you should be treating other people, how you should be treating other beings, and how you should be treating the environment.”

“One thing I’ve learned (and I learned real quick working with these churches) is that, especially post-Covid, the community, for a lot of people, is just as, if not more healing and spiritual than the actual ceremonies.”

Links

Psilomethoxin.com

*Psychedelicalpha.com: Opinions | The Church of Psilomethoxin: Fantasy Chemistry Gets Fact Checked

*Chemrxiv.org: Fungi Fiction: Analytical Investigation into the Church Of Psilomethoxin’s Alleged Novel Compound Using UPLC-HRMS

Entheoconnect.com

Psychedeliceducationcenter.com: Psychedelics and Religious Liberty in the United States

Wikipedia.org: 4-Hydroxy-5-methoxydimethyltryptamine

Cognitiveliberty.org: Ask Dr. Shulgin Online (Shulgin’s response to a question about Psilomethoxin)

Tripsitter.com: What Is the Federal Analogue Act?

Quantifiedcitizen.com

Psychedelics in Mental Health Series: Psilocybin, by George G. Lake Esq.

Law.justia.com: United States v. Meyers

Wikipedia.org: Religious Freedom Restoration Act

Wikipedia.org: Employment Division v. Smith

Wikipedia.org: City of Boerne v. Flores

Wikipedia.org: State Religious Freedom Restoration Acts

Law.justia.com: New Hampshire v. Mack

Leary.ru: Timothy Leary: Start Your Own Religion

Justia.com: Church of the Eagle and the Condor et al v. Garland et al

Psychedelics Today: Psychedelics, Religion, and the DEA’s Quest for Soul

Casetext.com: Ariz. Yage Assembly v. Garland

Cannadelic.miami

Posted on

PT392 – Vital Psychedelic Conversations

In this episode of Vital Psychedelic Conversations, Kyle interviews Carla Kieffer: psychedelic educator, Certified Psychedelic Facilitator, Community Liaison at Maya Health, and Founder of Kairos Integration, a company offering psychedelic training, preparation, facilitation, integration, and microdosing support.

This episode was recorded in-person, in between the first and second psilocybin retreats at Atman Retreat in Jamaica, where Kyle, Johanna, and a large group of Vital students just worked with Carla last month. Many participants that attend retreats are new to psychedelics, and often don’t know each other, so it was powerful to have a group of classmates follow the breathwork model of having sitters and journeyers take turns (which is the same model she uses for her Psychedelic Guide Training and Certificate Program), and demonstrates how much one can learn when taking the role of the sitter and how the journey becomes the teacher. They talk about how big the therapy part of psychedelic-assisted therapy is, in how rare it is to have someone attending to your every need for hours on end, and wonder: How can we take that aspect of holding space for each other and apply it to everyday life?

She discusses the importance of data collection and how her Internal Family Systems training has helped her balance her love for the mystical with her more science and data-based mind; the importance in facilitators meeting some sort of baseline harm reduction and safety training (and the need to establish an agreed-upon set of standards); the need for increased accessibility; how important it is to further educate about and normalize conversations about psychedelics; and how integration isn’t just a box you check off as part of the experience, but a continuous process and part of our lives, where checking in on ourselves should be a regular practice.

Notable Quotes

“If we could hold space for each other to have our own experiences, I think there might be a lot of learning on both sides.” 

“The medicine is one part, but it’s also that experience of being held in a container – being heard, being witnessed. I think we also have to acknowledge that about this type of work. Even if it is individual therapy, if it’s psilocybin or MDMA-assisted [therapy]: when do you have somebody just there for you for six hours, giving so much attention to every little need? Does that have a healing quality to it?” -Kyle

“How can you do that in your life: show up for people in support and name what you need and really feel held by each other? I have visions of communities and spaces as we move forward with psychedelics and psychedelic awareness, where people can actually actively listen and avoid the need to interject, and any competitive talking goes away. …I think that, in turn, will reverb into the rest of the world.”

“In the end, you are the medicine. Whether you’re working with psilocybin or LSD or breathwork, these are just ways to access your true self, your higher self (whatever resonates for you), and really, as you move through life, as you have these journeys, whatever they may be, just continuing to integrate that into your life, integrate that into your higher self.”

Links

Kairosintegration.com

Kairos Integration linktree

Atmanretreat.com

Vital Psychedelic Training

Being True To You Coach Training Program

Mayahealth.com

IFS-institute.com

Zendoproject.org

Oneretreatsjamaica.com

The University of Texas at Austin Dell Medical School Center for Psychedelic Research & Therapy

Imdb.com: Fantastic Fungi

Psychedelics Today: PT293 – Stanislav & Brigitte Grof – The Evolution of Breathwork and The Psychology of the Future

Greathimalayannationalpark.org: Parvati Valley

Bakertilly.com: How Section 280E is hindering the cannabis industry

Psychedelics Today: PT271 – Jeremy Narby, Ph.D. – Anthropology, Ayahuasca, and Plant Teachers

Posted on

PT391 – MDMA-Assisted Psychotherapy For Fibromyalgia and Other Central Sensitization Syndromes

In this episode, Joe interviews Dr. Devon Christie: Senior Lead of Psychedelic Programs at Numinus, educator at CIIS and Vital, and MAPS-certified MDMA therapist; and Dr. Pamela Kryskow, MD: founding board member of the Psychedelic Association of Canada and Medical Lead of the nonprofit, Roots To Thrive.

Christie and Kryskow recently co-authored one of the first papers looking at MDMA for chronic pain, “MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorder,” which came about after they received access to MAPS’ Phase 2 data from a lead-in PTSD study and noticed significant improvements in pain measurements – something the study was not looking for at all. They’re looking into where chronic pain fits within the frameworks of Western medicine and psychedelic-assisted therapy, and discuss the many reasons why MDMA should be tremendously helpful for chronic pain and other conditions that fall under the large umbrella of central sensitivity syndromes and nociplastic pain. They are currently working on a new study following the MAPS protocol that will research MDMA-assisted psychotherapy specifically for people with fibromyalgia, which some believe might be physicalized PTSD. If you’d like to contribute a tax-deductible donation, visit giving.viu.ca, select “other” from the dropdown, and type in “MDMA for Fibromyalgia.”

They talk about how research trials focus too much on the molecule while ignoring what the patient is saying; how a large percentage of physicians and patients don’t at all like the psychometrics used in measuring data; how physicians regularly use expectancy bias but research trials don’t (and how that affects results); why everyone needs to place higher importance on the biopsychosocial model; the idea of being more humble with science and using “theoretical” more often; the problems with microdosing trials; and the issues with evidence: If there isn’t sufficient evidence, why isn’t there? And what exactly would be sufficient?

Notable Quotes

“It’s kind of an irony because it’s really a single molecule pharmaceutical model to go: ‘Is it working?’ whereas every day, every clinician out there is using expectancy and placebo effect to their patients’ benefit. So, I would like us to have that conversation in a much more intelligent way, saying it’s going to be there, it’s not a bad thing, and in fact, if you don’t have that, you’re probably a bad clinician. So, let’s harness it, and then say, ‘and is the treatment [going] above and beyond that?’” -Pam

“Where’s the scientific curiosity? That’s what we need to be. When our patient says: ‘This is helping me,’ we should never be saying, ‘No, that’s not possible because there’s no evidence.’ We should be leaning in and being curious: ‘Tell me more.’” -Pam

“Homogenizing through trying to do the randomized control trials, you end up sort of sterilizing to isolate one specific variable in trying to make your study population as similar as possible. And in the real world, that’s just not the case. In the real world, people are on 10 different medications. So what’s really even the applicability when we sterilize and homogenize so much [for] what we believe is giving us the best evidence?” -Devon

“If we really look and open our eyes, in many, many circumstances, the pathology is not individual whatsoever. The pathology is in our culture and in our society and how disconnected we are and the intergenerational trauma that’s passed along, and then parents without support and no hope of not passing that along because our society isn’t providing the optimal environment on a societal level for us to be thriving. So I think a cure on an individual level needs to be couched within thinking about a cure on a collective level.” -Devon

“The reason I got involved even in the research is because so many of my patients were coming to me and saying, ‘I am microdosing. It is helping.’ So it goes back to: Do you believe people? And I personally believe my patients when they say that. …When I have people coming in and saying ‘I’m out of bed now. I used to lay in bed for 18 hours a day and now I’m out, I bought a dog, I’m exercising’; if it’s a placebo or expectancy, awesome. I’m going to celebrate that.” -Pam

Links

Donate to the MDMA for Fibromyalgia study (select “other” from the dropdown, and type in “MDMA for Fibromyalgia.” (tax deductible and no fees)

Drdevonchristie.com

Psychedelics Today: PT259 – Dr. Devon Christie and Will Siu, MD, DPhil – The Mind-Body Connection, MDMA, and Chronic Pain

Psychedelics Today: PT306 – Dr. Devon Christie – Vital Psychedelic Conversations

Numinus.com

Rootstothrive.com

Earthguardians.net

Psychedelics Today: PT331 – Julie Zukof & Dr. Michelle Weiner – Psychedelic Women, Coaching, and Ketamine For Fibromyalgia

Frontiersin.org: MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorder

Dolenlab.org

NYU Langone’s Department of Psychiatry: Center for Psychedelic Medicine

Peoplescience.health

Imperial College London: Centre for Psychedelic Research

Researchgate.net: Psychometrics is not measurement: Unraveling a fundamental misconception in quantitative psychology and the complex network of its underlying fallacies

BPI: Brief Pain Inventory (short form example)

Psychedelics Today: PT369 – Chronic Pain and Phantom Limb Pain: Could Psilocybin Be the Answer? Featuring: Timothy Furnish, MD & Joel Castellanos, MD

Microdose.me

Vancouver Island University Center for Psychedelic Research

Posted on

Psychedelics Weekly – The Legalization of Medical MDMA & Psilocybin in Australia, and The World’s First Ayahuasca Pill

In this episode of Psychedelics Weekly, Kyle is joined by another new voice from the PT team: one of the main instructors and facilitators from our Vital program, Diego Pinzon. 

Originally from Colombia, Diego has been living in Australia since 2008 and has been involved in the Australian psychedelic scene, playing roles in the charity sector, research with Psychae Institute, and is one of the researchers in the St. Vincent’s Melbourne trial, Australia’s first trial using psilocybin for end-of-life depression and anxiety. Diego gives his insight into the recent TGA re-scheduling of psilocybin and MDMA for treatment-resistant depression and post-traumatic stress disorder, respectively.

They cover the details, unknowns, and concerns: Is there enough time to train enough people? Do they have the infrastructure for this? What are the substances actually going to be? What percentage of people who apply will be granted access? What will it cost? And while psychiatrists will be able to prescribe, how much will the program really focus on therapy? 

And they discuss Vancouver’s Filament Health creating the world’s first ayahuasca pill, which is close to FDA authorization to begin a Phase 1 trial. Of course this news begs some questions as well, mainly: with psychedelic use being such an active experience, how much does something like this change our relationship to ayahuasca? And with a consistent, more predictable experience, does that kill the magic?

Links

Svhm.org.au: Australia’s first psychedelic clinical trial commences recruitment

TGAov.au: Change to classification of psilocybin and MDMA to enable prescribing by authorised psychiatrists

Time.com: Psychedelics May Be Part of U.S. Medicine Sooner Than You Think

Psychedelicsociety.org.au

AHPRA.gov.au

Psychedelicspotlight.com: Vancouver Company Creates World’s First Ever Ayahuasca Pill

Goodreads.com: Terence McKenna’s “feather bed” quote

Posted on

PT390 – Vital Psychedelic Conversations

In this episode of Vital Psychedelic Conversations, Johanna takes the helm for the first time, hosting a conversation with Jungian analyst-in-training, writer, researcher, 5Rhythms® teacher, and Vital student: Mackenzie Amara; and clinical psychologist, long time PT collaborator, and Vital instructor: Dr. Ido Cohen.

As this episode features three huge fans of Jung (Johanna wrote her Master’s dissertation on The Red Book and teaches a course through PT), they focus less on education and the future of psychedelic therapy, and instead get pretty deep; shining a light on an integral part of psychedelia (and life) we often avoid: the shadow. What is the shadow and what is true shadow work? What did Jung give us, and why is Jungian psychology so relevant for integrating psychedelic experiences? 

They discuss the notion of the unconscious as a place you can develop a relationship with and access by very different means; the idea of the healer as the container; the problematic binary of good vs. evil; the flawed concept of ego death; the differences between authentic and neurotic suffering and personal and collective consciousness; the archetype of the wounded healer and why facilitators should both be wounded and in the process of healing; and how wonderful it is that society is beginning to embrace the weird and what makes us unique. 

There are no shortcuts in life and there is no “cure” for the parts of the human condition we aren’t comfortable with, but in the capitalist, efficiency-above-all-else West, we aren’t raised to sit with the unpleasant, and instead learn to seek a quick fix, which has created an environment where we’ve lost the ability to feel in the ways that we need to. Can you be with someone else’s pain if you’re running from your own? Can you have real compassion if you’ve never suffered? Can you be complete without knowing your shadow?

Notable Quotes

“Yes, we’re all suffering and suffering is scary and shadow is scary and it can overwhelm us and it takes time. And there is this thing where we can build a relationship with it. It’s all about the relationship.” -Ido

“Nature is a perfect representation of how the unconscious is. It’s unfinished. It’s in process. It’s not perfect. It’s human consciousness, and [it’s] our egoic, persona-driven striving that have us believe that we can be perfect, AKA not human, AKA have no shadow. So the shadow is this part of the unconscious; it’s the frills, it’s the weirdness, it’s the awkward pauses, it’s the burps and the disgusting stuff and the repulsion, and also the quirks, the idiosyncrasies. In Swiss German, they talk about a square that’s missing a corner – it’s the missing corner. You need to have a piece missing so that life can live there.” -Mackenzie

“There is no ego death. You can have ego disidentification, you can release the center of your consciousness from your ego, but you will never kill your ego, and you shouldn’t want to kill your ego. If you’re going to kill your ego, who’s going to be home to integrate? Where are you going to take all these beautiful experiences? Who’s going to synthesize them and alchemize them for you? …That is a way in which we’re banishing the feminine, which is process, which is yes, being in my body and suffering, because there is also so much beauty in suffering, because if you can’t be in your body to suffer, you’re not going to be in your body and experience love. They work together.” -Ido

“Psychedelics are the opportunity to get outside of oneself far enough that then I can come back and say: ‘Do I consciously want to choose to continue to be the way that I’ve seen that I am, or do I want to use my power, my influence over myself to make different choices?’” -Mackenzie

Links

PT308 – Dr. Ido Cohen, PsyD – Vital Psychedelic Conversations

PTSF79 – Psychedelic Facilitator Abuse and Space Holding Ethics with Dr. Ido Cohen

Psychedelics Today: Ido Cohen – Re-Turn to Wholeness: Jung and Integration

Psychedelics and The Shadow: The Shadow Side of Psychedelia

Mackenzieamara.com

Doubleblindmag.com: How to Become a Psychedelic Integration Therapist

Azquotes.com: Marion Woodman Quotes

Trauma and the Soul: A psycho-spiritual approach to human development and its interruption, by Donald Kalsched

Goodreads.com: Marie-Louise von Franz quotes

Women Who Run with the Wolves: Myths and Stories of the Wild Woman Archetype, by Clarissa Pinkola Estés, Ph.D.

Goodreads.com: Charlotte Joko Beck quotes

Posted on

PT389 – The Art of Ecstasy: The 90’s British Club Scene and MDMA

In this episode, Joe interviews artist and photographer, Rupert Alexander Scriven.

Under his brand, Vintage Disco Biscuit, Scriven recently released The Art of Ecstasy: a coffee table book that pairs high definition images of ecstasy tablets he collected over the course of 25 years with interviews and compositions written by himself and a host of other notable names from the 90’s British club scene, documenting the culture and rise of MDMA, while also promoting harm reduction and the work of UK drug charity, The Loop. The book has received some notable high praise, with Dr. Ben Sessa calling it “absolutely fucking awesome.” 

Scriven discusses why he started collecting ecstasy tablets and how the book came to be, as well as details behind the photography and writings, which he likes to think of as conversations at an afterparty. And he talks about his days in the club scene and how it was like his church; how MDMA changed culture; UK drug policy; talks with his parents about drugs; differences in the club experience when people are on different substances; and whether or not dancing on MDMA can be the therapy people need. And he asks a question many of us wonder regularly: Why are we, as a culture, so far behind with drug testing?

Notable Quotes

“It really did change the culture and society as a whole, because at the time, there was ‘Thatcherism’ ([from] Margaret Thatcher, our Prime Minister), and there was a lot of disdain, there was a lot of discomfort. And this was just an outlet for everybody to enjoy themselves, whoever they were. So you could be a street cleaner, you could be an MP, you could be anybody. Everybody came together on a Saturday or Friday night and you just partied.”

“Each of these pills, even though they’re only eight millimeters across, that stamp; it didn’t signify just quality, it signified somebody’s memory of meeting a friend, a loved one, an experience, a time. You can go on any forum and people will go, ‘Oh, can you remember the dove?’ …You can ask them, and they’ll be able to recap a full story or an experience they had just from that one on element.”

“A few years ago before the lockdown, [there were] only three festivals that didn’t have The Loop or some form of drug awareness testing charity at them in the UK, and those were the three festivals that there were fatalities. Now that just speaks volumes. It really does.”

Links

Vintagediscobiscuit.com

Wearetheloop.org

Dmagazine.com: How the Starck Club Changed Dallas

Wikipedia.org: Vague Club

David Nutt’s Drug Harm Chart

Sen1.squarespace.com

Imdb: “Once Upon a Time in America”

Britishculturearchive.co.uk: Blitz Club, London, 1980 | Photographs by Andrew Holligan

Thedea.org: What is Molly? (Leo Zeff is who had the penicillin quote)

Wikipedia.org: Marshall Jefferson

Sciencedirect.com: Drug safety testing, disposals and dealing in an English field: Exploring the operational and behavioural outcomes of the UK’s first onsite ‘drug checking’ service

Awaknlifesciences.com

Lawenforcementactionpartnership.org (LEAP)

Carlcox.com

Kollectiveshop.com

Posted on

Psychedelics Weekly – AIMS vs. the DEA: An Update on the Fight to Reschedule Psilocybin

In this episode of Psychedelics Weekly, David is joined by Kathryn L. Tucker, JD: Director of Advocacy at the National Psychedelics Association and a founding member of the Psychedelic Bar Association with over 35 years in advocacy in protecting the rights of dying patients. 

Tucker is currently working with Dr. Sunil Agarwal of the Advanced Integrative Medical Science (AIMS) Institute in a battle against the DEA: Agarwal works with end-of-life cancer patients and approached the DEA to see how they’d accommodate state and federal Right to Try laws to grant his patients access to psilocybin, which the DEA denied. This led to the federal case, AIMS vs. the DEA (AIMS I), then AIMS II (which petitions their denial of Right to Try access), and now, AIMS III, which appeals their denial of the petition to reschedule psilocybin. 

As with all things government-related, the story shows how little these people actually care about any of us, but Tucker gracefully walks us through the whole convoluted mess; explaining each step, what should happen next, where the DEA blatantly disregarded rules, what you can do to help, and ultimately, the importance of this case in how situations like these could be handled in the future (from both sides). She discusses the problems with state legalization under federal jurisdiction; what we can learn from what we saw with safe injection sites being canceled in Philadelphia; Cory Booker and Rand Paul’s Breakthrough Therapy Act; the idea of having state-legal programs actually run by the government to create a federal safe harbor; and more.  

And in the news, they cover recently submitted legalization bills, Australia legalizing the medical use of psilocybin and MDMA (for specific conditions by approved practitioners), and the concern over what will happen with ketamine telehealth when the Covid-19 Emergency is finally put to an end in May.

Notable Quotes

“As you may have seen just last week in Australia, MDMA and psilocybin were rescheduled. And you might have noticed in the press release a reference to the fact that the Australian agency took in a considerable amount of medical and scientific data when it was considering that rescheduling. That’s proper. That’s necessary. That did not happen here. So what happened in Australia exemplifies and throws into sharp light that the DEA failed as a matter of process here.”

“The problem with state legalization as mentioned earlier is that it can do no more than offer state safe harbor. It cannot alter federal law. …Under the Oregon statute, all psilocybin must be consumed at a psilocybin service center, which must be licensed by the state, and it must be purchased and consumed at that center in the presence of a licensed facilitator. That is what is legal under Oregon state law. However, the operation of those psilocybin service centers is still a federal crime. And I think there has been a hope and possibly even an expectation that the federal government is going to look the other way. We have no indication that that is going to happen.”

“Within the Controlled Substances Act, there’s a provision that if the action is taken by a government official, then there is a federal safe harbor. So one of the ways that one might be looking at creatively revising these state legalizations is to have the program be run by the government. Now could you make an argument that when, for example, the Oregon Health Authority issues licenses to Oregon service centers, that that means it’s a government-run facility? Maybe. I mean, I think that’s an argument worth fully vetting, because it could bring you within federal safe harbor.”

Links

National Psychedelics Association

Psychedelic Bar Association

Psychedelics Today: PT307 – Kathryn L. Tucker, JD – The Right to Try Act and the Battle for Psilocybin Access

FDA.gov: Right to Try

Pubmed: Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

Congress.gov: S.4575 – Right to Try Clarification Act

Marijuanamoment.net: Cory Booker And Rand Paul File Bill To Reschedule Psychedelic Breakthrough Therapies And Remove Research Barriers

Shroomer.com: The 101 of the Bipartisan Breakthrough Therapy Act

DMT: The Spirit Molecule: A Doctor’s Revolutionary Research Into the Biology of Near-Death and Mystical Experiences, by Rick Strassman

Sunstonetherapies.com

Marijuana Moment: Psychedelics Bills Filed In Four More States As 2023 Reform Efforts Heat Up

Psychedelicalpha.com: Psychedelic Legalization & Decriminalization Tracker

Wikipedia.org: Cole Memorandum

Justice.gov: Appellate Court Agrees with Government that Supervised Injection Sites are Illegal under Federal Law; Reverses District Court Ruling

Rstreet.org: Overdose Prevention Centers and the Federal “Crack House Statute”

Microdose.buzz: Activists Protest the DEA for Psilocybin Access

The Nowak Society: Right to Try Psilocybin Advocacy Fund

Psychedelicinvest.com: The Future of Ketamine Telehealth When Biden Ends the Covid-19 Emergencies in May 2023

Yahoo.com: Field Trip and Nue Life Are Collaborating To Bring Psychedelic Therapy Into the Home

Posted on

PT388 – Vital Psychedelic Conversations

In this episode of Vital Psychedelic Conversations, we do something a little different: instead of interviewing a teacher and student to hear their different perspectives, Kyle (Vital’s main creator/developer) has a conversation with Johanna Hilla (our Coordinator of Education and Training), with the two basically interviewing each other. 

Johanna is originally from Finland but now lives in the UK, where she is pursuing a Ph.D. in philosophy at the University of Exeter. She has worked with us before, but became a full-time part of PT right around the time we launched Vital, so we thought it’d be interesting to hear a talk between two of the main figureheads behind this year’s cohort as it comes to an end. 

They discuss the beginnings of Vital and how the pandemic actually helped; how it’s been for Johanna to experience powerful group work for the first time; and what it’s been like to see virtual connections turn into real friendships as groups came together at retreats (this was recorded at Altman Retreat in Jamaica). And they analyze Vital and look to the future: What worked? What didn’t? What were the biggest takeaways from this year? How can we add more somatic work (and maybe even have a retreat centered around getting into flow state and hiking or snowboarding)? How can we incorporate state-specific models as more states legalize? And most importantly: Can we become a new gold standard in the training/education world? We hope so!

Applications for the 2023/24 edition of Vital have been extended until March 26, so check out the curriculum here.

Notable Quotes

“The whole curriculum, the way in which it’s structured with the five elements, the way in which it emphasizes experiential learning and process-oriented thinking and incorporates all of these transpersonal elements but also has a really sufficient amount of clinical backing: I just thought that it was really brilliantly structured (which I think you did most of that work) and I thought that this is exactly what we need right now.” -Johanna

“The emotional density and the charge that happens in a room when people are either doing some kind of plant medicine ceremoniously or doing breathwork: I think it’s always really something tangible, and it’s a great privilege to witness people going into these deep psychological processes. But obviously, it also takes something from you. You really have to be very present, there for many hours, and you go through the experience with the people as a witness. Even though you don’t know what they’re going through, you’re still going through it with them in a way.” -Johanna 

“I think breathwork really honors the idea that we all come from a certain baseline and that people have different levels of intensity that they’d like, and different comfort zones. And I think that’s also fine. Not everybody is going to go for the five grams in silent darkness, and I don’t think everybody has to either. If there’s people who are feeling a bit more anxious about going into new experiences, I think breathwork is a really great gateway into the psychedelic world. And then maybe some people will really fall in love with the method and actually want to continue with it. I think it offers something for everyone.” -Johanna

Links

Vitalpsychedelictraining.com

Psychedelics Today: John B. Cobb – Whitehead and Psychedelics – Part 1 (there are 4 parts)

Imagination as Revelation: The Psychedelic Experience in the Light of Jungian Psychology

Posted on

PT387 – Psychedelic Ethics & Self-Reflexivity and Proposition 122 Conflict & Resolution

In this episode, Joe interviews Jessica “Jaz” Cadoch: anthropologist, Co-Director of the Global Psychedelic Society, and Prop 122 steering committee member; and Sovereign Oshumare: Founder of XRYSALIS, an online community and retreat for queer, transgender, and intersex people of color, and Founder of Shelterwood Collective, a 900-acre eco-village and retreat center led by LGBTQ Black and Indigenous people.

Together, they are Co-Founders of ALKEMI, a consulting firm for psychedelic ethics and accountability, created due to the amount of businesses coming into this space who likely have very little understanding of the values that were established while they weren’t paying attention. They’re asking businesses questions many don’t consider: Is there a true need for them? Do they know their community and does the community want them there? Are their internal operations hierarchal or decentralized? Do employees feel heard and seen? And most importantly, have they taken any of the lessons from psychedelics and applied them towards the way they handle business and treat each other? 

As Cadoch was a member of the steering committee for Colorado’s Natural Medicine Act (AKA Prop 122), she discusses what it was like from the inside: the problems (complaints about who was involved, if the voices from the community were a true representation, language in the bill); how the conflict showed how easily money and power could embody people; the problems with fighting over perfection while people are being sentenced to prison; and, where everyone is now: together in the aftermath, trying to figure out how to work together, unite missions, and build bridges between seemingly disparate parties.

They also discuss the problems with binary thinking, the concept of a business recalibrating its relationship to profit and ROI, what true access means, why it’s ok to go slow and not rush through the uncomfortable, and more.

Notable Quotes

“How are you really taking the lessons that the medicines are teaching us and applying them to the way you’re building your company? …Are you doing psychedelic business or are you doing business psychedelically?” -Jaz

“Each time that I’m broken, I’m rebuilt stronger. And that, to me, is such a journey. And committing to that journey is what I hope we as ALKEMI bestow upon people; giving them the endurance and stamina to be broken and be rebuilt, because we all need that. This system needs that. This world needs that. And we live in a system where we’re rewarded for not doing it.” -Sovereign 

“At the end of the day, we are all we got. And the more we know who we are, the more we find alignment, the more we find each other, the more we mend our differences, the stronger we’ll be.” -Sovereign

“When we talk about access, it’s not only like financial access, but it’s also cultural access – to make it make sense for people who don’t speak this language, make it make sense for people who have survivor’s guilt from growing up in the hood in D.C., make it make sense for Hispanic rural communities, make it make sense for my Grandmother that needs a doctor in a white coat to tell her that this is safe. That’s what access means. It’s all of that.” -Jaz

Links

Alkemi-consulting.org

Alkemi-consulting.org: Community Needs Assessment

Mayahealth.com

Mayahealth.com: Ethics

Psychedelics Today: PT265 – Jessica Cadoch, MA – Cooperation, Drug Exceptionalism, and 12-step Programs

Xrysalis.net

Shelterwoodcollective.org

Montrealpsychedelicsociety.org

Thespore.org: Society for Psychedelic Outreach, Reform, and Education

Ballotpedia.org: New Approach PAC

Thenowaksociety.org

Psychedelic Club of Denver

Denver Mushroom Cooperative

Thespore.org: The People’s Medicine Council of Colorado

Thepsychedelicbar.org: The Psychedelic Bar Association

National Psychedelic Conference

The Structure of Scientific Revolutions, by Thomas S. Kuhn

Posted on

Psychedelics Weekly – Research Explained: Ketamine and the Corticothalamic Network, Psilocybin and the Immune System, & Canalization and Plasticity

In this episode of Psychedelics Weekly, the rest of the team is out or at Cannadelic, so a new voice steps up to the plate: Julian Bost, who works with the Vital team and handles the majority of our email, records his first podcast with Ph.D. candidate in Neuroscience, friend of the show, and speaker at Convergence: Manesh Girn.

You may remember the team covering some articles at the end of December and early January that were quite confusing and immediately met with a response of: “yea, we should have someone on to explain this to us.” This is that episode, with Manesh breaking down three very scientific articles into much simpler terms (at least we hope). 

He covers:

 “The psychotomimetic ketamine disrupts the transfer of late sensory information in the corticothalamic network,” which found that ketamine created hyperconnectivity in rodents’ brains, impairing their ability to process sensory input, which could lead to a better understanding of schizophrenia;  

“Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteers,”: which showed an interaction between psilocybin and the stress system, immune system, and central nervous system – showing a greater recognition for how the immune system and inflammation are involved in disorders;

And a paper he co-wrote with Dr. Robin Carhart-Harris and many others, “Canalization and plasticity in psychopathology,” which aims to reframe neuroplasticity, disorders, and psychedelic interventions, and leads to a discussion on how adaptive thought patterns develop, the ability to relearn as “Temperature or Entropy Mediated Plasticity (TEMP),” Daniel Kahneman’s idea of fast and slow thinking, early trauma intervention, and the concept of viewing mental illness as a process rather than an identity. 

As confusing (at least to the layperson) research seems to pop up daily, we may have Manesh on from time to time to help us understand some of these studies. How did he do? Did he clear up any of these articles for you? And should Julian be on the podcast more?

Links

YouTube: The Psychedelic Scientist

Psychedelics Today: PT258 – Manesh Girn – Psychedelics and the Brain: Neuroplasticity and Creativity

Psychedelics Weekly on YouTube

Wiley.com: The psychotomimetic ketamine disrupts the transfer of late sensory information in the corticothalamic network

Medrxiv.org: Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteers

Sciencedirect.com: Canalization and plasticity in psychopathology

Wikipedia.org: Thinking, Fast and Slow

Thinking, Fast and Slow, by Daniel Kahneman

The Myth of Normal: Trauma, Illness, and Healing in a Toxic Culture, by Gabor Maté, MD with Daniel Maté

Posted on

PT386 – Vital Psychedelic Conversations

In this episode, David once again interviews a teacher and student from Vital, speaking with Grof-certified Holotropic Breathwork® practitioner, author, and developer of InnerEthics®: Kylea Taylor: M.S., LMFT; and therapist and Lead Consultant of psychological therapists at NEU: Shabina Hale. 

This Vital Psychedelic Conversation is largely centered around ethics: how practitioners and facilitators define ethics; how InnerEthics® is involved; power dynamics; accountability; how the energy in a session is transferable and can bring up shadow elements for both parties; the need to be honest about one’s own scope of competence; the need for facilitators to have more experience both as a sitter and experiencer; and the very simple but most vital aspect of facilitation: considering how any decision made will affect the person on the psychedelic.    

They also discuss having a code of ethics inspired by Indigenous culture and decades of underground use; how the psychedelic experience is affected by the ways it’s treated by its surrounding culture; how the practitioner becomes a protector; defining what is normal in a psychedelic experience (can you?); informed consent and the importance of explaining how roles will change throughout the process; and what the world would be like if everyone followed the same set of ethics.

Have you seen our commercial for Vital yet? We’re pretty thrilled with how it came out.

 

Notable Quotes

“We’re doing psychedelics in a different culture and a different community. I come from an Asian community that is often more tight knit and more tribal in its way of being, and mental health is seen differently within that community, care for elders is seen differently in that community. And so immediately, you’ve got these different rules and different structures that happen. And psychedelics obviously have come from some of those communities, but we don’t have the same communities anymore. We’re in the West. People will take them [and] they don’t go back to communities. They’re on their own. And that’s really isolating. …How do you keep people safe in some form of community when they go back into a society which is much more individualistic?” -Shabina

“I think it helps to just consider it all normal and not abnormal, because it’s only abnormal in the context of our society and our culture. What happened to Indigenous people in their psychedelic experiences was held; whatever it was was held by the culture, so it was not abnormal. It was normal in the extraordinary state of consciousness, and they assumed that it was healing and worked with it.” -Kylea

“You can see things that may not make sense on the outside, but to that person, on the inside, they really do make sense. And they make sense of it in a way that is far more profound than you could ever interpret or analyze or try and take apart.” -Shabina

“I think if people really find out what is theirs to do and do it, that is so satisfying that all these other things that cause problems for other people disappear.” -Kylea

Links

Kyleataylor.com

Innerethics.com

Holotropic.com

Brainspotting.com

Psychedelics Today: PT290 – Kylea Taylor, M.S., LMFT – Vital Psychedelic Conversations

The Ethics of Caring: Finding Right Relationship With Clients for Profound Transformative Work in Our Professional Healing Relationships, by Kylea Taylor

Neupractice.com

Greencamp.com: Honoring the Legends: Stephen Gaskin and The Farm

Maps.org: MAPS MDMA-Assisted Therapy Code of Ethics

Posted on

PT385 – Relationships, Conviviality, and The Strength of Empathic Attunement

In this episode, Joe interviews Portland, OR-based licensed marriage and family therapist, ketamine-assisted therapist at Rainfall Medicine, lead educator at InnerTrek, and speaker at our upcoming Convergence conference: Gina Gratza, MS, LMFT.

She talks about how she decided she wanted to become a therapist and when she knew psychedelics were the next step; meeting Rick Doblin at Burning Man; the efficacy of MDMA being used in conjunction with traditional therapy; how the self-compassion of MDMA gives her tremendous hope for its use in treating eating disorders; how non-ordinary states of consciousness teach us the wiseness (and uniqueness) of our inner healer; and her healthy concerns for how Oregon handles psilocybin legality: InnerTrek will be graduating some of the first licensed facilitators in Oregon and they should be certified by summer, but with OHA-approved service centers and manufacturers still up in the air, what happens next?

She and Joe also discuss how non-ordinary states of consciousness teach us the wiseness (and uniqueness) of our inner healers; the need for therapists to continuously do their own work; the idea of a psilocybin-licensed facility doubling as a music venue; David Nutt’s drug harm scale; Kylea Taylor; “The Trialogues”; archetypes of Burning Man; and how in psilocybin-assisted therapy, we can only do so much before the spirit of the mushroom ultimately takes over.

Notable Quotes

“There’s a strength in the empathic attunement that’s happening in the heart space that’s coming forward, so it’s not just talk therapy. There’s a connection happening. And we are creatures of love and belonging and connection, and when we feel that with another human being [and it’s] authentic – that is a very powerful force. We don’t have to compare it, but it’s just as powerful as medicine.”

“I hope to never be a master of any domain. I know that the juiciness of this life and this existence is continuing to stay open to learning and growing and evolving, and for me, that’s coming back to humility: I’ll never know everything, especially when it comes to the realm of altered states of consciousness. We’re trying to understand life in this state of consciousness, let alone bringing in altered states and the many different dimensions at which things can come through to you, and the uniqueness of everyone’s experience.”

“This is what we humans are able to do: Here are the measures, here are the ways in which we’re training. And then there’s the spirit of the mushroom. There’s what we are going to bring and then there is going to be what the mushroom brings: …the mycelium network, the earth, the nature; like a total other force that is beyond our ability to really know or read what will move through that.”

Links

Ginagratza.com

Rainfallmedicine.com

Innertrek.org

Chrisstauffermd.com (SNaPLAB: Social Neuroscience and Psychotherapy Lab)

YouTube: MDMA-assisted Therapy for Social Anxiety in Autistic Adults – Alicia Danforth

Clinicaltrials.gov: Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder

Clinicaltrials.gov: Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in Veterans (MPG1)

Pubmed: MDMA-assisted therapy significantly reduces eating disorder symptoms in a randomized placebo-controlled trial of adults with severe PTSD

Hopkinspsychedelic.org: Anorexia Nervosa Study Seeking Research Participants

David Nutt’s Drug Harm Ranking scale

Marijuanamoment.net: Most States Will Legalize Psychedelics By 2037, Analysis Published By American Medical Association Predicts

Wikipedia.org: Feminist pedagogy

Psychedelics Today: PT288 – Annie & Michael Mithoefer – Vital Psychedelic Conversations

Pubmed: Combining Cognitive-Behavioral Conjoint Therapy for PTSD with 3,4-Methylenedioxymethamphetamine (MDMA): A Case Example

Psychedelics Today: PT227 – Dr. Anne Wagner – Couples Therapy, MDMA, and MAPS

The Ethics of Caring: Finding Right Relationship With Clients, for Profound Transformative Work in Our Professional Healing Relationships, by Kylea Taylor

Psychedelics Today: PT290 – Kylea Taylor, M.S., LMFT – Vital Psychedelic Conversations

Exploring Holotropic Breathwork: Selected Articles from a Decade of the Inner Door, Edited by Kylea Taylor

Sheldrake.org: The Sheldrake – McKenna – Abraham Trialogues

Damer.com (Dr. Bruce Damer)

Psychedelicsalon.com: Dr. Bruce Damer

Posted on

PT384 – Vital Psychedelic Conversations

In this episode, David interviews two people from different sides of Vital: clinical psychologist, adjunct professor, Co-Founder of the Psychedelics R2R nonprofit, and Vital instructor, Dr. Dominique Morisano, CPsych (the teacher); and writer, psychedelic-assisted medicine facilitator, integration coach, and Women On Psychedelics Co-Founder, Jessika Lagarde (the student). 

With the 2023-24 edition of Vital set to begin in April and applications closing at the end of March, we thought it would be interesting to relaunch Vital Psychedelic Conversations, but with the spin of speaking to both instructors and students to hear their different perspectives on retreats, facilitation, psychedelic education, the quickly advancing psychedelic space, and of course, Vital itself. 

Morisano and Lagarde mostly discuss experience: how it’s gained, how it changes perspectives and methodologies, how one decides they’ve experienced enough to be able to know the terrain enough to help others, the importance of knowing when a patient needs a facilitator/therapist who has had the same life experience, and knowing when one’s own skills and limitations means a patient would be better off seeing someone else. And they discuss safety, the importance of being trauma-informed (and what does that mean, really?), and the puzzling cases when facilitators haven’t had their own psychedelic experience but feel the need to use psychedelics to help others. 

And of course, they talk about Vital: the joy in joining together in community with people they’ve only known virtually; how interesting these retreats are compared to others due to the level of the participants’ experience; how partnering up and taking turns as the sitter and experiencer shows how little of a difference there is between student and teacher; and how many people have reported the most impactful part of the retreats was not their own experience, but being there for someone else.

Notable Quotes

“Do you know the terrain? Let’s say you’ve taken ketamine once, and you’re doing six sessions of ketamine with a client. Do you really know what they’re going to be experiencing, and can you have had the full range of experience? …How do we define this? I can tell you: You have a hundred psychedelic experiences; most likely you’re going to have a different experience each time, and a different connection to inner/outer terrain or different realms or different ways of thinking and being. So when is enough enough? When did you learn your lesson? When did you gain the experience necessary to navigate someone [else’s experience]?” -Dominique

“You learn a lot about yourself as well, I find at the end of a day. Every journey is also a journey for the facilitator, and we are constantly mirrors to each other, so it’s very interesting work to do in that sense as well, because your own inner work is continuously being done.” -Jessika

“It’s never the same. Two sessions are never the same, and even how you show up on that day for that session, or set and setting; all of that influences [the experience], so we have to constantly be placing ourselves between being a student [and being] a teacher sometimes, but never put ourselves in the spot that we think, ‘Okay, now I know everything. Yeah, I’m done.’” -Jessika

“How do you develop wisdom? The way to develop wisdom is through experience, and often, pain.” -Dominique

Links

Drmorisano.com

Fromresearchtoreality.com: Global Summit on Psychedelic-Assisted Therapies and Medicine

Celebrating Women in Psychedelics podcast: Mental Health for the Masses – The Potential and Pitfalls of Scaling Psychedelic-Assisted Therapy, with Dr. Dominique Morisano and Sonia Stringer

Psychedelics Today: PT315 – Dr. Dominique Morisano – From Research to Reality: Planning a Global Psychedelic Summit

Jessikalagarde.com

Womenonpsychedelics.org

Psychedelics Today: Reclaiming Ownership of Your Body With Psychedelics, by Jessika Lagarde

Spotify: The Jimi Hendrix Experience- Are You Experienced (it’s an album, not a song, David!)

Plants of the Gods: Their Sacred, Healing, and Hallucinogenic Powers, by Richard Evans Schultes, Albert Hoffman, & Christian Rätsch

CIIS.edu

Synthesisretreat.com

Vitalpsychedelictraining.com

Journals.sagepub.com: Developing Guidelines and Competencies for the Training of Psychedelic Therapists

Posted on

PT383 – Identity, Rage, Culture, and Venture Capital

In this episode, David interviews Raad Seraj: host of Minority Trip Report, a podcast for underrepresented views in psychedelics and mental health, and founder of Mission Club, an education and investment platform.

Seraj tells his story of growing up in Bangladesh and Saudi Arabia and eventually finding himself in Canada, and how the discomfort and rage he felt as a result of class and xenophobia affected him. He talks about the idea behind his podcast, Minority Trip Report, and how, while they need to be heard, underrepresented and BIPOC voices aren’t a monolith. And he talks about the incestuous and gatekeeping nature of venture capital and the complications of actually turning investments into lasting business. With Mission club (which is partnering with Microdose), he aims to create opportunities for people who don’t have a ton of money to invest in early stage companies in this space, to help the dreamers who don’t necessarily fit the bill for traditional VC.

And he discusses much more: David Chalmers’ theory of “The Extended Mind”; the problems with having one idea of mental health and summarizing complicated minds into little boxes; how we are made up of different selves and how psychedelics can help us to acknowledge and integrate our minority selves; the differences between anger and rage and how 5-MeO-DMT helped him shed his rage; how we can use technology, culture, and capital together to amplify what exists and build what doesn’t; the three places that have transformed him the most; and initiating a bus-wide Cyndi Lauper sing-along while on tour with Finger Eleven as a host for Much Music.

Notable Quotes

“If you talk about mental health and healing: all healing is the reintegration of the narrative landscape – the autobiographical story. But the problem is; when you only have one type of story, one type of autobiographical narrative that gets to be heard, that gets to be embedded, that gets to be shared, that gets to go viral; and from that, you build courses and infrastructure and definitions of what mental health is and then you sort of impose it on the rest of the world – that is a problem because mental health is ultimately about being a human being, and we are multipolar beings and we are forced to be summarized in very small ways, whether by society or by systems.”

“You have a part that is elevated above the body and the mind and the consciousness, and seeing and observing yourself and your truest nature and your truest needs and wants and desires and so on, and I think with people who are on the margins (again, whether you’re Jewish, whether you’re bisexual, whether you’re a person of color, whether you’re an immigrant, or whatever), the parts that you suppress the most all of a sudden find light. They can be seen; that’s where the light gets in. And then that temporary visibility of all of a sudden seeing that part of you without judgment, and being almost agnostic to those parts, is powerful.”

“I recognized very early on [that] there was class. Race came after. Race is a 400-year-old concept. Class is a permanent part of any human society, but class is so much more insidious. We don’t talk about it.”

“At the surface of everything, whether it’s culture, politics, music, tech: it’s all bullshit. There’s a thin sheen of garbage. You have to dig a little deeper to find the true stuff.”

Links

Minoritytrip.com

Missionclub.co

Your Symphony of Selves: Discover and Understand More of Who We Are, by James Fadiman, Ph.D., & Jordan Gruber, J.D.

Theculturetrip.com: Toronto Named The Most Diverse City In The World By BBC Radio

Wikipedia: Much (TV channel)

YouTube: Finger Eleven – Paralyzer

YouTube: Cyndi Lauper – Time After Time

Wikipedia: Extended mind thesis

Navalmanack.com

Angellist.com

Yahoo.com: Black women lead in starting businesses, but struggle to get funding

The Power Law: Venture Capital and the Making of the New Future, by Sebastian Mallaby

Microdose.buzz

Enthea.com

Psychedelics Today: PT376 – Ketamine and Psychedelic-Assisted Therapy as Employee Benefits, featuring Sherry Rais

Mayahealth.com

Fox4kc.com: Psychedelics Today Re-Launches Vital Diversity, Equity and Inclusion Scholarship Fund to Support Student Practitioners

Vital: Diversity, Equity & Inclusion Tuition Scholarship Access Fund

Ourcortes.com (Cortes Island)

Posted on

Psychedelics Weekly – Client Data Concerns in Oregon, Hopeful Legalization in New Hampshire, and Vital & The Five Elements

In this week’s episode, Joe is joined by Kyle, calling in from The Atman Retreat in Jamaica, where he’s running the fourth of five retreats offered through our Vital program. 

They first discuss some news: Oregon Senator Elizabeth Steiner introducing a bill (SB-303) to essentially override many of the recommendations of the Oregon Health Authority, especially around client data – which would be provided to government agencies instead of staying private (which the people voted for); a reparations proposal in San Francisco recognizing the harms of the drug war; GOP lawmakers in Missouri and New Hampshire proposing bills for psilocybin therapy and psychedelics legalization (respectively); and Canada’s Apex Labs being granted approval for a take-home psilocybin microdosing trial.

Then, Kyle gives us an update on his very busy last few months, running Vital retreats: breathwork in Costa Rica, breathwork and cannabis in Colorado, and psilocybin in Amsterdam and Jamaica. He talks about the retreats themselves, the five components of breathwork, the idea of safety and “brave spaces,” the power of community and being witnessed, the concept of focusing on technique over the substance, what students have been saying, and finally: how the five elements relate to Vital, psychedelic therapy, seasons, and the process of growth. Reminder that applications for Vital’s 2023 edition (beginning in April) close at the end of February (update: we’ve extended the date to March 26), so if you’re curious, head to the site to learn more or attend an upcoming Q+A here!

Links

Psychedelicweek.com: Psychedelic Surveillance Bill Would Raise Social and Economic Cost of Oregon Psilocybin Services

Psychedelic Science Funders Collaborative

Msn.com: San Francisco reparations committee proposes a $5 million payment to each Black resident

Cnn.com: North Carolina city votes to approve reparations for Black residents

SF.gov: African American Reparations Advisory Committee

Marijuanamoment.net: GOP New Hampshire Lawmaker Files Bill To Legalize Psychedelics Like LSD And Psilocybin

Marijuanamoment.net: Lawmakers Are Already Pursuing Psychedelics Legislation In Nearly A Dozen States For 2023

Marijuanamoment.net: New Hampshire GOP And Democratic House Leaders Team Up On Marijuana Legalization Bill For 2023 (there is progress!)

Wcia.com: Illinois lawmaker introduces bill to create regulated psychedelic therapy program

Newswire.ca: Apex Labs Granted Approval for 294 Patient Take Home Psilocybin Clinical Trial

Marijuanamoment.net: GOP Missouri Lawmaker Files Psilocybin Therapy Bill For 2023 Session

Psychedelics Today: What is Breathwork? (The five components)

Umaryland.edu: The 6 Pillars of a Brave Space

Brenebrown.com

Posted on

PT382 – The Body & Catharsis: Do We Need Psychedelics or Just Better Lifestyles?

In this episode, Kyle interviews researcher, speaker, writer, competitive freediver, and one of the world’s leading experts on 5-MeO-DMT: Dr. Malin Vedøy Uthaug.

As a society, we mostly live in our minds, emotionally constipated while surprisingly disconnected from our bodies, with basic human needs that are all too often not met. Uthaug and Kyle talk about what manifests when those needs aren’t fulfilled, the strength of one’s inner mind state to change perspective, and how powerful true catharsis and embracing grief can be. And they talk about somatics: why we don’t focus on the body more, and how we could embody experiences with non-ordinary states of consciousness to better connect to our inner world.     

She discusses the impact (or non-impact) of following a strict dieta before a big experience; preparing for an experience with physical exercise (even right before the ceremony); freediving; the challenge of therapists/facilitators sitting with someone through strong catharsis; the popcorn theory; the guilt people feel from experiencing love and bliss; and the paralysis-by-analysis problem of not making the connection between insight and action.

Notable Quotes

“What I’ve seen throughout all these years working in the field is that there is at least very commonly this notion that the psychedelic is going to heal them; they don’t have to do any other work – just popping that tab of psilocybin or smoking that pipe of 5-MeO is going to result in change. And that expectation is a bit dangerous, I think. They might not get the help that they are seeking because they’re placing that help externally to them. …Healing is actually hard work. It’s not something that happens overnight. It’s the tiny little steps of change accumulated that creates a bigger change. It’s changing your tiny, tiny habits until it changes your life.”

“You can realize a bunch of things, but if you’re not doing anything, nothing is actually going to change. It might feel like it changes because you have felt it in your brain or you’ve seen it or have this insight, but that needs to be translated actively into your life.”

“I think putting the body back into the equation is the way forward, however that might look.”

Links

Drmalinvedoyuthaug.com

Psychedelics Today: Dr. Malin Vedøy Uthaug – Ayahuasca and 5-MeO-DMT Research

Psychedelics Today: Malin Vedøy Uthaug – Exploring Ayahuasca Ceremonies and 5-MeO-DMT

The Ethical and Ecological Considerations of Inhaling Bufotoxins from Incilius Alvarius, by Malin Vedøy Uthaug

Dailymail.co.uk: Was Sigmund Freud really just a sex-mad old fraud? The founder of psychoanalysis was a money-obsessed cocaine addict who groped women patients and had a genius for self-promotion

Link.springer.com: Sigmund Freud’s Use of Catharsis and Cognition

The Smell of Rain on Dust: Grief and Praise, by Martín Prechtel

NeuroDynamic Breathwork online

The Plant Paradox: The Hidden Dangers in Healthy Foods That Cause Disease and Weight Gain, by Steven R. Gundry, MD

Psychedeliceducationcenter.com: DMTx Psychonaut Training Webinar

Johnheron-archive.co.uk: Catharsis in human development

Traumatized.com: Peter Levine – Somatic Experiencing

Your Golden Shadow: Discovering and Fulfilling Your Undeveloped Self, by William A. Miller

Love, Sex, and Your Heart, by Alexander Lowen, M.D.

Posted on

Psychedelics Weekly – Prince Harry and Psychedelics, Proposed Legalization, and The Roland R. Griffiths, Ph.D. Professorship Fund

For this week’s episode, we had plans for a guest to join Joe to talk about some legal battles, but as seems to be the norm this time of year, sickness postponed that conversation to a future date. With David taking some much-deserved time off and Kyle in Jamaica on a Vital retreat, this Psychedelics Weekly is a rarity: just Joe, monologuing the news.

It’s probably best to just listen and head to the links to follow along, but some highlights this week are: Prince Harry coming out of the psychedelic closet; Virginia lawmakers proposing the legalization of psilocybin; psychedelics legislation already in plans for nearly a dozen states in 2023; NBC news recognizing the need psychedelic therapists, facilitators, and education; the WHO aiming to rename 5-MeO-DMT to Mebufotenin; and Roland Griffiths creating The Roland R. Griffiths, Ph.D. Professorship Fund to ensure his work continues to be recognized after he passes.  

He also talks about Convergence, and you should know that prices increase on January 16, so don’t wait any longer! Check back next week for more news and, *fingers-crossed* a co-host – hopefully Kyle calling in to tell us all about the retreat!

Links

Cbsnews.com: Prince Harry says he’s used psychedelics to help cope with grief

Npr.org: On Point podcast (“Psychedelics and who should be able to use them” from 1/6)

Psychedelics Today: PT338 – Melissa Lavasani – The Power of Storytelling, The Preservation of Peyote, and “How to Change Your Mind”

Psychedelics Today: PT223 – Daniel Carcillo – Life After Sports

Psychedelicmedicinecoalition.org

Cnn.com: Chasing Life Podcast, with Dr. Sanjay Gupta – What Promise Do Psychedelics Hold As Therapeutics​​

Marijuanamoment.net: Lawmakers Are Already Pursuing Psychedelics Legislation In Nearly A Dozen States For 2023

Virginiamercury.com: Virginia lawmakers propose legalizing medicinal use of psychedelic mushroom compound psilocybin

Westword.com: Drug Record-Sealing Clinic In Wake of Colorado’s New Psychedelics Law

Cityweekly.net: Dr. Strangelove: Accused killer Dr. Robert Weitzel has a troubled career, but plenty of defenders.

Atmanretreat.com

Nbcnews.com: Psychedelic therapies are on the horizon, but who will administer the drugs?

Futurism.com: Startup Trying to test Whether People on DMT Experience a Shared Alien Universe

Dmtx.org

Psychedelics Today: Daniel McQueen – DMTx and Future Psychedelic Technologies

Twitter.com: Psychedelic Alpha: WHO Gives 5-MeO-DMT Generic Name: Mebufotenin

Tim Ferriss Show #646: Brian C. Muraresku with Dr. Mark Plotkin: The Eleusinian Mysteries, Discovering the Divine, The Immortality Key, The Pagan Continuity Hypothesis, Psychedelics, and More

Psychedelics Today: Mark Plotkin – Bio-Cultural Conservation of the Amazon

Psychedelics Today: PTSF 35 (with Brian Muraresku)

Griffithsfund.org

Hopkinspsychedelic.org

UCLA Psychedelic Studies Initiative

UCLA Psychedelic Studies Initiative’s survey: Psilocybin to treat drug addictions

Mixmag.net: New Zealand Authorities Believe 4KG of MDMA Was Flushed Down A Toilet

Psychedelics Today: Convergence

Posted on

PT381 – DMT, Hierarchies of Complexity, and Reality Switch Technologies

In this episode, Joe interviews Dr. Andrew R. Gallimore: computational neurobiologist, chemical pharmacologist, researcher, and writer of Alien Information Theory: Psychedelic Drug Technologies and the Cosmic Game.

Gallimore feels that DMT is the most efficient and effective reality switching molecule we’ve seen, and that there is no other psychedelic experience that is so in your face: If we really could communicate with entities not of our known universe (who may have created our universe), how can so many dismiss that as a hallucination? Why would we not want to pursue something so mind-bending and revolutionary? His hope for his newest book, Reality Switch Technologies: Psychedelics as Tools for the Discovery and Exploration of New Worlds, is that it will be the quintessential guide for how psychedelics work in the brain from all levels of organization, what happens when you perturb the brain, and the future: how we might be able to fine-tune our brains to access different realities at will. 

He discusses the element of design used in his books; why understanding something as complex as DMT is a multidisciplinary practice; the genius of Terence McKenna; what Alien Information Theory was about; his work with Rick Strassman in researching intravenous infusion DMT pumps to keep someone in the DMT verse; Conway’s Game of Life and the unpredictable levels of complexity that can arise from simple rules; lucid dreaming; John Mack, alien abductees, and trusting a patient’s experiences as real; psilocybin yeast; and much more. 

This one will definitely make you think!

Notable Quotes

“It’s always felt a little bit sci-fi in a way, in that you’re planning basically a program of inter-dimensional citizenship. It feels like that. I mean, Terence McKenna used to [say] ‘galactic citizenship,’ and it’s almost like we’ve leapfrogged over galactic citizenship and we’re now going straight to inter-dimensional, trans-dimensional citizenship (whatever you want to call it) where we’re interfacing and communicating with an intelligence not of this universe. I mean, that’s a wild idea. And we have the technology now. To me, this infusion technology; this is the way to do it.”

“We’re just at the beginning now. You take virtual reality technology and the way that that is progressing, then you add artificial intelligence into the mix, and then you add pharmacology and neuropharmacology, chemical pharmacology and other neural manipulation systems, and you begin to realize that our brain is this tool – this world-building machine that we can learn to tune to access other worlds.”

“There’s also deja vu of course, the sense of having been there before – this very profound, deep sense of deja vu; not like we’ve all had, that occasionally you get that sense of deja vu that something has happened before. This is like, ‘I really, really have been here before. This is the most bizarre place I couldn’t possibly have imagined or conceived of; an impossible place of impossible geometry, and yet at the same time, it seems bizarrely familiar. ‘Why? Why would some place that should be the most unfamiliar place possible– There isn’t a more unfamiliar realm that you could imagine than the DMT world, and yet people think, ‘Oh my God, I’ve come home.’ And the entities, the elves will sing and cheer and bells will ring and lights will flash and [they’ll] say, ‘He has returned! The one has returned home! Welcome back! We’re so pleased to see you!’ This great uproar, this great celebration as you burst into this space. Why would that happen?”

Links

Alieninsect.net

Alieninsect.substack.com

Reality Switch Technologies: Psychedelics as Tools for the Discovery and Exploration of New Worlds, by Andrew R. Gallimore

Psychedelics Today: Dr. Andrew Gallimore – Accessing High-dimensional Intelligence through DMT

Pubmed: A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic Experience

Medicinalmindfulness.org

DMT-nexus.me

Psychedelicreview.com: Early Clinical Research History of DMT

Wikipedia.org: Conway’s Game of Life

Stephenwolfram.com

Wikipedia.org: Edward Fredkin

How to Change Your Mind: What the New Science of Psychedelics Teaches Us about Consciousness, Dying, Addiction, Depression, and Transcendence, by Michael Pollan

Wikipedia.org: Chaos magic

Psychedelics Today: What do Alien Abduction and Psychedelic Experiences have in Common? Let Dr. John E. Mack’s Work Explain

Ralph-abraham.org

Drzee.org

Newatlas.com: Scientists turn yeast into psychedelic psilocybin factories

Posted on

Psychedelics Weekly – Psilocybin-Assisted Psychotherapy for I.B.S., NY Aims to Legalize, and B.C.’s Decriminalization Experiment

In this week’s episode, Joe and David meet up to talk about Vital, Convergence, and the latest news: 

-Tryp Therapeutics and Mass General signing a letter of intent for a Phase 2 clinical trial investigating the effects of psilocybin-assisted psychotherapy for the treatment of Irritable Bowel Syndrome – interesting because it further highlights the likely effect of psychedelics on the brain-gut connection and that psychotherapy is involved;

-New York lawmakers pre-filing a bill to legalize DMT, ibogaine, mescaline, psilocybin and psilocyn (and remove them from the state’s banned substances list) for 2023;

-New York’s first cannabis dispensary finally opening on December 29;

-British Columbia responding to their opioid crisis (the latest data reports 14k deaths since 2016) by beginning a Portugal-like decriminalization model, allowing people 18 years and older to carry a combined 2.5 grams of drugs (heroin, fentanyl, cocaine, methamphetamine and even MDMA);

and finally, an interesting but confusing (maybe a follow-up is necessary) article showing that what we’re learning about ketamine could lead towards a better understanding of psychosis and schizophrenia.

Links

Accesswire.com: Tryp Therapeutics and Massachusetts General Hospital Sign Letter of Intent for Clinical Study Investigating the Use of Psilocybin-Assisted Psychotherapy for the Treatment of Patients Suffering From Irritable Bowel Syndrome (IBS)

Psychedelics Today: PT350 – Psilocybin and Accessing the “Off” Switch For Nociplastic Pain, featuring Jim Gilligan

PT283 – Greg McKee – Nociplastic Pain and Psychedelics

PT369 – Chronic Pain and Phantom Limb Pain: Could Psilocybin Be the Answer? Featuring: Timothy Furnish, MD & Joel Castellanos, MD

Lucid.news: Researcher Charles Nichols Studies the Impact of Psychedelic Substances on Inflammation

Marijuanamoment.net: New York Lawmakers File Psychedelics Legalization Bill For 2023

Fox5ny.com: NY lawmakers propose bills to decriminalize, study psychedelics

Nydailynews.com: Crowd swarms first legal NYC marijuana shop on second day; long line to enter East Village store

Housingworks.org

Cheknews.ca: B.C. poised for drug decriminalization experiment, but will it help stem deadly tide?

Wiley.com: The psychotomimetic ketamine disrupts the transfer of late sensory information in the corticothalamic network

Neurosciencenews.com: Ketamine Found to Increase Brain Noise

Sciencedirect.com: Canalization and plasticity in psychopathology

Posted on

PT380 – Microdosing, Talking to Physicians About Psychedelics, and Nurses as the Scalability Solution

In this episode, Kyle interviews C.J. Spotswood, PMHNP-BC: author and board-certified psychiatric-mental health nurse practitioner currently enrolled in CIIS’ Psychedelic-Assisted Therapies and Research certificate program.

Spotswood has worked with Psychedelics Today, teaching masterclasses for our Vital and Navigating Psychedelics for Clinicians and Therapists courses, but this is his first appearance on the show. His first book, The Microdosing Guidebook: A Step-by-Step Manual to Improve Your Physical and Mental Health through Psychedelic Medicine came out last year, and we’re giving away three signed copies (US and Canada only). Click here to enter!

He talks about his introduction to psychedelics and his first patient immediately asking him about microdosing; why he changed his mind on microdosing and why he wrote his book; microdosing studies he’s most excited about; the terms: treatment-resistant depression, risk reduction, and flight nurses; Irving Kirsch’s work uncovering the bad science of research studies; the need for physicians to know enough about psychedelics to be able to meet their patients where they are; the importance of group work; and how, while they’re already so well-versed in caring for patients, using nurses to their full licensure could be the answer to the quickly growing psychedelics and scalability problem.

Notable Quotes

“When you look at the early research into the 50s in the 60s; they were doing microdosing research, they just didn’t have a title for it. They thought they were using placebo levels but they were actually looking for threshold levels; things like that. Really, it was what by today’s standards [would be an] amount that we would consider as a microdose.”

“I don’t like the term [treatment-resistant depression] when we use that because if you’re using [it] when you’re looking at the standard medications like SSRIs [or] SNRIs, they’re basically all the same. …So when you say that someone’s ‘treatment-resistant’ for three medications, four medications that are all basically working the same pathways and in the same amount; is that truly treatment-resistant, or are we just trying the same thing with just different medications, whereas doing microdosing is a different pathway [and] is a different approach?”

“My first patient I ever saw as a new clinician, like, literally my first patient: I come in and I’m starting to talk to them for the first interview and I got to the point and I’m asking them: ‘Where are we going, what do you need?’ and they said to me, ‘Do you know anything about microdosing?’ …I said to them, I go, ‘Yeah, I know a little bit.’ …So I asked her what she knew, and she knew quite a bit. And she goes, ‘What do you know?’ and I kind of just said to her: ‘I don’t really know how to put this, [but I] wrote a book on it and it’s going to be coming out next year.’ …It reinforced my feeling [that] I’m doing the right thing: this career suicide I’ve thought of, going into working with psychedelics and being open and talking about it, hearing my first patients talking about it – it’s got to be serendipity.” 

Links

Entheonurse.com

Win a signed copy of The Microdosing Guidebook: A Step-by-Step Manual to Improve Your Physical and Mental Health through Psychedelic Medicine here!

Wmtw.com: ‘Zombie’ drug Spice worsening Maine epidemic, officials say

The Psychedelic Explorer’s Guide: Safe, Therapeutic, and Sacred Journeys, by James Fadiman, Ph.D.

Journals.sagepub.com: A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers

Psychedelics Today: Surprising Results: Psilocybin Trial for Depression Alleviates Chronic Pain

Psychedelics Today: PT369 – Chronic Pain and Phantom Limb Pain: Could Psilocybin Be the Answer?, featuring Timothy Furnish, MD & Joel Castellanos, MD

Pubmed: Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity

Nature.com: The Discovery of Serotonin and its Role in Neuroscience

Psychedelics Today: PTSF50 – Microdosing and the Placebo Effect, with Balázs Szigeti and David Erritzoe

Psychedelics Today: PTSF89 – A Macro Dive Into Microdosing

Pubmed: Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing

Madinamerica.com: Irving Kirsch: The Placebo Effect and What It Tells Us About Antidepressant Efficacy

Emperor’s New Drugs: Exploding the Antidepressant Myth, by Irving Kirsch, Ph.D.

Spiritpharmacist.com

Psychedelics Today: PT285 – Andrew Penn, NP – The Need for Nurses in Psychedelics, The Placebo Effect, and Appreciating the Subtle

Maps.org: Notes From a Psychedelic Research Nurse

Grecc.org: Developing Guidelines and Competencies for the Training of Psychedelic Therapists, Janis Phelps 2017

Watsoncaringscience.org: Psychedelic-Assisted Psychotherapy Practices and Human Caring Science: Toward a Care-Informed Model of Treatment

Posted on

Psychedelics Weekly – Psilocybin and Stress Response, the Minnesota Medical Association Endorses Decriminalization, and Scott Wiener Introduces Senate Bill 58

In this week’s episode, Joe and Kyle are together again before Kyle sets off for a 2-month road trip centered around Vital retreats, where we hope he’ll be able to report in from live while in Jamaica. 

They talk about Vital: applications are open for the April 2023 edition and close in February, so if you have questions, check out the website or attend an upcoming Q+A. And Joe and other members of the team will be at MAPS’ conference in Denver this June (use code PT15 at checkout for 15% off), as well as Cannadelic in Miami this February.  

And for the news, they highlight four stories this week: “Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteers,” showing that, even with a small study, long-term stress response was much lower than the placebo group; The Economist highlighting psychedelic medicines as one of the five stories to watch out for in 2023; the Minnesota Medical Association endorsing the decriminalization of drugs with a 219-34 vote, mimicking the Portugal model and saying that there is insufficient evidence to support the claim that criminal penalties for possession deter drug use; and San Francisco Senator Scott Wiener submitting a new version of his previously denied SB-519 (now SB-58) that no longer includes LSD and MDMA – modeling the more natural medicine model that we’ve seen succeed in other states. As Joe says often, we want everything and we want it now, but every step helps, as we’ve seen with recent posts about people not being sent to prison for the rest of their lives.

Links

Convergence

Vitalpsychedelictraining.com

Vital 2023: Informational Session and Q&A

Microdosing Masterclass: Investigate the history, science, and best practices for safe and effective microdosing

Psychedelicscience.org (MAPS conference, use code PT15 for 15% off)

Medrxiv.org: Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteers

Psychopharmacology in Maastricht’s Twitter thread about this study

Springer.com: Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning

The Economist: The World Ahead 2023: five stories to watch out for

Awaknlifesciences.com

Yahoo.com: Medicine Innovations Group Announces Closing Under Share Subscription Agreement

Marijuanamoment.net: Minnesota Medical Association Endorses Decriminalizing Drugs

Marijuanamoment.net: New Jersey Senate President Files Psilocybin Legalization Bill That Includes Home Grow Option, Unlike Current Marijuana Law

Sfgate.com: ‘Magic mushrooms’ would be decriminalized in California under new bill

Lawenforcementactionpartnership.org

Instagram: ICEERS’ post about Kat Courtney, who was sentenced to 40 years in prison in the USA for ayahuasca

Cannadelic.miami

Posted on

PT379 – Intergenerational Trauma, Late-Stage Capitalism, and the Urban Indigenous Collective

In this episode, David interviews published researcher, social entrepreneur, and internationally recognized Indigenous rights activist: Sutton King, MPH.

In New York City alone, 180,000 people identify as Indigenous, Native American, or Alaskan Native, and this community is facing a disproportionate prevalence of mental health disparities, poverty, suicide, and PTSD due to intergenerational trauma from attempted genocide, forced relocation, and the erasure of culture and identity via boarding schools. Her purpose has become to bring light to what Indigenous people are facing due to being forced to live under a reductionist, individualistic Western approach that is in direct opposition to their worldview.

She talks about growing up being instilled with the importance of ancestry and tradition; why she moved to New York; how psychedelics helped her move through the trauma she felt in herself and saw so commonly in her family tree; and capitalism: how we need to move away from our private ownership, profit-maximalist, extractive model into a steward mentality inspired by the Indigenous voices and principles that have been silenced for so long.

And she lays out all that she’s doing to push these goals forward and help these communities: her work with the Urban Indigenous Collective, Shock Talk, the Indigenous Medicine Conservation Fund, Journey Colab and their reciprocity trust, and even her time last year at the World Economic Forum in Davos. We’re thrilled that she’ll be speaking at our conference, Convergence, this March 30 – April 2.

Notable Quotes

“One of the principles that I always was taught is that Indigenous peoples were always taught to be humble and not to be proud and not to be loud. But I have always felt like that was a way to keep us stagnant, to keep us complacent. So I would say I’m definitely a disruptor of this generation.”

“We are dealing with a burden of poverty, we’re dealing with so much chronic morbidity and mortality, as well and our chronic health. There is a number of different issues that we’re facing as Indigenous peoples. However, I’d also like to highlight how resilient we are as well. To be able to survive genocide, forced relocation, boarding school, and the poor socioeconomic status that many of us face [and] our families face, but continue to be a voice for our communities; continue to be on the front lines, advocating for missing and murdered, advocating for the protection of our land and demanding land back – I see a resurgence.”

“When you look at that skyline of that concrete jungle in New York City, I love to remind folks that it was the Mohawk ironworkers who risked their lives on that skyline, to be able to create the world we see around us. The paths that we walk today [and] the rivers that flow have always been used by the Indigenous peoples who came before us.”

“When we think about the economy and this market, it’s not capital that creates economic growth; it’s people. And it’s not this reductionist, individualistic behavior that’s centered at the core of economic good; it’s reciprocity, and being able to make sure that we have a market and an economy that’s inclusive; that’s bringing in all voices, that’s also considering all voices, all of the different parts of the ecosystem – not to silo people, but to bring everyone together, I think, will be the opportunity of a lifetime to really be able to really enact change.”

Links

Sutton-king.com

Urbanindigenouscollective.org

Imc.fund

Doubleblindmag.com: Why the “Psychedelic Renaissance” is just Colonialism by Another Name

Menominee-nsn.gov

YouTube: The Jingle Dress Dance

Wikipedia: Carlisle Indian Industrial School

Wikipedia: Ingrid Washinawatok (Flying Eagle Woman)

NPR.org: The pope’s apology in Canada was historic, but for some Indigenous people, not enough

Nysenate.gov: Senate Bill S6924A

IHS.gov (Indian Health Service)

Shocktalk.io

Wikipedia: Potlatch

Theseventhgeneration.org: Introducing The Seventh Generation Principle – to Promote True Sustainability

YouTube: TED Talk: The dirty secret of capitalism — and a new way forward (Nick Hanauer)

Bloomberg.com: Forget Burning Man — Psychedelic Shamans Now Heading to Davos

Journeycolab.com

Journeycolab.com: The Journey Colab Reciprocity Trust

Posted on

Psychedelics Weekly – Prop 122 and Data Privacy, Ending the Crack/Cocaine Sentencing Disparity, and the High Cost of Psychedelic Therapy

In this week’s episode, Kyle is back on the podcast, joining Joe to discuss three recent articles; two of which pose a lot of questions. 

They first look at Colorado’s Proposition 122, which, now that it has passed, enters into the long and arduous process of being figured out – all while existing in the complicated paradigm of state vs. federal legality. One of the biggest concerns revolves around data collection and privacy: Is the collected data truly anonymous? Since psychedelics will still be federally illegal, how can we trust that the DEA isn’t going to abuse their power? 

Next, they discuss Attorney General Merrick Garland making moves to end the sentencing disparity between offenses involving powder cocaine and crack cocaine: while essentially the same substance, being caught with 28 grams of crack cocaine currently carries the same sentencing as having 500 grams of powder!  

And lastly, they touch on a very interesting article from Lucid News about the value of psychedelic therapy, which gives some staggering data points showing why the black market will always exist: MDMA-assisted therapy sessions likely costing $11,500 (with the MDMA itself costing between $480 and $9,600), Esketamine treatments costing as much as $32,400 a year, and more – all with results that don’t seem to be as long-lasting as many believed they would be. This one deserves more analysis, but Joe and Kyle had limited time for recording this week, so stay tuned for more. For now, enjoy this episode, and Happy Holidays from the Psychedelics Today team!

Links

5280.com: Big Questions Surround the Rollout of Psychedelics in Colorado

Wired.com: Seeking Psychedelics? Check the Data Privacy Clause

Nbcnews.com: AG issues new guidance on ending sentencing disparities for crack versus powder cocaine cases

Psychedelicstoday.com: PT236 – Drugs: Honesty, Responsibility, and Logic, featuring Dr. Carl Hart

Lucid.news: Is the High Cost of Psychedelic Therapy Worth It?

Blossomanalysis.com

Tim.blog: Dennis McKenna — The Depths of Ayahuasca: 500+ Sessions, Fundamentals, Advanced Topics, Science, Churches, Learnings, Warnings, and Beyond (#523)

Posted on

PT378 – Course Corrections, Preparation, and High-dose Experiences: “Who Are You Now?”

In this episode, Joe interviews Zach Leary: host of the MAPS podcast, facilitator at Evo Retreats, author, and of course, son of psychedelic legend, Timothy Leary. 

Leary was last on the podcast four years ago, so this episode serves as a bit of a check-in and reconnection, and truly goes all over the map. He discusses his relationship with Ram Dass and reconnecting to psychedelics (and himself) after a 13-year spiritually-bankrupt career and not quite understanding his identity outside of his father’s shadow; why the psychedelic facilitation role shouldn’t be standardized; Dave Hodge, Kilindi Iyi, and super high-dose experiences; ancestor work; solo ski trips compared to the Vipassana experience; the ease with which people play Monday Morning Quarterback with the story of his father; floatation tanks and the birth of ketamine; why Ram Dass held a grudge against Dr. Andrew Weil; and critiques of Michael Pollan – how much How to Change Your Mind skipped, how little experience Pollan had before essentially jumpstarting a revolution, and how many people now think they’re ready for a psychedelic experience when they’re likely not.

Leary just recorded with Rick Doblin for the MAPS podcast, he’s finalizing his first book (tentatively titled And Now the Work Begins – Psychedelics in the 21st Century and How to Use Them), and launching an online 8-week course called “Psychedelic Studies Intensive,” which begins February 8. He will also be a guest at our first conference, Convergence (March 30 – April 2).

Notable Quotes

“I don’t believe that the psychedelic facilitation role or experience should be standardized. There are just so many ways to do it. There’s no one way to do it. Sure, there are some wrong ways to do it, there’s no doubt about that. But it shouldn’t be standardized. It shouldn’t be generic. It shouldn’t be one-size-fits-all. It really doesn’t matter to me if somebody has gone through the MAPS training program or CIIS; that doesn’t make them any more qualified than some of the amazing underground visionaries who are doing healing work as well. …No one psychedelic experience is the same. Why should the facilitation experience be the same?”

“It sort of becomes like a catch 22: If you have to ask if you’re ready for psychedelics… I don’t know, maybe you’re not.”

“If you look at every iteration on the war on drugs; every single one, going back to the late nineteenth century criminalization of opium against Chinese immigrants in the bay area, to African Americans [and] cocaine, to [the] Hispanic population and ‘Reefer Madness’ to white, long-haired, anti-authoritarian hippies dropping LSD, African Americans [and] the crack epidemic – every single time (I mean, this list is endless), it always goes back to a war against people [they] don’t like. And once you do that, you create an inherent system of corruption to fuel that, because it’s a civil war. It’s not a war against the drug. It’s a civil war against behavior [and] against consciousness.”

“This isn’t a political issue. It’s a human rights issue. Like it or not, every single society on the face of the Earth since recorded history has used mind and mood-altering chemicals. And that is never going to change, ever.”

Links

Zachleary.net

Zach’s Psychedelic Studies Intensive 8-week course

MAPS Podcast

Evoretreats.com

Psychedelics Today: Zach Leary – Trans-humanism, psychedelic use, over-use and taking a break

Spotify: The Joe Rogan Experience #891 – Zach Leary

The Wayback Machine: Maps.org

Zidedoor.com (Dave Hodge’s church)

Psychedelics Today: Remembering Kilindi Iyi

Theancestorproject.com

Goodreads.com: Lon Milo DuQuette’s quote

Floatworks.com: John C. Lilly: The pioneer of floating

Marijuanamoment.net: DEA Admits ‘Racial, Ethnic and Class Prejudice’ Led To Drug Criminalization And The Agency’s Own Founding

Thedailybeast.com: A Drug Kingpin, the CIA, and Prisoners: Freeway Rick Ross and America’s Mass Incarceration Problem

Newsweek.com: Two-Thirds of American Voters Support Decriminalizing All Drugs: Poll

Psychedelics Today: PT377 – Integrative Medicine: Health, Wellness, and Psychedelics, featuring Andrew Weil, M.D.

The Harvard Psychedelic Club: How Timothy Leary, Ram Dass, Huston Smith, and Andrew Weil Killed the Fifties and Ushered in a New Age for America, by Don Lattin

From Chocolate to Morphine: Everything You Need to Know about Mind-Altering Drugs, by Andrew Weil, M.D.

Posted on

Psychedelics Weekly – Proposition 122 in Action, The Economics of Psychedelics, and Could States Legalize by 2037?

In this week’s episode, Joe and David team up again to discuss what news interested them the most this week: the DA dropping a felony drug charge against a mushroom rabbi in Denver due to the passing of Proposition 122; Numinus Submitting a Clinical Trial Application to Health Canada that would give in-training practitioners the ability to experience psychedelics with their psilocybe-containing EnfiniTea; and a University of Exeter-led trial moving forward with the next step in a study using ketamine for alcohol use disorder (with 2/3 of the money coming from the National Institute for Health and Care Research).

They also review a paper that analyzed the economics of psychedelic-assisted therapies and how insurers come into play; as well as The Journal of the American Medical Association stating that, based on current trajectories compared to cannabis legalization, they believe the majority of states will legalize psychedelics by 2037. So nice to see these continued steps in the right direction!

And if you missed it, we just announced that applications are open for the next edition of Vital. There are incentives to paying in-full by certain dates, so if you missed out on last year’s edition or have been curious, attend one of our upcoming Q+As!

Links

Cure for common cold? New research finds immune response in nose that plummets when temps drop

Vitalpsychedelictraining.com (Applications open now!)

Vital 2023: Informational Session and Q&A (Have questions about Vital? Attend one of these sessions)

Convergence: Where Conference Meets Festival

The Way of the Psychonaut Vol. 1: Encyclopedia for Inner Journeys, by Stanislav Grof, MD, Ph.D.

Microdosing Masterclass: Investigate the history, science, and best practices for safe and effective microdosing

The Psychedelic Explorer’s Guide: Safe, Therapeutic, and Sacred Journeys, by James Fadiman, Ph.D.

Denverpost.com: DA drops felony drug charge against Denver’s mushroom rabbi, citing voter legalization of psilocybin

Congress.gov: H.R.1308 – Religious Freedom Restoration Act of 1993

Thesacredtribe.org

Numinus.com: Numinus Submits Clinical Trial Application to Health Canada for Experiential Psilocybin-Assisted Therapy Training Research

Frontiersin.org: The economics of psychedelic-assisted therapies: A research agenda

Therapsil.ca: Quebec first province to cover costs of psilocybin-assisted psychotherapy, done by two physicians

Jamanetwork.com: Psychedelic Drug Legislative Reform and Legalization in the US

Marijuanamoment.net: Most States Will Legalize Psychedelics By 2037, Analysis Published By American Medical Association Predicts

Psychedelicalpha.com: Psychedelic Legalization & Decriminalization Tracker

Bbc.com: Ketamine for alcoholics trial goes to next stage

Psychedelics Today: Webinar: Psychedelic Integration and Depth Relational Process – 12/9

Posted on

PT377 – Integrative Medicine: Health, Wellness, and Psychedelics

In this episode, Joe interviews New York Times best-selling author, pioneer in the field of integrative medicine, and overall legend in the health and wellness space: Andrew Weil, M.D.

As the author of 15 books on health and wellbeing and a regular in the media, you’re probably familiar with Weil and some of his work, but you may not know of his more psychedelic connections: a long history of experimentation, leading Paul Stamets in the direction of functional mushrooms, co-writing one of the first papers about the Sonoran Desert toad and 5-MeO-DMT with Wade Davis, and being a strong advocate for psychedelics being the spark that could spur a global change in consciousness.

He talks about the connection between true osteopathy and integrative medicine; why the traditional Chinese medicine approach to mushrooms made so much sense to him; academia’s lost interest in pharmacognosy; how psychedelics may help people with autoimmune diseases; turmeric (he largely popularized it as an anti-inflammatory supplement); matcha; why we should be studying the placebo effect much more than we are; humanity’s innate drive to experience altered states of consciousness; and why a big part of the psychedelic revolution is so many people starting to believe in panpsychism. 

We’re pumped to finally have him on the podcast, and we’re even more excited that he’s spreading the gospel of psychedelics to a health and wellness crowd who may still be a bit apprehensive about something they were taught to fear.

Notable Quotes

“I’m tremendously interested in [psychedelics’] potential at the moment for therapeutic use and ceremonial use, and actually, if I think about it, I would say I’m really interested in the possibility that they can save the world. I don’t see many other things out there that can do that.”

“I don’t know anything else that is so readily available and that, with at least some attention to how you do them, has such a potential to change how people interpret their perceptions and interpret their experience of the world around them. I’ve seen just such dramatic changes in people and in myself as a result of psychedelic experience. …My first book, The Natural Mind, that was published in 1972, said that only a global change in consciousness could really transform our world, and I think that the psychedelic revolution has the potential to do that.”

“I think the placebo response is the meat of medicine. That’s what you want to try to make happen. It’s pure healing response from within, mediated by the mind and unmixed up with the direct effects of treatment. …The commonest way I hear that word used is things like, ‘How do you know that’s not just the placebo response?’ or ‘We have to rule out the placebo response.’ I mean, we should be ruling it in. You want to make it happen more of the time.”

“Human beings have an innate drive to experience altered states of consciousness, not necessarily through the use of drugs (although drugs are a very convenient way to do it). One of the examples I gave was of kids learning to spin until they get dizzy and fall over and the world changed, and that’s universal as far as I can tell, in all cultures. So I got a lot of crap from people for saying that there was an innate drive toward altered states of consciousness, but I absolutely believe that, and I think that a part of the drug problem in our culture has been our failure to acknowledge that and teach people safe and better ways of satisfying it.”

Links

Drweil.com

The Andrew Weil Center for Integrative Medicine

Dr. Weil’s Matcha (use code: PsyToday for a generous discount!)

Wikipedia.org: Robert C. Fulford

Psychedelics Today: Wade Davis – Ayahuasca and a New Hope for Colombia

Psychedelics Today: Could the Sonoran Desert Toad Cure Narcissism?

Pubmed: Bufo alvarius: a potent hallucinogen of animal origin

Psychedelics Today: Dr. Malin Vedøy Uthaug – Ayahuasca and 5-MeO-DMT Research

Riverstyxfoundation.org

Wikipedia.org: Pharmacognosy

Psychedelicpharmacist.org

Psychedelicreview.com: Psychedelics as Anti-Inflammatory Agents

Usnews.com: Is the Green Mediterranean Diet Healthier Than Regular Mediterranean?

Psychedelicmedicinecoalition.org

Vogue.com: Can Psilocybin Challenge Our Pharmaceutical Dependence?

​​From Chocolate to Morphine: Everything You Need to Know about Mind-Altering Drugs, by Andrew Weil

Psychedelics Today: PT236 – Drugs: Honesty, Responsibility, and Logic, featuring: Dr. Carl Hart

Psychedelics Today: Psychedelics, Philosophy, Transhumanism, and Peter Sjöstedt-H

Exploringyourmind.com: Panpsychism: A Fantastic Theory About Consciousness

Posted on

Psychedelics Weekly – Genetic Memory, “The Psychedelic Renaissance,” and Harm Reduction at Music Festivals

In this week’s episode, Joe and David team up for the first time to discuss three articles: Chacruna’s breakdown of the study, “Ceremonial Ayahuasca in Amazonian Retreats – Mental Health and Epigenetic Outcomes From a Six-Month Naturalistic Study,” Double Blind’s “Why the ‘Psychedelic Renaissance’ is just Colonialism by Another Name,” and the results from the trial of a 20-year old woman who died at the 2017 Lightning in a Bottle music festival – where the jury found Do Lab, Inc., RGX Medical, and RGX Founder Richard Gottlieb to hold 75% of the liability in her death, with MAPS holding 25%.

In discussing these articles, much is covered: methylation and genetic memory; addiction; gut biome; cesarian births; how much inequality is built into the “psychedelic renaissance” due to it primarily evolving out of inherently unequal Western societal paradigms; permaculture; new ways to be together; Burning Man; the concept of the nuclear family; the power in working with your hands; creativity; harm reduction and the lack of readily available drug testing kits; and more.

Links

Vitalpsychedelictraining.com

Convergence

Microdosing Masterclass: Investigate the history, science, and best practices for safe and effective microdosing

The Microdosing Guidebook: A Step-By-Step Manual to Improve Your Physical and Mental Health Through Psychedelic Medicine, by C.J. Spotswood, PMHNP

Chacruna.net: Ceremonial Ayahuasca in Amazonian Retreats: Mental Health and Epigenetic Outcomes From a Six-Month Naturalistic Study

The study on Pubmed

Psychedelics Today: PT295 – Sidarta Ribeiro – Dreams, LSD, and Biopiracy

Psychedelics Today: PT270 – Dr. Rachel Yehuda – Research Trials and The Future of Psychedelic Neuroscience

The Way of the Psychonaut Vol. 1: Encyclopedia for Inner Journeys, by Stanislav Grof, MD, Ph.D.

The Fellowship of the River: A Medical Doctor’s Exploration into Traditional Amazonian Plant Medicine, by Joseph Tafur, MD

Psychedelics Today: PT326 – Dr. Rick Barnett, Psy.D – Addiction, Recovery, and Competency in Psychedelic Therapy

Doubleblindmag.com: Why the “Psychedelic Renaissance” is just Colonialism by Another Name

Psychedelics Today: PT376 – Ketamine and Psychedelic-Assisted Therapy as Employee Benefits, Featuring Sherry Rais

Wikipedia.org: Nagoya Protocol

How Soon Is Now?: A Handbook for Global Change, by Daniel Pinchbeck

Shop Class as Soulcraft: An Inquiry Into the Value of Work, by Matthew B. Crawford

Maps.org: Jury Finds in Favor of Plaintiffs in Trial on Harm Reduction and Medical Responsibility

Lucid.news: MAPS Found Liable in Wrongful Death Lawsuit

MAPS’ Settlement-and-Release-Agreement-5.27.21

Zendoproject.org

Wearetheloop.org

Psychedelics Today: PT370 – Prohibition, Civil Disobedience, and The Coca Leaf Cafe, featuring Dana Larsen

YouTube: Israeli Harm Reduction – A Real World Trip From Raves to Parliament (A Psychedelics Today webinar)

Posted on

PT376 – Ketamine and Psychedelic-Assisted Therapy as Employee Benefits

In this episode, David interviews Sherry Rais: Executive Director of the Boston Psychedelic Research Group, Grants Manager for CIIS, and CEO/Co-Founder of Enthea.

Enthea is a benefit plan administrator that provides health plan benefit riders and single case agreement services for psychedelic healthcare with a provider network including certified and credentialed Ketamine-Assisted Therapy (KAT) and Psychedelic-Assisted Therapy (PAT) practitioners. In other words, if a company wants to offer psychedelic-assisted therapy as a benefit for their employees, Enthea makes this possible (and affordable). Their first client was the very psychedelically-minded Dr. Bronner’s Magic Soaps, and they’ve just announced the signings of three new clients that you may not expect to provide KAP to their employees: Daybreaker, Tushy, and Guinn Partners. Their goal is to have 100,000 covered lives in 40 cities by the end of 2023, and, alongside the guidance of MAPS, hopefully roll out MDMA-assisted therapy in Q2 of 2024. 

Rais talks about Enthea’s process, costs, and goals; her Ismaili religion; her nomadic, marathon-running life; her experience sleeping on the streets of Toronto at 16 and her need to help the less-fortunate; how her most powerful psychedelic experience was watching someone else transform; and why companies are suddenly interested in these emerging therapies.

Notable Quotes

“For me, the most powerful psychedelic experience I had was actually in a situation where I was sitting with someone else and saw this person transform in front of me. That was two years ago and that person; I still see the effects of that experience on that person’s life and how much he’s changed from this one experience, and I’ve never seen anything like it. It was the most beautiful thing I’ve ever witnessed.”

“I think you and I know that these medicines work, and we also know that they cost way more than $500, and immediately, that tells me there’s an equity crisis in the ecosystem; that we’ve finally found medicines that may be able to help millions of people that are suffering from a variety of issues, and there’s this huge barrier and its cost. So the goal of Enthea is to solve that problem by making these medicines affordable.”

“The fact that you have a plan that doesn’t cover mental health is very telling of the landscape and the culture in America today and why you’ve made the case for me on why Enthea is needed. Because if this doesn’t happen, when will people get access? They’ll continue waiting and waiting and waiting that their primary insurance provider covers this.”

Links

Enthea.com

Minority Trip Report Podcast: 1-7 – Sherry Rais: Social Impact, Psychedelic Therapy as Employee Benefit, and Finding Strength as a Female CEO

Bostonpsychedelicresearchgroup.com

Psychedelics Today: PT364 – Burning Man, Psychedelic Maturity, and Radical Hope, featuring: Jamie Wheal

Drbronner.com: Dr. Bronner’s to Provide Psychedelic-Therapy as Employee Healthcare Benefit

Drbronner.com: Ketamine-Assisted Therapy, A Light In The Dark

Finance.yahoo.com: Laid-off workers can now get a free month of ketamine-assisted therapy services to help with their mental health

Flowintegrativeketamine.com

Nue Life Health

Tabularasahealthcare.com

Posted on

Psychedelics Weekly – Cannabis as an Adjunct Cancer Treatment & 5-MeO-DMT Reactivations

In this week’s episode, Joe and Alexa talk about the excitement brewing around our first conference-meets-festival, Convergence (March 30 – April 2 at the Wisdome in LA), and some of the sponsorships starting to come in (interested? email Alexa@psychedelicstoday.com).

Then, they dive into what intrigued them the most this week: a study looking into potentiality and possible causes of 5-MeO-DMT reactivation (and what reactivation actually is); New York cannabis farms sitting on $750 million worth of cannabis as the government drags its feet on licenses; and the story of a woman who used cannabis and psilocybin as an adjunct to standard therapy in the treatment of advanced metastatic breast cancer.

Links

Convergence (Use code PTINSIDER10 for 10% off!)

Thebrothersapothecary.com (Use code SHROOM for 30% off)

Hearthstonecollective.com

Psychedelics Today 236 – Drugs: Honesty, Responsibility, and Logic, featuring: Dr. Carl Hart

Psychedelics Today 268 – PCP, 5-MeO-DMT, and The Synthesis of New Psychedelics, featuring: Hamilton Morris

Frontiersin.org: Reactivations after 5-methoxy-N,N-dimethyltryptamine use in naturalistic settings: An initial exploratory analysis of the phenomenon’s predictors and its emotional valence

YouTube: Norm Macdonald talks LSD

Psychedelics Today: HPPD and Flashbacks: Everything You Need To Know – And What We Don’t Know, Too

Bloomberg.com: New York Cannabis Farms Have $750 Million of Weed — and Nowhere to Sell It

Grace Health & Wellness

Journals.sagepub.com: Raising awareness: The implementation of medical cannabis and psychedelics used as an adjunct to standard therapy in the treatment of advanced metastatic breast cancer

Ricksimpsonoil.com

Lucid.news: Researcher Charles Nichols Studies the Impact of Psychedelic Substances on Inflammation

Righttotry.org: What Is Right To Try?

Leaf411.org: The cannabis nurse hotline

Posted on

PT375 – Microdosing & Citizen Science: Introducing the World’s First Take-Home EEG Microdosing Study

In this episode, Victoria hosts a bit of a microdosing roundtable, speaking with three champions of microdosing: “The Father of modern microdosing,” James Fadiman, Ph.D.; Adam Bramlage, Founder/CEO of Flow State Micro (a functional mushroom company and microdosing educational platform); and Conor Murray, Ph.D., a neuroscientist at UCLA who conducted the world’s first EEG microdosing study. 

Fadiman and Bramlage recently launched a very popular course through our Psychedelic Education Center: “Microdosing Masterclass,” which covers the history and science of microdosing, as well as best practices for microdosing safely and effectively. They discuss the roots of microdosing, decriminalization and concerns over the corporatization of psychedelics, what we’ve seen so far in research, and how we’re finding ourselves in an era where people are going to be allowed to actually help themselves.

Murray is hoping to make big waves in the promotion of microdosing with the world’s first take-home EEG microdosing study: participants will be mailed a wireless headband that will be able to track brain activity in real world scenarios – the citizen science we’ve so desperately needed in comparison to lab studies that couldn’t be more different from how people actually live day-to-day. There is no criteria to participate, and, in contrast to lab studies, they want all data possible: people who are in therapy or not, people following different microdosing protocols, people microdosing for different reasons, etc. Will microdosing improve brain scores on cognition and emotion? Will participants see measurable improvements? And how will these numbers look when comparing scores months after initial peak neurological windows? 

If you’d like to participate, head to psynautics.com and sign up. The first 50 people to do so will receive the wireless EEG to track their brain for one month for only $40.

Notable Quotes

“Because it’s inherently interesting for people to find that their consciousness can be improved (not necessarily changed) and that their whole physical system can also be improved, microdosing has found a natural niche which is: it might be good for you, and as far as we can tell, it’s very, very, very, very, very rarely bad for you. And that’s a nice risk/reward ratio.” -James

“It’s hard to fool the brain. You can maybe have a good placebo effect if you’re trying to ask someone: how much do you think your cognition’s improving today or emotion’s improving today? But it’s harder to fool the brain into having a different answer.” -Conor

“There’s so many people who will not buy into this until it’s proven by modern science, and that’s why Conor and his work is so important, and this new study with the wireless headbands and the idea that every citizen scientist on the planet can write Conor at Conor@psynautics.com and be a part of this study and get a wireless headband – I mean, that is fascinating. That is taking microdosing out of a sterile lab and putting it into the natural environment where it came from, as hunter-gatherers, for hundreds of thousands of years.” -Adam

“That’s really the metaphor, which is: the more windows, the more you see different views, and there’s nothing good or bad about any particular window except how clean it is. …We’re opening up bigger windows in more directions than has been the case in the past.” -James

Links

Adam and James’ Microdosing Masterclass

The Art of Microdosing Q+A with Dr. James Fadiman & Adam Bramlage (A Psychedelics Today webinar)

Jamesfadiman.com

Psychedelics Today: PT353 – Psychedelics and Creativity, featuring: Dr. James Fadiman, Dr. Sam Gandy, Dr. David Luke

Psychedelics Today: PT275 – Transpersonal Psychology, Microdosing, and Your Symphony of Selves, featuring James Fadiman, Ph.D.

Psychedelics Today: PT303 – Cannabis, Microdosing, and Our Evolutionary Connection to Psychedelics, featuring Adam Bramlage

Flowstatemicro.com

Psychedelicsocietysf.org: Microdosing Movement masterclass

Psynautics.com (order your headset here)

UCLA Psychedelic Studies Initiative

Wikipedia.org: Pituri

The Psychedelic Explorer’s Guide: Safe, Therapeutic, and Sacred Journeys, by James Fadiman, Ph.D.

Hightimes.com: North America’s First Take Home Psilocybin Trial Approved in Canada

Microdose.me

YouTube: “Drugs: The Children Are Choosing” 1969 Drug Abuse Awareness & Discussion Film

Posted on

Psychedelics Weekly – Bipartisan Political Movement & Psychedelics and Pain

This week features David Drapkin, Joe Moore (for the first part), and introduces Alexa Jesse, who you’ve probably heard in ads, but who makes her first appearance on the podcast. 

They discuss two big political moves in the advancement of psychedelics: the creation of the Congressional Psychedelics Advancing Clinical Treatments (PACT) Caucus (led by Representatives Lou Correa (D-CA) and Jack Bergman (R-MI)), and the filing of the Breakthrough Therapies Act by Senators Cory Booker (D-NJ) and Rand Paul (R-KY).

And they talk about the story of Jim Harris overcoming paralyzation through psilocybin; NICE (National Institute for Health and Care Excellence) determining that Esketamine is not cost-effective; new progress in Germany and Finland; MDMA-assisted therapy (and other psychedelics) showing alleviation of chronic pain; a ramp up in LSD research for Alzheimer’s studies; and more.

Plus, we hear a bit of Alexa’s story, wish Joe and Johanna happy birthdays, and talk about what’s most immediate in the PT world: Early Bird pricing ending today for our first conference, Convergence (use code PTINSIDER10 for a 10% discount!), and the next round of Navigating Psychedelics launching next week. 

 

Links

Bipartisan Lawmakers Form New Psychedelics Caucus In Congress (Marijuana Moment)

Psychedelicmedicinecoalition.org

House Lawmakers Launch Bipartisan Psychedelics Caucus (High Times)

Jim Harris Was Paralyzed. Then He Ate Magic Mushrooms (Outside Online)

Surprising Results: Psilocybin Trial for Depression Alleviates Chronic Pain (Psychedelics Today)

Why Did Psychedelics Relieve My Chronic Pain? (Psychedelics Today)

Chronic Pain and Phantom Limb Pain: Could Psilocybin Be the Answer? featuring: Timothy Furnish, MD & Joel Castellanos, MD (Psychedelics Today)

National Institute for Health and Care Excellence (NICE): Esketamine nasal spray for treatment-resistant depression

MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorder (Frontiers)

Second MAPS-Sponsored Phase 3 Trial of MDMA-Assisted Therapy for PTSD Completed (MAPS)

Finland grants license for psychedelic drug therapy study (YLE)

Apollopact.org

Psychedelic Storytelling: Transforming Out Loud, featuring: Cory Firth (Psychedelics Today)

German Government Funds Psilocybin Study for Depression (Mind and Brain Institute)

LSD Research Ramps Up: Full-Dose & Microdosing For Alzheimer’s Studies Led By Beckley Foundation Coming Soon (Benzinga)

Chris Hemsworth Learned He Has a High Alzheimer’s Risk: What to Know (Healthline)

Posted on

PT374 – Personalizing Psychedelic Integration

In this episode, Kyle interviews psychologist, psychotherapist, author, and certified Holotropic Breathwork® facilitator: Marc Aixalà.

Aixalà is part of the International Center for Ethnobotanical Education, Research and Service (ICEERS), offering integration psychotherapy sessions, developing theoretical models of intervention, and training and supervising therapists. He is also the writer of the recently released, Psychedelic Integration: Psychotherapy for Non-Ordinary States of Consciousness, of which you can win a copy by entering our giveaway here!

Aixalà wrote the book after receiving more and more emails from people asking for guidance on how they were supposed to process a recent experience, and he realized that so much was unknown around the concept of integration: What exactly does it entail? Has the psychedelic space created a narrative that you need integration when maybe you don’t? When is the work considered integration and when is it psychotherapy?

He talks about some of the metaphors he uses to explain integration; the seven scenarios he typically sees in people seeking integration (and how to respond to each); philosophical constructivism and the importance of working with someone within their preferred cosmology; how the psychedelic hype has created a marketplace full of competition (and why that could be bad); and why he thinks being trained in Holotropic Breathwork is perhaps more important than being trained in facilitating a psychedelic experience. 

Notable Quotes

“One of the things that psychedelics show us (or for me, the main thing) is that somehow, healing is inside of us and growth is inside of us, and they teach us accountability, they teach responsibility, and they teach us that we are the expert of ourselves – that our journey does not depend on an external person. So in my way of practicing integration, I also want to honor that, and do integration when it’s needed, but not create an additional need for people that don’t have it.”

“I think that that’s the richness and the beauty of psychedelics and the psychedelic experience, is that it cannot be understood from just one prism. No, it’s a trans-disciplinary approach that will give us a more subtle understanding of different dimensions included. I don’t think that there’s one way that is better than the other of using psychedelics, [just] as I don’t think that there’s one Shamanic tradition that is better than another Shamanic tradition. Things are there for a reason and we find what resonates more with us.”

“I believe that breathwork can be more effective than psychedelics to deal with certain emotions; things like anger, rage. The body and the somatic part of a traumatic event; that has worked very well with breathwork in my opinion – better than with other substances because it provides some sort of mental clarity that is not distorted by the archetypal aspects of psychedelics.”

Links

Marcaixala.com

Psychedelic Integration: Psychotherapy for Non-Ordinary States of Consciousness, by Marc B. Aixalà

Win a copy of Psychedelic Integration here!

Iceers.org

Psychedelics Today: PT368 – Ketamine, Group Work, and the Power of Just Being There

Wikipedia.org: Constructivism (philosophy of education)

Psychedelics Today: PT316 – Lenny Gibson, Ph.D. – Vital Psychedelic Conversations

Posted on

Psychedelics Weekly – Oregon Measure 109: Approaching the Proposed Final Rules

This week’s episode features David Drapkin and Jon Dennis, who you know from Eyes on Oregon and all of the work he’s done in an effort to protect religious freedom under Oregon’s Measure 109.

They discuss opposition and concerns around Colorado Proposition 122 (which officially passed last week with 53% of the vote!) and recent cannabis legalization in three states, then move on to Oregon: what it’s been like being so involved in Measure 109’s rulemaking progress, what people were saying during this week’s final public comment period, whether María Sabina would be able to work under the proposed guidelines, and even the idea of microdosing under this new framework. 

Links

Eyes on Oregon

Psychedelics Today: Religious Practice Under Oregon Measure 109

Navigating Psychedelics For Clinicians and Therapists

Microdose.buzz: Colorado Votes to Legalize Psilocybin Therapy; Allow Personal Use of Psychedelics (Microdose)

Native coalition against Colorado Natural Medicine Health Act (Indian Country Today)

Oregon Psilocybin Business Bans Approved By Voters In Cities And Counties Across The State (Marijuana Moment)

Nearly 70% of Oregon bans psilocybin, but clinics will still open next year (Leafly)

Oregon Psilocybin Services Act (Measure 109) Local Jurisdiction Tracker (Psychedelic Alpha)

Oregon Psilocybin Advisory Board Overview

Eyes on Oregon: Last Call – Proposed Final Rules for Measure 109 (Psychedelics Today webinar replay)

With speeches, stars and a blow-up joint, protesters press Biden on pot (Washington Post)

Most Voters In Two States That Defeated Marijuana Ballot Measures Actually Support Legalization In General, Election Poll Finds (Marijuana Moment)

Psychedelicalex.com

Posted on

PT373 – Integrative Psychiatry & The Safety of At-Home Ketamine

In this episode, David interviews Dr. Ben Medrano: Co-Medical Director with Nue Life, board-certified psychiatrist specializing in integrative psychiatry, and former Senior Vice President and US Medical Director of Field Trip Health.

He discusses his path to Nue Life; from growing up around mental illness, to the rave scene, to Buddhism, to his years working for the underserved in an East Harlem Assertive Community Treatment, and his biggest takeaway from that time: that the healthcare system he knew was not truly helping people. He talks about stigmatization (of some modalities like electro-shock treatment, of psychedelics, and of ketamine – which seems to be stigmatized even within the psychedelic space); his concerns that the at-home ketamine model is at risk as we make our way out of the pandemic; and how at-home ketamine can drastically reduce the cost of treatment. 

Medrano tells a great story of a patient who saw incredible improvements through ketamine, and discusses some Nue Life highlights: their just-released 664 participant-study in Frontiers Psychiatry showing the safety of at-home ketamine (and that at-home is just as effective as other routes of administration); Nue Care, their model for aftercare using digital phenotyping, goals, and a scoring system (which he believes could be the new model for integrative psychiatry); and their Nue Network, which could be a solution for better education on ketamine and for granting access for patients through prescribers who typically don’t understand much about its efficacy.

Notable Quotes

“All the different interests, personalities, visions, [and] goals that are in this sort of circus of psychedelic commercialism is very necessary to understand. And for me, I think the biggest takeaway is that there is one thing that binds everybody who’s involved, and that is hope, really. I think there’s a lot of hope in this sphere.”

“The hazards of a benzodiazepine are well known, and to some extent, one might even argue that with some of these DEA-regulated substances that we do ship at home; that if we’re going to say that we need to subject ketamine to a higher standard, then we need to do it for the rest of these DEA-regulated substances, because they have very hazardous risk profiles. …I can’t help but think that there’s a little bit of …stigma [around] what it is that we’re doing.”

[On an at-home ketamine patient’s success]: “He is able to get out of the house every day and enjoy the sunshine, and the way he views his trauma is at a level that I think all of us would aspire to: really, as something that has sort of made him into the man that he is today, with something really unique and powerful to offer as a human to others – rather than as a wound.”

Links

Benmedranomd.com

Nue.life

Psychedelics Today: Free Webinar – NueLife: Empowering Patients with At-Home Ketamine Therapy

Wikipedia.org: Assertive community treatment

Fieldtriphealth.com

Legitscript.com: A Post-Pandemic Ryan Haight Act May Create Uncertainty for Telemedicine

Nue.life: Nue Life Publishes First Peer-Reviewed Study in Frontiers in Psychiatry

Frontiersin.org: Safety, effectiveness and tolerability of sublingual ketamine in depression and anxiety: A retrospective study of off-label, at-home use

Sciencedirect.com: At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial

Psychiatryinstitute.com

Posted on

Psychedelics Weekly – Wonderland Controversy and Colorado Proposition 122

In April of 2020, the world was locking down at the same time the Black Lives Matter movement was gathering steam, and Joe and Kyle found themselves in new territory, filled with uncertainty and fear while watching conflicts explode everywhere. They felt an immediate need to talk about all that was happening, largely as a way to break through the lockdown malaise and connect with each other, and hopefully, our audience. And so, Solidarity Fridays was born: a different style of podcast that, instead of interviewing a guest about their story, focused on what was most pressing in their world: in the psychedelic space, and in their lives.

Other priorities took over and the series slowly faded away, but today, we’re happy to announce that the spirit of Solidarity Fridays has returned in a new weekly show, aptly titled Psychedelics Weekly.

The show will feature a rotating cast of familiar voices, while introducing new hosts and friends of the show, covering the most important psychedelic news (and our take on it), while giving you all a glimpse into what’s going on in our lives and at Psychedelics Today.

This week features Joe and Kyle, discussing the controversy around Wonderland banning a small list of people from attending, Colorado Proposition 122 passing (at least we think…), and the newest round of Navigating Psychedelics (starting November 29th; reserve your seat now!). 

Links

Colorado Voters Approve Psychedelics Legalization Ballot Initiative (Marijuana Moment)

Proposition 122: Decriminalization and Regulated Access Program for Certain Psychedelic Plants and Fungi Initiative details (Ballotpedia)

Native coalition against Colorado Natural Medicine Health Act (Prop 122 opposition from Indian Country Today)

Prop 122 Opposition from Protecting Colorado Kids

The 2nd Annual Microdose Awards winners (where’s Podcast of the Year?)

Navigating Psychedelics for Clinicians and Therapists (new round begins November 29th!)

Posted on

PT372 – The Heroic Hearts Project: Veterans and The Impact of Storytelling

In this Veteran’s Day episode, Joe checks in with two members of the Heroic Hearts Project: Founder and President, Jesse Gould, and Chief of Operations, Zach Riggle.

Heroic Hearts’ mission is to create a healing community that helps veterans suffering from military trauma recover and thrive through helping them gain access to psychedelic treatments, professional coaching, and ongoing peer support – and we’re always happy to have them on the podcast to remind listeners about the extremely important work they do. 

Among other projects, they are currently running several studies: psilocybin for gold star wives (spouses of fallen soldiers), ayahuasca for combat veterans, and ibogaine for special operations veterans through the University of Texas at Austin Dell Medical School’s Center for Psychedelic Research & Therapy; a study with the University of Georgia on personality change through psychedelics; a gut microbiome study with University of Colorado Boulder; and a psilocybin for head trauma study through Imperial College London. And today, they released the short film, “It’s Time – A Documentary of Veterans and Pro Athletes Seeking Healing Through Psychedelics.”

Gould and Riggle discuss the growth in interest and acceptance in psychedelics they’ve seen over the last few years; the importance of people telling their stories; relative trauma and how people too often wait to seek help; how trauma isn’t always due to a single event; Colorado’s Proposition 122 (which passed!); the need to have standard measurements in psychedelic studies; and how people who go through trauma together can heal together.

Notable Quotes

“At what point do we ask for help? I think, just as a society, we feel like things have to be in full-on crisis before we need to seek some sort of assistance. And we want to put [it] out there that that doesn’t have to be the case – that if you’re able to look at your life and realize that there may be some areas where things could improve and you might need some help in improving them, then don’t be afraid to reach out, because we’re not going to turn you away.” -Zach

“In the standard medical world, the physicians [or] the psychologists are looking at that qualifying incident and trying to heal that, trying to address that. And there’s some things that are pretty effective …but they’re working largely on that single incident, and ignoring all the other things that may have happened over time. And that’s where psychedelics can be so beneficial, is that they address that whole issue with a full system reset.” -Zach

“You take a population that largely (due to their illness) has been isolating, pushing everyone away, and just sitting back and looking at how amazing everyone else’s life is while theirs continues to deteriorate. Well, we plug them back into a community, bring them in, and help them to heal together. That’s a powerful thing to realize: that communities that were traumatized together; they heal better together.” -Zach

Links

Heroicheartsproject.org

YouTube: “It’s Time – A Documentary of Veterans and Pro Athletes Seeking Healing Through Psychedelics”

Heroic Hearts Project – Canada

Heroic Hearts Project – UK

Psychedelics Today: PTSF77 – Progress and Context, with Jesse Gould of the Heroic Hearts Project

Jesse Gould and Keith Abraham – Heroic Hearts Project: Connecting Veterans to Psychedelic Treatment

Veteransofwar.org

VETsolutions.org

Menshealth.com: This Veteran Is Helping Other Soldiers Restore Their Mental Health

University of Texas at Austin Dell Medical School: Center for Psychedelic Research & Therapy

Goldstarwives.org

Missionwithin.org

Psychedelichealth.co.uk: Heroic Hearts to research psilocybin treatment for brain injury in veterans

Soundmind.center

Mayahealth.com

Ayahuascafoundation.org

Justice.gov: uBiome Co-Founders Charged With Federal Securities, Health Care Fraud Conspiracies

Psychedelics Today: PT223 – Daniel Carcillo – Life After Sports

Drbronner.com

Marijuanamoment.net: Colorado Voters Approve Psychedelics Legalization Ballot Initiative

Reason-for-hope.org

Firesideproject.org

Chacruna.net

Posted on

PT371 – The Trickster Archetype and the Need for Comic Relief

Unless you’ve somehow managed to stay away from it all, there’s a lot of conflict in the world right now, and arguments and vitriol never seem to be more abundant and impassioned than in the time leading up to an election – which is where we find ourselves today. So, what a perfect time to laugh!

In this episode, Victoria interviews podcaster and Instagram comedian gone-viral, Dennis Walker, who talks about the value of satire: how people are realizing that often, humor is the way to cut through the noise and make difficult news more palatable, and how this is something we especially need to remember in our psychedelic echo chamber where it’s all too easy to start yelling rather than hear each other out. He views his platform, Mycopreneur, as “The Onion of the psychedelic space,” – a way to embrace the classic Trickster archetype and laugh at some of the absurdity in our lives, while also calling attention to important issues that aren’t always easy to talk about. 

He discusses his long relationship with mushrooms; how “The Daily Show” and other satirists changed the way we consume news; his experiences with having people he’s parodied appreciate his work; going viral (his most popular reel has 164k views); and also, on a more serious note, how mushrooms could be the answer to many of humanity’s geopolitical challenges around pollution, hunger, and sustainability.

Head to his instagram to check out some of his characters like Don Chad or his ideas like “PsychoNaughty,” and if his humor doesn’t do it for you, go spend time with something that does. It’s important to take things seriously (if you’re in the US, get out and vote!), but it’s just as important to laugh.

Notable Quotes

“I think we just live in a state of perpetual crisis right now as a society, and the psychedelic movement can’t help but internalize that and reflect that. …We’re dealing with a powder keg right now of all of these underlying issues that are bubbling up to the surface and that we’re having to confront collectively, and I think that even in the most serious dramas in theater or in television, there’s comedic relief.”

“I started reading through these 17 goals and producing the interviews that students did with various stakeholders from the Los Angeles Mayor’s office or from representatives from the United Nations and this and that and the other, and all of the subject matter they were talking about – about the need for sustainable development all over the globe; the need for cleaner, safer, smarter cities; the need for more equity across industry and across society; etc., etc. – I realized that in my perspective, mushrooms filled a lot of these niches.”

“Remember to have fun. Remember that even the most serious political, geopolitical, business, this and that and the other intersections that are going on in our world; there’s room to laugh about it and there’s room to not take everything so seriously, because that’s actually bad for your health. So if we’re talking about therapeutic value in psychedelics; laughter, humor, levity, [and] wit are extremely valuable from a therapeutic perspective.”

Links

Mycopreneur.com

Mycopreneur podcast

Instagram: @mycopreneurpodcast

Psychedelicalpha.com: Opinions | The Psychedelic Community Takes Itself Too Seriously

Psychedelics Today: Mark Plotkin – Bio-Cultural Conservation of the Amazon

Food of the Gods: The Search for the Original Tree of Knowledge a Radical History of Plants, Drugs, and Human Evolution, by Terence McKenna

Psychedelics Today: PT362 – Psychedelic Storytelling: Transforming Out Loud, featuring Cory Firth

The Official Navy SEAL Podcast

Mycopreneur: Season 1, Ep. 1 – Michelle Janikian: Psilocybin and Mental Health

“The Woke Capitalist Spiritual Retreat Center” reel that went viral

IMDB.com: Succession

Lonerwolf.com: 11 Trickster Archetypes That Provoke and Heighten Your Consciousness

Organic Mushroom Farming and Mycoremediation: Simple to Advanced and Experimental Techniques for Indoor and Outdoor Cultivation, by Tradd Cotter

UN.org: The Sustainable Development Agenda

”PsychoNaughty” reel

Psychedelics Today: PT269 – Adam Strauss – Comedy, OCD, and The Mushroom Cure (not mentioned, but another psychedelic-minded comedian)

Posted on

PT370 – Prohibition, Civil Disobedience, and The Coca Leaf Cafe

In this episode, Joe interviews Dana Larsen: one of Canada’s most well-known advocates for cannabis reform and long-time anti-drug-war activist.

Larsen discusses his path from a high school kid sending letters to Canadian Parliament about cannabis drug policy, to his recent Overgrow Canada stunt (where he gave away 10 million cannabis seeds in order to encourage people to grow plants everywhere), to opening his mushroom dispensary where he sells psilocybin and LSD, to last year; opening The Coca Leaf Cafe: a Vancouver, BC-based store that sells peyote and coca leaf tea (and they’re apparently the only store in the world doing this). As a long-time fighter of the drug war who has clearly made great strides, he talks a lot about prohibition and its many problems; and how, in all of his work, it’s been civil disobedience that has been the most successful. 

He discusses what it’s going to take to establish a recreational mushroom market; differences between US and Canadian reform; his feelings on peyote; his thoughts on new designer drugs; his concerns with current rehab and safe supply systems; and he gives and an oddly fitting analogy between the stereotypical picture of an opiate user and the masturbation panic that spread through Europe for hundreds of years.

Notable Quotes

“I’ve been doing this for over 30 years, and looking back at this time, the one tactic that was the most effective was the civil disobedience. I’ve done a lot of political work, I’ve done lobbying and other things, and there’s a role and a place for that. But for me, I think the most success has come from myself and others openly breaking the law.”

“Large doses of mushrooms can be great, but for a lot of people, they don’t want to be super high. They just want a little bit. And I think that there’s a tendency, if it’s legal, for most people to move towards milder forms of use. When there’s prohibition, a lot of folks stop using, but those that continue to use are pushed towards the most extreme forms of use, which is most harmful for them and for society in general.”

“We talk about harm reduction, and I think that’s important, but the other side of harm reduction is benefit maximization. These substances aren’t just harmful; like with anything, you want to reduce the harms, but there’s positive things about cannabis use and mushroom use and cocaine use and heroin use. …There are a lot of positives about these substances as well as the negatives. Prohibition just makes the positives very hard to manifest and it accentuates the negatives to an absurd degree.”

Links

Danalarsen.com

Mushroomdispensary.com

Cocaleafcafe.com

Potheadbooks.com

Vancouver.ca: Decriminalizing simple possession of illicit drugs in Vancouver

Overgrowcanada.com

NYpost.com: Pot protest slams Biden for ‘self-serving’ and ‘disgusting’ pardon stunt

Mashed.com: Did The Government Really Poison Alcohol During Prohibition?

Psychonautwiki.org: Proscaline

Vicetv.com: Hamilton’s Pharmacopeia: Positive PCP Story

Dana’s Twitter thread about police corruption in Mexico

Getyourdrugstested.com

Psychedelics Today: PT311 – William Leonard Pickard – LSD, Fentanyl, Prison, and the Greatest Gift of All: The Natural Mind

Posted on

PT369 – Chronic Pain and Phantom Limb Pain: Could Psilocybin Be the Answer?

In this episode, Joe invites Court Wing to co-host, interviewing two members of UC San Diego’s Psychedelics and Health Research Initiative (PHRI): Joel Castellanos, MD (Associate Medical Director of PHRI and board-certified physical medicine and rehabilitation and pain medicine physician), and Timothy Furnish, MD (Medical Director of PHRI and Associate Clinical Professor of Anesthesiology and Pain Medicine). 

As one of the early participants of a psilocybin-for-depression trial in NYC, Court Wing (of REMAP Therapeutics) discovered that immediately after the session, his chronic pain had miraculously gone away. He began researching how psychedelics could be used (with or without other therapies) to continue the alleviation of pain psychedelics had brought him. Through the Psychedelics and Health Research Initiative, Drs. Castellanos and Furnish are following that that same road, and are currently recruiting for a randomized controlled trial on psilocybin for phantom limb pain. 

They talk about the relationship between the mind and chronic pain: how people confuse pain with the simple act of nerves firing, but how it’s so much more. And they discuss how pain can become part of one’s identity (and how the Default Mode Network could be contributing); how physical therapy is related to neuroplasticity; mirror box therapy; microdosing for chronic pain; the unusual nature of phantom limb pain; and where the mystical psychedelic experience may come into play. If this topic is as fascinating to you as it is to us, stay tuned – we will be featuring much more on chronic pain and psychedelics, including a blog series from Court Wing coming soon.

Notable Quotes

“One of the things that may be unique about or interesting about chronic pain is that the longer it goes on, the more people start seeing pain as a part of their identity and that Default Mode Network is probably playing a role in that. And it’s possible that something like psychedelics could open up the possibility of changing that internal story so that pain is no longer so much a part of one’s identity.” -Tim

“I think that people oftentimes confuse pain with simply nerves firing. …[But] there is this rich interplay between the way we think about pain, the way we perceive pain, and how we feel about it.” -Tim

“When you’re not really dealing with chronic or severe pain on a daily basis, it’s really hard to think about how life-changing that is or can be.” -Joel

“When we hear things like ‘It’s only just in your head,’ I don’t think people quite get [that] the head can be a scary place to be trapped sometimes.” -Court

Links

PHRI.ucsd.edu: Psychedelics and Health Research Initiative at UC San Diego

REMAPtherapeutics.com

Psychedelics Today: Court Wing – Pain and Its Relationship to the Mind

Pubmed: Chronic pain and psychedelics: a review and proposed mechanism of action

Sciencedirect.com: Mirror Visual Feedback Therapy. A Practical Approach

Psychologytoday.com: Catastrophizing

Physio-pedia.com: Kinesiophobia

Sinobiological.com: What is tumor necrosis factor (TNF)

Neuropathycure.org: Cryoneurolysis: A Freezing Cold Way To Treat Chronic Nerve Pain

Journals.lww.com: Microdosing psilocybin for chronic pain: a case series

Clusterbusters.org

Clinicaltrials.gov

Healthgrades.com: Diagnosing and Treating Anhedonia: Loss of Pleasure Explained

Posted on

PT368 – Ketamine, Group Work, and the Power of Just Being There

In this episode, Kyle interviews Dr. Steven Radowitz: Medical Director at Nushama, a wellness center in New York City primarily offering IV ketamine, with a strong focus on letting the experiencer explore their journey undisturbed. 

Recorded in-person at Nushama’s flagship location just over a year after opening, Radowitz talks about his past and why he became interested in ketamine, the look and feel of Nushama, their process, and why they favor IV ketamine. He highlights his biggest takeaways from the year: the surprise in just how effective ketamine has been; the role of integration and what aftercare truly looks like; and the importance of learning to hold space and be a compassionate listener – that the doctor isn’t the healer and the psychedelic isn’t the magic bullet cure; instead, they are just tools that allow the patients to heal themselves.  

He discusses how he sees psychedelics as a dimmer switch for the ego; how disorders are tools to deal with trauma; why he is reframing trauma as a learning experience; why he thinks ketamine will survive once psilocybin and MDMA are legal; why group work is so effective and powerful (and likely the new model for psychedelic therapy); and the importance of staying humble through all of this – humble to the power of the medicine and humble to the amazing capacity for people to heal and grow, simply by being allowed to explore their journey and be heard.

Notable Quotes

“I’m not a healer, and I often tell people [that] during their preparation, when I do my medical intake. I talk to them about that. I say, ‘I’m not here [to heal you], I’m here just giving you a tool. You’re the healer. All this stuff does is [that it] just takes away what’s blocking you from realizing that. It’s like a dimmer switch on the ego [and] on the mind.”

“I’m trying to move away from the word ‘trauma.’ It’s a difficult life event that’s there to teach us. It’s there for something. And with every one of those events; there’s a little jewel within it, but you have to go in there and go through it. And it’s just a cloud, just a myst, almost, that’s preventing you. Just push [through it] and hold space. As long as people are in a safe place to go there and journey there, then they’ll realize that it’s just an event. It’s just an experience, and you move on. That wisdom is: a memory without the emotion.”

“I think any type of journey work, any type of psychedelic work, I almost think you have to be called to it in a way. You shouldn’t be coerced, ever, into this. …I find that the ones that are really ready to do the work are finding us on our own.”

Links

Nushama.com

Wavepaths.com

Rootstothrive.com

Kyle and Dr. Radowitz at Nushama
Nushama’s office, courtesy of Nushama and Costas Picadas
Posted on

PT367 – Colorado Proposition 122 and the Decriminalization of Natural Medicines

In this episode, Joe interviews David Bronner: CEO (Cosmic Engagement Officer) of Dr. Bronner’s, a top-selling natural soap brand, that has, over the years, branched more and more into social (and psychedelic) activism. 

Bronner visits largely to discuss Colorado’s Proposition 122, which they describe as “the most progressive policy yet” and would define natural plants like psilocybin, psilocin, mescaline-producing plants (excluding peyote), ibogaine, and DMT as “natural medicine,” and decriminalize their personal use, possession, growth, and transport for people over 21 years of age. If it passes, the statute would also create a Regulated Natural Medicine Access Program for licensed healing centers to administer these substances in safe, controlled environments. 

He discusses the details of the proposal and its friction points with Decriminalize Nature’s efforts (most recently in their Initiative 61); some of the false narratives driven by opposition to Proposition 122; the ways the psychedelic movement is connecting with traditionally psychedelic-averse conservatives; peyote and the need to focus on sustainability; what happened with California’s Senate Bill 519; research into ibogaine; Biden’s federal prison “pardon”; and more. 

While some say the people of Colorado aren’t ready for Proposition 122, we believe that they are, and we join Bronner in voicing our support for the measure – which could be a massive win for Colorado and the psychedelic movement in general. If you live in Colorado, we urge you to research the measure and think hard about which way you’ll be voting on November 8.

Notable Quotes

“Everyone here really wants to bring the healing power of these medicines and is understandably suspicious of corporate takeover like we’re seeing in big pharma. The way I see it; this regulated program and access is what competes with big pharma.”

“Conservative leanings on this could play in our favor, I don’t know. I mean, maybe not, but a crushing victory in Colorado, man, makes a lot of things possible. If we crush it with a 2/3 majority across a political spectrum in an off-year election in a purple state; that’s just going to send a shockwave to the political establishment and just make a lot of things easier, I think, at both the state and federal level.”

“What is a sustainable source of medicine? What’s not? This whole cognitive liberty/religious liberty [belief]: you need to balance that against ecological sustainability and Indigenous rights and not just say, ‘I have the right to use anything. It doesn’t matter how endangered it is or unsustainable that is.’”

Links

Drbronner.com

IMC.fund

Growmedicine.com

Ballotpedia.org: Colorado Proposition 122, Decriminalization and Regulated Access Program for Certain Psychedelic Plants and Fungi Initiative (2022)

Naturalmedicinecolorado.org

Ballotpedia.org: Denver, Colorado, Initiated Ordinance 301, Psilocybin Mushroom Initiative (May 2019)

Ballotpedia.org: Oregon Measure 109, Psilocybin Mushroom Services Program Initiative (2020)

Ballotpedia.org: Oregon Measure 110, Drug Decriminalization and Addiction Treatment Initiative (2020)

Filtermag.org: Colorado’s Two Psychedelic Ballot Efforts Present Competing Visions

Psychedelics Today: Religious Practice Under Oregon Measure 109

Psychedelic Education Center: Psychedelics and Religious Liberty in the United States

Rollingstone.com: These Mormons Have Found a New Faith – in Magic Mushrooms

Churchofeagleandcondor.org

Psychedelics Today: PT246 – Amber and Marcus Capone of VETS – Foundational Healing and the Brain

Psychedelics Today: PTSF77 – Progress and Context, with Jesse Gould of the Heroic Hearts Project

Filtermag.org: California’s Psychedelic Decrim Bill Was Gutted and Pulled; It Should Be Back in 2023

ICEERS.org: First Ever Clinical Trial with Ibogaine for Opioid Dependency

Reason.com: Biden’s Marijuana Pardons Did Not Free a Single Federal Prisoner or Deliver the Expungement He Promised

SSDP.org: Rally for Cannabis Clemency on October 24th at the White House

Brooklyn Psychedelic Society

Posted on

PT366 – Neurotransmitter Systems and Novel Psychedelic Molecules

In this episode, Joe interviews the Co-Founders of Tesselate Therapeutics: Dr. Rochelle Hines, Ph.D. (also the CEO and an Associate Professor at UNLV), and Dr. Dustin Hines, Ph.D. (the CSO as well as an Assistant Professor at UNLV).

While Tesselate’s primary objective is the development of novel psychedelic molecules, the Hines’ work goes much deeper than that, as they are researching the ways the brain communicates with itself and other parts of the body: how neurotransmitter systems interact, why synaptic partners find each other, and how certain substances may be able to modulate the actions of specific receptors. They are exclusively studying phenethylamines and using EEG to isolate signatures that could help predict the outcome of a therapy session. Additionally, they’re attempting to build a “tripnogram,” modeled after the hypnogram that explains the stages of sleep.

They talk about the reductionist base of neuroscience; the biodiversity in human populations and how heterogeneous depression can be; the reliability of the head twitch model; the structure of the cerebral cortex; neuroplasticity; the price of bringing new drugs to the FDA and the strategy of “failing fast,” and much more. You’ll likely learn a lot from this one, especially if terms like polypharmacy, laminar, ocular dominance columns, synaptic pruning, and “psychedelicitivity” (thanks for that one, Joe!) are new to you. 

Notable Quotes

“I’m really fascinated by these connections that cells form with one another in the brain. And I’m really fascinated by how they form these partnerships so reliably, and all the right equipment gets there. And generally under typical conditions, we have this really high fidelity system so that [a] neurotransmitter gets released, and the right receptors are there to receive it, and the signal gets passed on. That always struck me as just this incredibly cosmic process. How do we make it right all the time, hundreds of thousands of times during development?” -Rochelle

“The average drug that gets into the clinic costs about 3 billion. And most of that cost is racked up from failures that get pushed along, pushed along, make it into clinical, a lot of money goes into them, and then they ultimately fail. So I think a big strategy now is to see how quickly you can get something to fail, because then you’ll save yourself some time and money in the long run.” -Rochelle

“If you want the answer, you should listen to everyone. You should be [a] skeptic, but you should listen to everyone.”-Dustin

“I’m not at the stage where I think this is our last hope; I think there’s other hopes. But I see a revolution here. I really do, because it’s impacting the basic science that we’re doing also. People need this. People deserve it.” -Dustin

Links

TSL8.ai: Tesselate Therapeutics

UNLV.edu: Dustin Hines, Ph.D.

UNLV.edu: Rochelle Hines, Ph.D.

Hinesgroup.net

MIT.edu: Why it’s a problem that pulse oximeters don’t work as well on patients of color

Sciencedirect.com: Head-Twitch Response

Wikipedia.org: Ocular dominance column

Dolenlab.org (Gül Dölen)

The Future Is Faster Than You Think: How Converging Technologies Are Transforming Business, Industries, and Our Lives, by Peter H. Diamandis and Steven Kotler

Encyclopedia.com: Illness And Sick-Role Behavior

JAMAnetwork.com: Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018

The Myth of Normal: Trauma, Illness, and Healing in a Toxic Culture, by Gabor Maté, MD, with Daniel Maté

Lucid.news: Journey Colab Looks to Mescaline for Treating Alcohol Use Disorder

Posted on

PT365 – KAP: Self-Agency Through Intention, Titration, and Ceremony

In this episode, Kyle interviews Dr. Jennifer Montjoy: Tucson, Arizona-based psychiatric nurse practitioner with a private practice specializing in ketamine-assisted psychotherapy, and Medical & Research Director at TRIPP (Transpersonal Research Institute of Psychotherapeutic Psychedelics); a 501(c)(3) organization that provides psychedelic training and research opportunities largely for female and BIPOC scientists.

A Vital student introduced Kyle to Montjoy’s research on ketamine and PTSD and presented with her at the recent ICPR conference in Amsterdam, where this was recorded in-person (as Kyle and Johanna were there, representing Psychedelics Today). Montjoy talks about her protocol, the self-transcendent scale she’s using with clients pre- and post- induction, how ketamine can help people get over past trauma through shifts in emotional memory, and what she sees most in successful cases: a gradual shift toward self-agency.

She discusses how integral titration is to her process; how ACE (adverse childhood experience) scores work; how dissociation can help with childhood trauma; how clients often naturally fall into using Internal Family Systems to describe their process; and how physicians and therapists shouldn’t be afraid of the concept of ceremony and opening sessions with intention – and, as she likes to say, giving one’s mind coordinates on where it can end up.

Notable Quotes

“I do think it’s helpful to have a skillset and general understanding of that so you know what’s happening in real time, but for the most part, I subscribe to the philosophy that we all have an inner healer. We all have that inner wisdom, but most of us don’t have access to it because we have these managing protectors from our trauma.” 

“Often [for the] opening, I’ll ask the higher self to step into the light, to take the reins and let all those parts know that the goal here is not to annihilate or bypass them. That’s the language I consistently use in opening, because as the facilitator, we want to align with those parts too. We’re not the enemy.”

“Don’t be afraid to incorporate ‘ceremony.’ …I think that makes a lot of physicians maybe uncomfortable; that idea. [But] opening and closing [the ceremony] can be very helpful tools, [and] making sure we’re asking about intention before each session. I call that the coordinates, because we want to give the unconscious mind the coordinates.”

Links

Jenmontjoy.com

Resiliencetucson.com

TrippAZ.org: The Transpersonal Research Institute of Psychotherapeutic Psychedelics

Resiliencetucson.com: 4-Day Experiential Training in Ketamine-Assisted Psychotherapy For Clinicians

Psychedelics Today: Ketamine and Trauma Treatment

Ncjfcj.org: Finding Your ACE Score

Psychedelics Today: PT300 – Dr. Richard C. Schwartz – Vital Psychedelic Conversations

Psychedelics Today: Veronika Gold – Methods of Ketamine Assisted Psychotherapy

Biomedcentral.com: Ketamine can be produced by Pochonia chlamydosporia: an old molecule and a new anthelmintic?

Dr. Montjoy and Kyle recording at the The Interdisciplinary Conference on Psychedelics Research (ICPR) in September

Posted on

PT364 – Burning Man, Psychedelic Maturity, and Radical Hope

In this episode, David interviews Jamie Wheal: author of the global bestseller, Stealing Fire: How Silicon Valley, Navy SEALs, and Maverick Scientists Are Revolutionizing the Way We Live and Work, and most recently, Recapture the Rapture: Rethinking God, Sex and Death In a World That’s Lost Its Mind.

Wheal believes that in our current culture, we’ve over-fetishized our feelings and jumped too often at selfish psychedelic insights and short-term novelty instead of real long-term growth and maturity – that one’s constant search for freedom can become a prison in itself. As such, he founded the Flow Genome Project, an organization dedicated to human performance research and training, with a different attitude than we’re used to seeing: in their words, “ecstasis without the crave,” “catharsis without the cringe,” and “communitas without the cults.” 

He discusses Burning Man and what makes it so life-changing for people; the sliding scale of psychedelics and the need to regularly do a hard reset of our brains; neuroplasticity; his issues with virtual reality; what Hanukkah has to do with psychedelics; eschatothesia; permaculture and sustainability; and radical hope- the belief in an unknown future that one commits to nonetheless, even in the face of certain doom.

Notable Quotes

“Burning Man is, I think, arguably the most potent transformation engine ever assembled on this planet. I don’t think at any point in history have you ever had that many people – 70 to 80 thousand humans – gathered together at one time, all so concretely and coherently in a mind-blown and open state.”

“The relentless pursuit of freedom becomes a prison house of its own. So you’re not free; you’re actually incapable of committing to anything of lasting value, and therefore, because you have nothing of lasting value to ballast yourself or to justify sacrificing or trade offs, you’re forever seeking the new and the novel. And that just becomes a hamster wheel straight into the Hell realms. So I would say that the freedom of no escape, the freedom of finding your hill to die, the place to take your stand is a non-negotiable part of manhood.”

“Most of us are seeking fucking sugar high joy: distractions, diversions, novelties, quick fixes. And that’s the wrong kind of joy. That is not going to work. But deep, true, abiding joy – ‘We’re all dead men walking,’ ‘Today is a good day to die,’ [attitude], like Leonidas and Thermopylae …It’s that level of out-of-fucks, non-bargaining commitment that gets us access to the joy on the other side of all the facts.”

Links

Recapturetherapture.com

Flowgenomeproject.com

Jamie Wheal substack

Burningman.org: Researchers Share First Findings on Burners’ Transformative Experiences

Nature.com: Prosocial correlates of transformative experiences at secular multi-day mass gatherings

Psychedelics Today: Erik Davis – High Weirdness: Drugs, Esoterica, and Visionary Experience in the Seventies

The Master Switch: The Rise and Fall of Information Empires, by Tim Wu

Wikipedia.org: Eschatology

Radical Hope: Ethics in the Face of Cultural Devastation, by Jonathan Lear

Goodreads.com: Talmud “Do not be daunted by the enormity…” quote

Psychedelics Today: Wade Davis – Ayahuasca and a New Hope for Colombia

IMDB.com: “The Biggest Little Farm”

Gaviotas: A Village to Reinvent the World, by Alan Weisman

Wendell Berry’s “Be joyful though you have considered all the facts” quote

Posted on

PT363 – Cannabis and Psilocybin: The Complications of Legality Inside an Endless Drug War

In this episode, Joe interviews Reggie Harris: Advisory Board member of Decriminalize Nature and Founder of Oakland Hyphae, which organizes events like the Hyphae Cup (previously the Psilocybin Cup), and performs psilocybin potency testing through Hyphae Labs. 

As Harris is an activist with over a decade of political campaign experience and over a decade in the cannabis industry, this conversation focuses largely on his concerns over the burgeoning psychedelic industry not learning from the mistakes of a failing (at least in California) cannabis industry, as well as one of the key principles of Psychedelics Today: the need to end the drug war immediately and allow the people who got us here to once again live their lives freely. 

He discusses mycology, what a hypha is, and psilocybin potency; how an Eminem song changed his life; why he thinks Oregon is legalizing psilocybin much too quickly; why he thinks we should decriminalize now (and legalize later); the overbearing burden of cannabis industry taxes and how legacy operators are switching to psilocybin; the stories of Kole and Seth Rosenberg; why Mike Tyson is one of the most important influencers in psychedelics; and why “Fuck around and find out” has become a bit of a personal mantra for him and so many others looking to advance our quickly evolving psychedelic space.

Notable Quotes

“I think [that] all we’ve got to do is catch the right politician with drugs, and then the right political parties will start hollering: ‘End the DEA!’ I’m waiting on it. I never thought I’d hear these people start saying ‘Defund the FBI,’ so I think there’s hope.”

“I’d much rather try to hold the wall for a year or two or even five more years and give legacy operators a chance to get their business together, to get their paperwork together, to save up some money, to get their infrastructure together; so that when the wall does come down, they’ve either built something that somebody can buy for a fair price, or they can actually compete. I just want to give people like myself a fair shot at something that they’ve all helped build.”

“I watched a lot of the cultivation decisions being made and crafted and I watched who was making the decisions. I think Oregon is going to be a cautionary tale that the rest of the country uses, again, as to why you don’t want to legalize quickly.”

“You see prices on the street at an all time low, but you still see the people who try to operate within the legalized framework being crushed by being taxed through the nose. You can’t write anything off, you get taxed through the nose, you can’t really bank [any money], you’ve got to pay extra expense because of the nature of your business, and a lot of people make it hard to stand up. It’s funny – as I watch the cannabis industry; in 2018, when they legalized, everybody wanted to play by the rules. Everybody wanted to comply. And so, they cut a lot of the brokers off that they dealt with [and] a lot of relationships were altered because people wanted to go legal. But then when they tried to play around in the legal space for a year, year and a half, and they realized that they were being taxed into oblivion, people opened that back door right on up.”

Links

Oaklandhyphae510.com

Hyphae Labs

Oakland Hyphae Substack

Reggie Harris Linktree

Rollingstone.com: Can Psychedelics and Capitalism Co-Exist? 3 Things I Learned at the Oakland Psychedelic Conference

Biologydictionary.net: Hyphae

Edibleeastbay.com: Mycologist with a Microscope: Alan Rockefeller

Uproxx.com: William Padilla Brown Wants To Save The Planet With Mushrooms

YouTube: Eminem- My Fault

Cannabisni.com: Breckenridge City Colorado Legalizes Marijuana

Psychedelics Today: PT324 – Amanda Reiman, Ph.D., MSW – Web3, NFTs, Cryptocurrencies, and A Deeper Relationship With Plants

Sacrdgardn.com

Occultsentinel.com: OS ep 49 – Kilindi Iyi – The Mushroom and our trans-human future (Joe’s interview with Kilindi Iy from his first podcast)

People.com: Aaron Rodgers Defends Ayahuasca, Says He May Be ‘Called’ to Take the Psychedelic Again

Psychedelicspotlight.com: Will Smith Comes Out of the Psychedelic Closet

Marijuanamoment.net: Dave Chappelle’s Marijuana And Psychedelics Parties Don’t Concern Local Sheriff

NBA.com: NBA Will Not Randomly Test Players For Marijuana Again This Season

Washingtonpost.com: Law enforcement took more stuff from people than burglars did last year

IMDB.com: We Own The Night

The Cannabis Connection podcast: Dave Hodges- Church of Ambrosia & Zide Door 3/11/2022

Healing-mushrooms.net: Uncle Ben’s Mushroom Tek Guide: Fruiting, Colonization Time & Yield

PT319 – Kole – Activism and Trust: A Cautionary Tale From Someone Who Got Caught

Psychedelics Today: PT351 – Seth Rosenberg – The Trauma In Being Arrested and The Injustice of the Drug War

YouTube: Willy’s World

Psychedelics Today: PT236 – Dr. Carl Hart – Drugs: Honesty, Responsibility, and Logic

Psychedelics Today: PT348 – Steve DeAngelo – Cannabis and Psychedelics: Industry, Consciousness, Justice, and Joy

Edrosenthal.com

Merryjane.com: California Cannabis Growers Are Suing the State Over Legal Loophole for Large Marijuana Farms

Colorado.gov: Natural Medicine Health Act of 2022

Marijuanamoment.net: Colorado Psychedelics Legalization And Psilocybin Therapy Measure Qualifies For November Ballot

Psychedelics Today: Addressing Abuse in Psychedelic Spaces

Posted on

PT362 – Psychedelic Storytelling: Transforming Out Loud

In this episode, Victoria interviews Cory Firth: Chief Storyteller at the Nikean Foundation, one of the world’s leading charities funding psychedelic research and advancing education.

Rick Doblin has famously said that while the FDA responds to data, it’s stories that most resonate with people, and the current direction of the Nikean Foundation is rooted in that idea – that there is a massive population of “psychedelic seekers” who could likely benefit greatly from the psychedelic experience, but who just need to hear that one special story that inspires them to take the leap towards change. While the efficacy of psychedelics and psychedelic-assisted psychotherapy is proven over and over again in study after study, most people don’t connect with that data – it’s the nuance and human connection in personal stories that cut through the “drugs are bad” media bias, and Firth believes that as more people share their transformational tales – who “transform out loud” – society can really change for the better. 

He discusses the value of storytelling in affecting change on multiple levels; the idea of integration as an ongoing practice; the wisdom gained through trauma; and the trust and vulnerability required to be able to share a powerful story. And to practice what they preach, he and Victoria share their own personal stories of healing with the help of psychedelics. We hope they’re stories that someone out there needs to hear.

The Nikean Foundation is aiming to build the largest collection of transformational stories, and they want to hear yours. You can join in by sharing your story at their website, or by sharing the site with a friend. You can submit now, but they officially launch this storytelling project next week, on October 14 at Horizons NYC, where Victoria, Kyle, and David will be! If you haven’t bought a ticket yet, use code PSYCHEDELICSTODAY-NY-17 at checkout to receive 17% off, and when you’re there, come say hello!

Notable Quotes

“Everybody who gets into psychedelics in a transformational way does so because of a friend or a colleague or someone in their family that tells them a story about how they were able to experience them and find some healing potential. …One of the main ways people get into this is through stories. How can we put a little gasoline on that fire and see how it can evolve?”

“You can’t change someone’s mind unless you show them how you changed yours.”

“My goal, eventually, is to have enough stories where someone who’s seeking something can come to the site and see another story of someone who looks like them, in their position – but in the future, where the potential has been reached. They see the potential in themselves. They see the potential of the transformational mechanisms of psychedelics, and they’ve gone through it, and now they see that it’s possible for them.”

Links

Nikean.org: The Nikean Foundation

Psychedelics Today: PT342 – Spencer Hawkswell – The Right to Psilocybin in Canada: TheraPsil’s Charter Challenge

Tim.blog (Tim Ferriss)

Therapsil.ca

Maps.org: MDMA-Assisted Therapy for PTSD

Integration.maps.org: Psychedelic Integration List- Mental Health Support Practitioners by Location

How to Change Your Mind: What the New Science of Psychedelics Teaches Us about Consciousness, Dying, Addiction, Depression, and Transcendence, by Michael Pollan

Rootstothrive.com

GQ.com: Where the Psychedelic Revolution Is Headed, According to the Guy Who (Arguably) Started It (Rick Doblin’s discussed quote is here)

Therapsil.ca: Psilocybin Therapy Offered Cancer Patient Thomas Hartle More Than He Could Have Asked For

Psychscenehub.com: David Nutt’s Drug Harm Ranking scale.

Posted on

PT361 – Mycology and Evolutionary Genomics

In this episode, Joe interviews Jason Slot, Ph.D.: Associate Professor of Mycology and Evolutionary Genomics at Ohio State University, and founding member and scientific advisor to the Entheome Foundation, which has the goal of publishing 200+ fungal genomes by 2023 – starting with all the psilocybin-producing species.  

Slot talks about evolutionary genomics and his process: how he looks for interesting gene clusters in the genomes of different fungi to hypothesize what these clusters could be responsible for, how different species interact, and how these genes and species have evolved over time. He discusses the state of mycology in 2022 and the booming interest in functional mushrooms; the regulations around psilocybin and how they all relate to the dispensing of mushrooms; the weirdest things he’s seen in the complicated process of mushroom reproduction; substrate supplementation (with different enzymes, tryptophans, or even DMT); and just how much there still is to discover in the world of mushrooms and other possible plant medicines. 

He also discusses illumina high throughput sequencing; tetrapolar mating systems; Paul Stamets’ P-Value scale and the hayflick limit; mushroom parasexuality; horizontal gene transfer; and a lot of other scientific aspects of the unique studies of a mycologist. If you’re interested in psilocybin-producing mushrooms and want to explore mycology more deeply, this episode serves as a great introduction.

Notable Quotes

“It’s a small field, but I think that it’s growing. I think we have a lot more interest coming in because the growth of gourmet and medicinal mushrooms is just ridiculous. It’s a huge industry in the making.”

“I do crazy evolutionary analyses with all the fungal genomes I can get my hands on, and then find something interesting in the evolutionary history, and then I find an organism that’s got that particular gene or gene cluster that I’m interested in. It gives rise to interesting hypotheses.”

“They’re organisms with their own existences. We tend to think of a mushroom as a tool for therapy, or we think of a mushroom as a product or something like that. But these are organisms with their own rights to exist and thrive as they would.”

Links

Ohio State University: Center for Psychedelic Drug Research & Education

Entheome: The Entheogen Genome Project

Psychedelics Today: Brian Pace and Jason Slot – Neurochemical Ecology, and the Evolution of Psilocybin Mushrooms

Ucdavis.edu: Illumina High Throughput Sequencing

Nanoporetech.com: Nanopore DNA sequencing

Scottsdaleinstitute.org

420dc.com: Penis Envy Mushrooms Review: The Shocking Truth Behind The World’s Most Psychedelic Shroom

Wikipedia.org: Parasexual cycle

Fungi.com (Paul Stamets)

Shroomery.org: Biotransformation of tryptamine derivatives in mycelial cultures of Psilocybe

Wikipedia.org: Horizontal gene transfer

Hostdefense.com: What Is the Stamets P Value® System?

Wikipedia.org: Hayflick limit

Convention on Biological Diversity: About the Nagoya Protocol

Posted on

PT360 – Kanna: Love and Wholeness Through Nature’s Alternative to MDMA

In this episode, Joe interviews Stephanie Wang: Founder and CEO of KA! Empathogenics, which has created the first-ever empathogenic supplement chew with the primary ingredient of kanna. 

Similar to our exploration of kratom with Oliver Grundmann, Ph.D., this episode dives deep into a plant rarely talked about in psychedelic circles: kanna (or Sceletium tortuosum), a succulent native to South Africa. As a natural serotonin reuptake inhibitor and serotonin releasing agent, kanna’s effects sound very similar to those of MDMA (heart-opening, feeling surrounded by love and wanting to connect, an increase in energy, hunger suppression), but with a lot more: sleep improvement, a decrease in gut inflammation, increased focus and awareness, and a feeling of brain recalibration and true homeostasis (and it’s legal!). KA!’s first product is their kanna chew: a healthy, pH-neutral snack with no sugar, preservatives, caffeine, or artificial sweeteners, made with the intention to “restore full spectrum aliveness for all human beings.” 

Wang breaks down the science behind why kanna works, its history with the Khoisan people of South Africa, her first kanna plant ceremony, contraindications and what pairs well with it, how you should take it and how long it can last, and why she chose KA! as the name for her company. She and Joe also talk about their shared past with Evolver, the complexity in the simple question: “How are you?”, the care needed when making comparisons, society’s move towards self-directed healing and more natural foods, and the question of whether or not every modern culture is truly ready for psychedelics and natural plant medicines.

Notable Quotes

“It was amazing to experience kanna in a ceremonial setting where it was incredibly expansive and heart-opening. That’s literally how it feels: You just feel this oneness and you feel enormous love. You feel everything around you is love, everyone is love. And what it also had an effect on is how we were relating to each other in that setting. So imagine that you’re in a place where nothing matters. Nobody cares what you look like, where you came from, what job you have, how much money you make, what social strata [you’re in]; nobody cares. All you care about is meeting each other in that heart-centered space, in a very human and intimate space.”

“One out of five Americans (at least) suffer from some kind of mental health issue. …[Something] you talk about a lot in your show is this wholeness: we are far more than just our minds. We are bodies, we are hearts, we are spirit as well. So really looking at that as a whole is tremendously important, and kanna is one of those amazing plants that starts to connect you to that understanding.”

“What we look for a lot, in terms of our own healing, is in nature already. And instead of trying to tease out, ‘Okay, here’s the active component and let’s just isolate this, patent this, etc. and then make a drug, and then…’ – that’s, to me, an old model, actually. And what happens is then… the wholeness is lost. …There’s a reason why this particular plant evolved this way and has all these properties.”

Links

Ohmyka.com (KA Empathogenics)

Evolverhealth.com

Thealchemistskitchen.com

Realitysandwich.com

Facebook: Evolver Boston (for a piece of Joe’s history)

Wikipedia.org: Khoisan people

Iamshaman.com: Lost Khoisan Tribe (and kanna usage)

5rhythms.com

Psychedelics Today: The Intertwined Prohibitionist Histories of Psychedelics and Kratom

Vice.com: This Legal Supplement Made Me Roll Like I’d Taken MDMA

NIDA: What are MDMA’s effects on the brain?

Biorxiv.org: Revised estimates for the number of human and bacteria cells in the body

Electricalclassroom.com: What is kA rating?

Trailblazerspresents.com

Posted on

PT359 – Art, Philosophy, Sexuality, and “Psychedelics Tonight”

In this episode, Joe interviews Sawyer Hurwitz: filmmaker, producer, editor, and augmented reality collage artist who releases animated art under the name, “Psychotronic Solutions.”

He is also the director and lead editor of something we’re quite proud of here at Psychedelics Today: our new TV show, “Psychedelics Tonight”; a series of 30-minute episodes hosted by Joe and Kyle exploring lesser-explored psychedelic compounds, presented through ALTRD.TV. Episode 1, “Investigating Iboga – The African Plant with Sacred Roots,” premiered last night, and a new episode will air each Monday through October at 6 p.m. PST. Since this podcast was recorded while the show was still being filmed, they don’t go into it much, but we will be having more in-depth discussion after season 1 finishes, and want to know what you think! To watch for free, click the link in our bio or head to ALTRD.TV and search for Psychedelics Tonight. 

Hurwitz discusses his past of feeling almost addicted to LSD exploration; his art and how LSD helped him overcome the classic artist’s restrictive “I’m not good enough” paradigm; Sarajoy Marsh’s Trauma-informed, Brain-sensitive Yoga being used in prisons to essentially create wellness communities; psychedelics and creativity; Nietzsche’s notion of Apollonian and Dionysian forces; entropy and negentropy; the relationship between psychological unwinding and sexuality and his realization (during a psychedelic experience) that he was queer; and how artists can differentiate themselves in a world where art is more readily available than ever.

Notable Quotes

“[LSD] helped me relinquish the idea that I am creating and that I am anything, and instead, just succumb to the process and engage with the medium in the way that one would a lover. And again, maybe that’s too heady or silly, but just being present with the art is what I think allows it to reach its fullest blossom, and just trusting the fact that I’m doing the best I can.” 

“I think that love on a spectrum and sexuality on a spectrum is so much more chaotic than the firm binary that we’ve put [faith] into for so long. And again, if psychedelics are something that open up your perspectives, it allows you to sort of break models that you’ve been born into and raised with. And for a lot of people, that’s discovering that their experience (wherever it falls on that spectrum) is maybe outside of what we’ve been calling the norm for a long time, as opposed to necessarily what is the norm. I suspect that the norm is that the experience of love and sexuality is so, so, so, so much more diverse than we’ve been characterizing it as for a very long time.” 

“I think that a lot of the drive for art comes from a need to communicate love and connection, and in a lot of ways, that connection is the experience of God. And I think that, in a sense, art comes from almost a divine place in that regard, and psychedelics are also a tool for us experiencing that. Again, I’m not a religious person by any means, but psychedelic experiences are often spiritual experiences, and I think it’s because they touch on the same thing: what it means to live in oneness with the world.” 

Links

Psychedelics Tonight

Psychotronicsolutions.com

Instagram: @psychotronicsolutions

Psychedelics Today: PT311 – William Leonard Pickard – LSD, Fentanyl, Prison, and the Greatest Gift of All: The Natural Mind

Sarahjoyyoga.com: Trauma-informed, brain-sensitive yoga training

Be Here Now, by Ram Dass

The Way of the Psychonaut Vol. 2: Encyclopedia for Inner Journeys, by Stanislav Grof, MD, PhD

YouTube: Let’s Talk: Psychedelics and Queer Identity (a Psychedelics Today webinar)

Epochemagazine.org: Eros and Thanatos: Freud’s two fundamental drives

The Birth of Tragedy and Other Writings, by Friedrich Wilhelm Nietzsche

Wikipedia.org: Negentropy

Alexgrey.com

Allysongrey.com

Androidjones-obtain.com

Amandasage.com

Screenshot from the opening of the animation, “Weird Trip.” Check out the full piece and more at psychotronicsolutions.com.

Posted on

PT358 – Contexts of Use: Exploring the Various Paradigms of Psychedelics

In this episode, Kyle interviews Clinical Psychologist, past guest, and Founder of the Psychedelic Society of Vermont, Dr. Rick Barnett, Psy.D.

This episode was recorded live in front of a small audience at the Railyard Apothecary in Burlington, VT, shortly after the Psychedelic Science & Spirituality Summit, which Joe and Kyle attended (hosted by Barnett’s Psychedelic Society of Vermont). They reflect a bit on the conference (perhaps the best one Kyle has attended) and Kyle’s history in Vermont, but most of their conversation revolves around exploring  the various contexts of use around psychedelics – how our current paradigm of a heavy focus on medicalization and treatment of disorders misses a huge portion of real-world use: self-improvement, ceremonial, celebratory/recreational, and to even help with addictions. 

They discuss MAPS and MDMA use for PTSD; psilocybin for end-of-life depression and alcohol use disorder; ibogaine for getting off opiates; Chris Bache, high dose LSD sessions, and preparing for death; how dietas are better preparation for an experience than what most studies call for; Jon Dennis’ fight for religious use of psychedelics; decriminalization vs. legalization; how psychedelics helped Barnett connect with the spiritual and communal aspect of 12-step programs; the beauty and pitfalls of celebratory/recreational use; and how there’s really no wrong door when it comes to how one uses psychedelics (as long as it’s safe and respectful).

For regular listeners, this episode may be a bit introductory, but it may also be a great episode to share with your friends who are starting to become interested in this exciting new world. Do you want to attend a live recording and ask the guest questions? Keep an eye on our events page for the next one!

Notable Quotes

“How do we integrate the science that’s happening (the research) with what’s already happening out there in communities? There are people using psychedelics in ceremonial use, [for] celebration, [and] for recreation, and I want to integrate it all, because there’s no wrong door here, I think.”

“That’s a highlight for me: how psychedelics can change our minds; not so much in terms of treating depression or PTSD or addiction, but really challenging us to see ourselves and the world differently, whether we have a psychiatric condition or not.”

“I think we need to embrace all paths, and that’s why I also think decriminalization may not go far enough for some people. That’s an argument out there. I believe in decriminalization, I believe in legalization. Again, there’s no wrong door here. We can medicalize, we can decriminalize, we can legalize, ‘recreationalize,’ buy LSD in Walmart, whatever. I think that having the broadest mind possible and recognizing that there are potential benefits and keeping safety top of mind [is key].”

“I was lucky enough to get really sick from alcohol and wind up in the hospital and eventually wind up in rehab. And I’ve said this publicly before: I don’t think I would have been receptive to the message of recovery in a 12-step based program, which has a lot of spiritually associated with it and there’s a tremendous amount of fellowship and community that comes with 12-step programs. And I had a sense of that because of my LSD use before I got sober. So coming into recovery knowing what I knew, having experienced what I experienced; it was a little bit easier for me to be receptive to that community, that fellowship, that message of spirituality, of surrender, of honesty and openness, willingness – all the principles in a 12-step program.”

Links

ALTRD.tv: Psychedelics Tonight

Drrickbarnett.com

Psychedelics Today: PT326– Dr. Rick Barnett, Psy.D – Addiction, Recovery, and Competency in Psychedelic Therapy

Vermontpsychedelic.org

Psychedelics Today: Kyle and Joe – Contexts of Psychedelic Use

The Psychedelic Renaissance: Reassessing the Role of Psychedelic Drugs in 21st Century Psychiatry and Society, by Dr. Ben Sessa

Awaknlifesciences.com

Psychedelics Today: PT229 – Dr. Matthew Johnson – What is Consciousness?

Usonainstitute.org

Fluencetraining.com

MAPS.org: MDMA-Assisted Therapy for PTSD

Pubmed: Why MDMA therapy for alcohol use disorder? And why now?

Clearmindmedicine.com

Psychedelicsdaily.com: Ibogaine

Psychedelics Today: PT294 – Andrew Tatarsky, Ph.D. & Juliana Mulligan – Vital Psychedelic Conversations (good episode about ibogaine)

Hopkinsmedicine.org: Hallucinogenic Drug Psilocybin Eases Existential Anxiety in People With Life-Threatening Cancer

Imperial.ac.uk: Magic mushroom compound performs as well as antidepressant in small study

Publichealth.jhu.edu: Comorbid Patterns with Alcohol Use Disorders research

NYtimes.com: After Six-Decade Hiatus, Experimental Psychedelic Therapy Returns to the V.A.

Wayofleaf.com: Psychedelics and Eating Disorders

NPR.org: A New Way To Quit? Psychedelic Therapy Offers Promise For Smoking Cessation

Hopkinsmedicine.org: Johns Hopkins Receives Grant for Psilocybin Research in Smoking Cessation

Psychedelics Today: Chris Bache – LSD and the Mind of the Universe: Diamonds from Heaven

LSD and the Mind of the Universe: Diamonds from Heaven, by Christopher M. Bache

Psychedelics Today: PT293 – Stanislav & Brigitte Grof – The Evolution of Breathwork and The Psychology of the Future

LSD: Doorway to the Numinous: The Groundbreaking Psychedelic Research Into Realms of the Human Unconscious, by Stanislav Grof

Marijuanamoment.net: Vermont Governor Vetoes Bill On Safe Drug Consumption Sites And Harm Reduction

Psychedelics Today: Oregon, Measure 109, and Community Access: The Final Vote

Congress.gov: H.R.1308 – Religious Freedom Restoration Act of 1993

The Road to Eleusis: Unveiling the Secret of the Mysteries, by R. Gordon Wasson, Albert Hofmann, and Carl A. P. Ruck

Clinicaltrials.gov: Mescaline

Mescaline: A Global History of the First Psychedelic, by Mike Jay

Dancesafe.org

Breadandpuppet.org

Psychedelicsinrecovery.org

Lucid.news: Bill Wilson, LSD and the Secret Psychedelic History of Alcoholics Anonymous

A picture of Kyle and Dr. Barnett from the live event

Posted on

PT357 – Precision Psychiatry, Ketabon, and The Stress Response System

In this episode, David interviews drug developer, clinical psychiatrist, and Chief Medical Officer at HMNC Brain Health; Dr. Hans Eriksson. 

Eriksson discusses the complexity of the human brain and his fascination with the ability for simple biological interventions to affect really profound disorders – that while psychotherapy and community can have a major effect, sometimes a simple chemical can fix everything. HMNC Brain Health is currently in Phase 2 trials for Ketabon, a ketamine-esque prolonged-release oral capsule which early studies show does not include any dissociation – something a lot of people do not want. And, as a lot of current medicine is guess work, they have also created a blood test (and are working on other predictive diagnostic tests) to identify specific common markers to show who will most likely respond to specific interventions. This work is firmly rooted in the idea of precision psychiatry, with the theory that there will be far fewer patients with treatment-resistant depression if their physicians are able to see which treatments will actually work for them ahead of time. 

He fully explains the stress response system and Vasopressin system, discussing the likely links between stress response dysfunction and depression; and goes into much more: his thoughts on Compass Pathways’ phase 2 data; the famous Escitalopram vs. psilocybin study; how much of progress can be attributed to psychotherapy vs. the compound itself; why it makes sense to study a new compound on top of SSRIs rather than on its own; AI and machine learning; and how science is truly beginning to come to terms with the fact that all systems in the body are connected.

Notable Quotes

“I was really fascinated by the understanding that on one level, this extremely complex system of the human brain (probably the most complex system in the known universe) can find some of the explanations regarding its functioning in chemicals [and] in compounds of different sorts interacting with targets, receptors, transporters, etc.; and that this can have a profound effect on how we feel and think. And this link between, on one hand, basic biology, and on the other hand, this complex emotional world that is being a human, is so fascinating.”

“If someone comes into the hospital after a car accident and needs a blood transfusion, no one would ever think the thought that: ‘We take any blood we have in storage.’ They would check what blood [type] you have. …But still, in psychiatry, when someone comes in with a severe depression, we hand out an SSRI typically as the first-line treatment. But think: if you could have a tool that could say, ‘Okay, but you belong to the 30% that has a very good likelihood of responding very well to a medicine that corrects your stress response system,’ that could lead to [a] much shorter path from the interaction with the healthcare [provider] to actually overcoming the depression.”

“One area that I expect to be developing quite a lot in [the] coming years is to understand how the brain is affected by things that are ongoing in other parts of our bodies; for instance, things such as peripheral inflammation: Does that affect the brain? The composition of the gut microbiome in our guts: What effect does that have on the brain? I think we are probably moving into an era where we see the brain not only as an isolated world swimming around in the cerebrospinal fluid protected by the blood-brain barrier, but actually as more of a dynamic part in our bodies.”

Links

HMNC-brainhealth.com

Compasspathways.com: COMPASS Pathways announces further positive results from groundbreaking phase IIb trial of investigational COMP360 psilocybin therapy for treatment-resistant depression

NEJM.org: Trial of Psilocybin versus Escitalopram for Depression

Max Planck Institute of Psychiatry

Psychedelics Today: Amanda Feilding – The Beckley Foundation: Changing Minds through Psychedelic Research

Pubs.asahq.org: The Vasopressin System: Physiology and Clinical Strategies

YouTube: Amanda Feilding on Trepanation

Washingtonpost.com: The Google engineer who thinks the company’s AI has come to life

Posted on

PT356 – Investing in Psychedelics and The Rush to Improve on the Classics

In this episode, Joe interviews Brom Rector: podcaster and founder of Empath Ventures, a venture capital fund that invests in psychedelic medicine startups.

Rector talks about which companies he sees succeeding, which companies are set up to fail, which he is investing in, and why the current crash in psychedelic business (where everything was once over-hyped and now we’re being overly skeptical) is a good thing. He believes that with the current focus on medicalization, the psychedelic community is being ignorant over just how big of an industry will exist outside of that paradigm, and finds it interesting how many people are focused on creating new compounds: How can anyone really improve on the classic psychedelics? 

Other than a focus on the business side of psychedelics, this was recorded in-person, and the conversation goes to a lot of other places: the theory of psychedelics damaging heart valves; the connection between Oprah, MDMA, and Mormons in UTAH; Xanax as a psychedelic security blanket; why so many psychedelic-friendly people love microdosing but have never had a deep experience; logical positivism and why “evidence-based” sounds pretentious; the DSM-5; Colorado Initiative 58; the power in branding and the emergence of high-end packaging; Mike Tyson; Compass Pathways; Christian Angermayer’s leaked memo; ibogaine; Dr. Zee and the next generation of Shulgins, other ways of knowing; and much, much more (just look at how many links there are). 

Notable Quotes

“The tech, future-y, optimist version of me that likes the idea of progress and experimentation at all costs loves it, but it’s also like: mushrooms have been around for like 2,000 years. In business, in order to succeed, you need to improve on something, and usually not just an incremental improvement either – you need to make a big improvement, otherwise no one really cares. Can you imagine what a 10x improvement over psilocybin would be? I can’t really imagine that.”

“You see all these …sketchy Canadian companies, and a lot of them are just making the slightest modifications to these molecules, calling them something new, sending out a bunch of press releases, raising money for investors; and is that – this bullshit thing started by this random company, going to replace psilocybin? I don’t think so.” 

“I’ve heard a lot of different companies talking about trip-stoppers as a big business plan, and I don’t know, dude. It’s interesting; the thing to me (and this is just my personal gut reaction about this) is in my experience, the moments immediately following when I thought I wanted the trip to stop is when I learned the lesson.”

“I think that they may realize eventually that this IP stuff may be helpful for them to achieve dominance in the pharma space, but it’s not going to prevent people from growing their own mushrooms, [or] people from seeking decriminalized care under Measure 109 or [in] Denver. …People are just kind of being willfully ignorant of how big this non-FDA market for psychedelics is going to be, I think. And maybe the people at Atai think that they can stop it by lobbying or something, but I don’t think they think they can do that. The people are going to speak, and the people want shrooms.” 

Links

Empath.vc

Apple podcasts: ”Brom Podcast” (formerly “The Integration Conversation”

Brom Podcast: 35: Sam Banister – The Art and Science of Designing Novel Psychedelic Compounds

Psylo: Psychedelic-inspired medicine to treat mental illness

Thethirdwave.co: Do Psychedelics Carry A Heart Risk?

Dancesafe.org: Is MDMA Neurotoxic?

Prnewswire.com: Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research

Psychedelicalpha.com: Psychedelic Bulletin: MINDCURE – A Canary in the Psychedelic Coal Mine?

Fieldtriphealth.com

Compasspathways.com

Psychedelics Today: PT233 – JR Rahn of MindMed – LSD, ADHD, and Decriminalization

Psychedelics Today: The Teafaerie – Psychedelic Emergenc(y), Shamanism, 5-MeO-DMT and more!

Huffpost.com: Drugs and the Meaning of Life

Aubreymarcus.com

YouTube: Alex Jones – Magellan is a lot cooler than Justin Bieber

Awaknlifesciences.com

Wikipedia.org: Logical positivism

Leafly.com: Election 2022: Colorado psychedelic legalization and decriminalization guide

Twitter: Zeus’ post (LSD atomizer, not a DMT pen)

Apple Podcasts: Hotboxin With Mike Tyson

Schedule35.co

Psychedelics Today: PT351 – Seth Rosenberg – The Trauma In Being Arrested and The Injustice of the Drug War

Wikipedia.org: Legal status of ibogaine by country

Twitter: Depressed panda meme

Beond.us

YouTube: Linton Kwesi Johnson – Inglan Is a Bitch

How to Change Your Mind: What the New Science of Psychedelics Teaches Us about Consciousness, Dying, Addiction, Depression, and Transcendence, by Michael Pollan

Vice.com: Investors Are Debating Who Should Own the Future of Psychedelics

Wavepaths.com

Psychedelics Today: PTSF 41 (with Mendel Kaelen of Wavepaths)

Nue.life

Kanna.health

Ethnopharmacologic Search for Psychoactive Drugs (Vol. 1 & 2): 50 Years of Research, Edited by Dennis McKenna

The Encyclopedia of Psychoactive Plants: Ethnopharmacology and Its Applications, by Christian Rätsch

Drzee.org

Posted on

PT355 – The Drug War, Caregiving, and Blue Sky Thinking

In this episode, David interviews Ifetayo Harvey: Social media manager for Caring Across Generations and Founder of the People of Color Psychedelic Collective (POCPC), which educates and builds community for people of color who are interested in psychedelics and ending the drug war.

She talks about her childhood and what it was like to have her father be arrested and sent to jail for selling cannabis; her realization of our history of systemic racism and law enforcement’s disproportionate targeting of Black people; why she wanted to try psychedelics; her first mushroom experience; and her path to MAPS, Drug Policy Alliance, living in New York, putting on a conference; and finally, entering the world of caregiving. 

She discusses how too often race is talked around (instead of about); what we can learn from the pitfalls of legal cannabis and the ongoing opioid crisis; drug war reparations; New York’s cannabis social equity programs; and the importance of centering society around care and caregiving. They talk a lot about “blue sky thinking,” and how a lot of problems exist largely because we’ve grown comfortable in complicity and simply haven’t come together to say: “We want this to change.” 

Notable Quotes

“It was overwhelmingly beautiful, being in nature. And I just felt like I saw a different side of life, a different side of my imagination and my mind. For a long time, I would say all of high school, I identified strongly with atheism. …I grew up around a lot of Christian folks, and spirituality; I knew existed because my mom was spiritual. But I didn’t feel that. When I took mushrooms, I felt that a lot more, and I’m like, ‘Whoa, there’s no denying this.’”

“There was a panel on race and I just remember going there and being really excited, being like ‘Hmm, what are we going to talk about?’ and then leaving feeling really deflated because it seemed like everyone on the panel was too cautious about talking about it. When it came to talking about race, everyone was talking around the issue instead of talking directly to it, and that kind of stuff makes me uncomfortable, because who does it serve to not talk directly about race? And who does it hurt?”

“What I hope happens is that people start to realize we do have a say-so in how things play out. We can come together as people who care, people who have aligned values, and say, ‘We want to organize around this, we want to build power around this.’ …There’s this tendency to just be passive and just say, ‘Oh well, the people with the money are going to do what they want to do and hey, there’s nothing we can do about it.’ …I hope that more people come together and realize that you can have an impact. You can have power in this.”

“In this time that we’re in with COVID, monkeypox, wars happening, climate change; hope feels like a discipline. And that can feel hard at times, but also, it reminds us that we have to work towards something.”

Links

Ifetayo.me

People of Color Psychedelic Collective

Drugpolicy.org

Drugpolicy.org: Children of Incarcerated Parents Bear the Weight of the War on Drugs

Ted Talk: Kimberlé Crenshaw- The urgency of intersectionality

MAPS.org

YouTube: “Dismantling Patriarchy in Psychedelics” panel

Leafly.com: How I got one of NJ’s first 11 cannabis dispensary licenses

NYCLU.org: Stop-and-Frisk Data

NBCnewyork.com: NYC Cops Told to Let People Smoke Weed in Public (Where it’s Allowed)

Thecannabisalliance.us

Caringacross.org

Posted on

PT354 – Psilocybe, Microdosing, and Multigenerational Mycology

In this episode, Joe interviews Laura Guzmán-Dávalos: 40-year veteran mycologist at the University of Guadalajara, Mexico; and daughter of Gaston Guzman, who most consider the world authority on the genus, Psilocybe. 

Much of Guzmán-Dávalos’ work revolves around collecting and documenting fungal specimens in and around Mexico, with an overarching goal of better understanding the interactions of different mushroom species. Even though many species were discovered in Mexico, the country seems to be a bit behind in terms of documented real-world evidence, so she’s speaking with microdosers to learn more about their habits, while also studying how alkaloids are involved in the effects of psilocybin. Additionally, one of her Ph.D. students is researching the use of mushrooms among different cultures in Oaxaca, and Guzmán-Dávalos believes they will uncover many differences and solid evidence to help lay the groundwork for legalization. 

She talks about ethnomycology and what she does as a mycologist; Psilocybe and psilocybin-containing mushrooms; what basidium is; functional mushrooms and how the mushroom hype has made her life a lot busier; and brings up a good point: With all the discussion about new companies isolating the drug and removing the psychedelic experience, have we considered how similar that concept is to microdosing?

Notable Quotes

“I am excited that normal people are looking to mushrooms because of [the hype around them] …because [there] was a time that they were forgotten. So it’s very good that normal people [are looking at] mushrooms again. But [they need] to be careful that not all mushrooms function or serve for everything.”

On her father, Gaston Guzman: “I am very, very grateful [for] him. I. He introduced me [to] this life, because it’s not work – It’s a life. And I love it.”

Links

Researchgate.net: Laura Guzman-Davalos’s research

Academia.edu: Laura Guzman-Davalos

UDG.mx: UdeG has the most important mycological collection in Western Mexico

Telluride Mushroom Festival Keynote Speaker: Laura Guzman-Davalos

Wikipedia.org: Basidium

Fantasticfungi.com

Posted on

PT353 – Psychedelics and Creativity

In this episode, Kyle interviews three past guests: author, microdosing enthusiast, and legendary researcher, Dr. James Fadiman; ecologist, researcher, and science writer focusing on psychedelics’ capacity to influence nature connectedness, Dr. Sam Gandy; and professor, writer, researcher, and Co-Founder and Director of Breaking Convention, Dr. David Luke. 

Gandy and Luke recently co-wrote a paper called “Psychedelics as potential catalysts of scientific creativity and insight,” and Gandy reached out to have us set up a conversation with Fadiman, since he was one of the early voices behind the concept of psychedelics for creativity. And this podcast is that conversation: less of a Kyle-lead interview and more of three people picking Fadiman’s mind. 

He talks about his 1966 paper on creative problem-solving and how his research team established its protocol with real-world experience, and then the three of them discuss much more: the differences between artistic and scientific creativity; how the psychedelic experience is similar to dreaming and the hypnagogic state; microdosing; why Indigenous cultures who say ayahuasca spoke to them are likely accurate; DMT entity encounters and problem-solving; society’s lost interest in divination; pluralistic perspectivism; why the West’s scientism obsession hurts research; how science has too few mystics and too many technicians; “pseudo-delics”; and the serotonin/depression conundrum.

Notable Quotes

“What the paper brings back is that altered states [are] part of the human condition.” -James

“One of the aspects of creativity is allowing us to adapt to a changing environment, to a changing world. So, any potential avenues at all; even if the promise of creativity isn’t guaranteed (it doesn’t need to be guaranteed) – even if there’s the possibility of harnessing or enhancing creativity somewhere; even the mere possibility, I think, makes this area worthy of exploration.” -Sam

On new compounds that take the psychedelic experience out of the substance (sarcastically): “I’m already ready for the next iteration of that, which is: they’re coming up with a substance which you can take which will eliminate the problem of pleasure during sex, …because all of the complications of relationships don’t come from the sexual act, they come from the emotional issues around it. So we can eliminate [the pleasure].” -James

“We’re at the edge of a couple of other possible revolutions. The revolution in mental health that you don’t have to be depressed and that you don’t have to take antidepressants is a major shift; and that it can come from a natural substance that you can grow in your closet; these are huge shifts. Again, what do Indigenous people do when they need a medication? They go out and find where it grows. We are returning to that, but at the level of a large civilization. That’s massive. We’re also taking in what we’ve talked about: a lot of experiences and a lot of parts of consciousness that science has prevented us from looking at for quite a while due to its dominance. And when a culture falls apart, into the cracks come all of these alternatives that have been denied. So that’s where we are, and it’s a wonderful time.” -James

Links

Convergence

Jamesfadiman.com

Psychedelics Today: PT275 – James Fadiman, Ph.D. – Transpersonal Psychology, Microdosing, and Your Symphony of Selves

Researchgate.net: Sam Gandy

Psychedelics Today: PT292 – Sam Gandy – Vital Psychedelic Conversations

Researchgate.net: David Luke

Psychedelics Today: PT296 – Dr. David Luke – Vital Psychedelic Conversations

Sagepub: Psychedelics as potential catalysts of scientific creativity and insight

Sagepub: Psychedelic Agents in Creative Problem-Solving: A Pilot Study (1966)

Futuresciencenews.com: Saudi Arabia starts shift to green fuel production, builds $5B hydrogen plant

What is a pluralistic perspective?

Entangled Life: How Fungi Make Our Worlds, Change Our Minds & Shape Our Futures, by Merlin Sheldrake

Wikipedia.org: Zener cards

Braiding Sweetgrass, by Robin Wall Kimmerer

Wikipedia.org: Hypnagogia

Goodreads.com: August Kekulé quote

On Beyond Zebra! By Dr. Seuss

Sciencedaily.com: No evidence that depression is caused by low serotonin levels, finds comprehensive review

Posted on

PT352 – HOLOS: Returning to Wholeness Through Nature and Community

In this episode, Joe interviews Alex Enchin & Ian-Michael Hébert, MA; Co-Founders of HOLOS, a company building hospitality wellness centers with a strong focus on community, reconnection to nature, and a return to wholeness. 

HOLOS is currently running retreats in Costa Rica, where they’re in the process of building out their dream wellness center on a very biodiverse 200-acre piece of land complete with 2 km of waterfalls and swimming holes, that, when finished, will have a self-sustaining farm, glamping setup, center for group work, dining hall, and most importantly, 30 lots that are being filled out by various wellness practitioners to round out a surrounding community of support. The idea behind HOLOS is that profound healing can be accomplished in the most beautiful of places with or without psychedelics – that nature’s psychedelic beauty can help visitors return to a wholeness they have likely forgotten. They want to be the place where the biggest psychedelic figureheads visit to relax, commune, and do their own work; to then spread that energy to their individual communities. And, as there isn’t much of an entry point to psychedelic medicine, their next step is to develop a boutique hotel-like wellness center for those who may not yet be ready for a psychedelic experience; to either prepare them for the next step, or to show that nature and community may be all they really need.   

They talk about our need for community and how HOLOS was born; viewing wellness centers and scalability differently; their relationship with Stan Grof and how a canyon can help people experience the perinatal matrices viscerally; consciousness; transpersonal psychology; nondualism; how viewing Mount Denali can be a psychedelic experience; what “returning to wholeness” really means; and Joe’s realization that the vision behind Psychedelics Today is in line with that of HOLOS: to bring back the attitude and energy of Esalen.

Notable Quotes

“We’re a place where people can come home: home to themselves, home to an understanding of our relational nature as human beings, and a place where people can reconnect to nature. …HOLOS was inspired by Stan Grof’s work and the holotropic paradigm, and the returning to wholeness. …The idea is: What is it like when we actually land there, inside of being whole, and recognizing ourselves as a fractal aspect of a greater universal pattern?” -Ian-Michael

“I lived in a condo in Toronto for a bunch of years, and I just don’t believe we’re meant to live like that. Whether I go down to HOLOS for a week or for a month, walking barefoot in the jungle and touching the dirt; it does something. It charges you. It invigorates you. Every time I leave there and come back to North America, I just feel alive and invigorated, and I really believe that’s our natural state.” -Alex 

“People are looking for something to be a part of. …We’re really trying to design and build HOLOS as not just a place that you come once a year or a couple times a year or once every 24 months, but really, something that you can be a part of on an ongoing basis. …We want to have the psychology shift from ‘HOLOS is a place that I go’ to ‘It’s something that I’m a part of.’” -Alex

“There’s an intergenerational reality that we live inside of, of acquired knowledge or knowledge that is transferred over time, and if we don’t start thinking about our cultures that way; where we have the opportunity to grow a body of knowledge or awareness about a particular ecology or particular healing modalities – if we don’t start thinking of that longer-term context of passing down knowledge, then we’re really a short-lived society.” -Ian-Michael

Links

HOLOS.global

Esalen.org

Psychedelics Today: PT293 – Stanislav & Brigitte Grof – The Evolution of Breathwork and The Psychology of the Future

Reuters.com: Canada’s British Columbia to temporarily decriminalize some drug possession to tackle abuse problem

Evaursiny.com: The Perinatal Matrices According to Grof

Spiritplantmedicine.com: Tony Bossis

Benzinga Psychedelics Capital Conference (April 19, 2022)

Erik Davis – High Weirdness: Drugs, Esoterica, and Visionary Experience in the Seventies

Psychedelics Today: PT302 – Dr. Adele Lafrance – Vital Psychedelic Conversations

Dradelelafrance.com: The Love Project

The Institute of Noetic Sciences

Exeter.ac.uk: Dr Peter Sjöstedt-Hughes

Wikipedia.org: Nondualism

Psychedelics Today: PT282 – Rabbi Zac Kamenetz & The Rev. Hunt Priest – Judaism, Christianity, and Embracing Psychedelics

Psychedelics Today: PTSF 35 (with Brian Muraresku)

Psychedelics Today: Aaron Orsini – How LSD Helped Bridge the ASD Neurotypical Divide

The Myth of Normal: Trauma, Illness, and Healing in a Toxic Culture, by Gabor Maté

Whitelions.org

Esalen.org: Michael Murphy Reflects on Esalen’s Past and Future

Track Two: Russian-American Program

Nasa.gov: John Allen

Synergiaranch.com

Posted on

PT351 – The Trauma In Being Arrested and The Injustice of the Drug War

In this episode, Joe interviews Seth Rosenberg: Washington DC-based mycologist and anti-drug war advocate who worked on DC’s decriminalization Initiative 81.

This episode is a companion piece to the Kole and William Leonard Pickard episodes, as Rosenberg has his own traumatic arrest story. He believes that it was his arrogance in posting pictures online about how to grow mushrooms that initially flagged him, and then an internet purchase of legal mescaline-containing plants that somehow led to 11 armed SWAT agents knocking on his door while he was cooking for his family. He tells his story, detailing the financial and emotional impact created from being arrested for legal activity, and asks some powerful questions: Why did they choose to arrest him in this way? With such an obvious case of injustice, why did nobody reach out and help him? And with charges later considerably lessened, are arrests like this done just to scare brazen people into fearful compliance?  

They also talk about the beginnings of (and racism in) the drug war; the fundamental problem with the “grow, gather, give” concept of the decrim movement; Dr. Carl Hart; why biotech companies racing to create new compounds likely won’t last; IV ketamine and concerns over ketamine being overhyped; the factor of spirituality in the psychedelic experience (and psychiatry’s disinterest in it); the fluidity of morality over time; the unintended segregation within the psychedelic space; and the very scary reality that no one can ever really hide anything from the government.

Notable Quotes

“My arrest with 11 people coming in for a mailed package of cactus, with machine guns, with a child in the house, could have been a traffic stop. I could have been called downstairs to sign for the package. There were a number of options that could have happened, but instead, they chose to wait for my daughter to be there and come in with machine guns.”

“The thing that bothers me the most about the decrim movement …is the ‘grow, gather, give’ model, which sounds great and it sounds very community-based, but the truth is: the grower, the gatherer, and the giver are one person. Everyone else is taking. And that’s a very risky person to be, as I found out. …There’s this idea that we’re all going to get together and do this thing, but once you follow the ideas out more logically, they don’t really seem to carry water.” 

“I don’t think anybody has any idea what being arrested is until you have been arrested. I mean, I get emotional just thinking about it. It’s incredibly traumatic. You can think, ‘Oh yeah, I can deal with that,’ and maybe if what happened is you got arrested at a DUI stop and it’s just a big hassle, fine – that’s one thing. But whatever you think your reaction is going to be when 11 SWAT guys bust in your door; you have absolutely no idea.”

“They know everything. They are paying attention to everything. They have seen all of your Facebook posts, they have seen all of your Reddit posts. If you are posting about drug use, they already know who you are. …They knew more than I ever imagined that they would know. They know everything. There is no privacy. Once they have decided you are a subject of interest; everything, everything, everything is in the open. That’s it. It’s done. And it’s in the open basically forever.”

Links

Districtpsychedelic.com

Linkedin

Ballotpedia.org: Washington, D.C., Initiative 81, Entheogenic Plants and Fungus Measure (2020)

Psychedelics Today: PT338 – Melissa Lavasani – The Power of Storytelling, The Preservation of Peyote, and “How to Change Your Mind”

Psychedelics Today: PT319 – Kole – Activism and Trust: A Cautionary Tale From Someone Who Got Caught

Psychedelics Today: PT311 – William Leonard Pickard – LSD, Fentanyl, Prison, and the Greatest Gift of All: The Natural Mind

The Mycological Association of Washington

Hopkinspsychedelic.org: Albert Garcia-Romeu, Ph.D.

This Is Your Mind on Plants, by Michael Pollan

Troutsnotes.com

Fieldtriphealth.com

Drug Use for Grown-Ups: Chasing Liberty in the Land of Fear, by Dr. Carl L. Hart

Psychedelics Today: PT236 – Dr. Carl Hart – Drugs: Honesty, Responsibility, and Logic

Chasing the Scream: The Inspiration for the Feature Film the United States vs. Billie Holiday, by Johann Hari

Psychedelics Today: Psychedelics and Religious Liberty in the United States

Wikipedia.org: Pegasus spyware

Posted on

PT350 – Psilocybin and Accessing the “Off” Switch For Nociplastic Pain

In this episode, David interviews Jim Gilligan: Interim CEO and Chief Scientific Officer of Tryp Therapeutics, a biotech company researching new compounds and delivery mechanisms for the treatment of eating disorders and nociplastic pain (fibromyalgia, phantom limb syndrome, complex regional pain syndrome). 

Gilligan discusses how nociplastic pain (and likely, eating disorders) seem to be caused by a switch staying on inside the patient’s brain, and wonders why psilocybin seems to be the key to accessing that switch. Tryp wants to understand this better, and is currently running exploratory studies with oral psilocybin to collect enough data to move forward with their next step; the development (and bringing to market) of TRP-8803: a novel delivery mechanism for psilocybin that he believes will allow clinicians to know when the psychedelic experience will kick in, control how long it lasts, end the experience if the patient needs it, or extend it if they believe the patient will benefit. He views the substance and experience from a different angle, considering the set and setting for the molecule itself: How can research studies be set up to give the molecule the absolute best chance to prove that it works on its own?

He also talks about how the neural network seems to hold onto memories (whether they’re accessible or not); the therapy factor and ways to manage long-term efficacy; Prader-Willi syndrome and hypothalamic obesity; the unfortunate necessity of patents to the companies spending millions trying to bring a drug to market; and why, in the newly-risky world of psychedelic stocks, he believes Tryp is a safe bet.

Notable Quotes

“There is an initial benefit that you derive from the administration of a psychedelic, but how do you maintain that durability? Even if you have been successful in changing the switch, I think the therapist is going to be important to make sure that switch stays turned off.”

“They see this even in patients with Alzheimer’s; that they may not remember their children’s names, but you put on a Frank Sinatra song and they know all the lyrics. So that neural network is still there. We know that that switch is in there. We know that there’s something that has to be changed. It’s: How do you get to it? And that comes back to the power of the psychedelics and knowing that it does have an effect on neural networks, and how do you create the environment, how do you create a situation where you can capitalize on that?”

“I’m really passionate about this. I think that [from] my nearly forty years of working in this field, I just see tremendous potential here. And it’s up to people like myself and others in the industry to deliver that potential to the patients.”

Links

Tryptherapeutics.com

Tryptherapeutics.com: Tryp Therapeutics Announces $2,000,000 Financing and Changes in Management, Board of Directors

Psychedelics Today: PT283 – Greg McKee – Nociplastic Pain and Psychedelics

Medicine.umich.edu: Daniel Clauw, M.D.

Psychedelics Today: PT245 – Robin Carhart-Harris – Psychedelics, Entropy, and Plasticity

Mayoclinic.org: Prader-Willi syndrome

Med.ufl.edu: Jennifer L Miller, M.D.

Pubmed: Hypothalamic obesity: causes, consequences, treatment

Fluencetraining.com

Posted on

PT349 – Slowing Down, The Ethics of Touch, and The Value of Preparation

In this episode, Joe interviews transformational coach and guide, Brenna Gebauer; in-person from her parents’ RV at this year’s Lightning in a Bottle festival. Facilitator, past guest, and friend, Mark Haberstroh stops in as well. 

Gebauer discusses her realization that everything that psychedelics show us is already within us; how to hold ethical spaces and establish accountability in underground, unregulated communities; touch in therapy and how to truthfully establish consent; the importance of slowing down; how Oregon’s impending legal psilocybin model is moving too fast for facilitators to truly get the training and (legal) experience they likely need; and the under-discussed value of preparing for the psychedelic experience, which is often where the transformation truly begins. 

In this very conversational talk, we get much more of Joe than usual, with Haberstroh jumping in from time to time as well, resulting in a Solidarity Fridays-esque episode (should we bring those back?) touching on many topics: Vipassana meditation, the hegelian dialectic; fusion therapy; Robert Anton Wilson and reality tunnels; Octavio Rettig and Gerry Sandoval; using the word “medicine” instead of “substance” or “drug”; the community that comes from our Navigating Psychedelics course (that’s where everyone met); why different communities need to share their techniques and knowledge with each other; and the necessity of conflict in progress – how can we open up opportunities for fair dialogue instead of just worrying about “winning” an argument?

Notable Quotes

“Everything that psychedelics show you is already inside of you.”

“There’s so many tools that [veterans] can start using on a day-to-day basis that are going to set the stages for these major journeys to be more transformative. And I think those tiny habits in general are where a lot of these big changes happen – tiny habits that are done consistently.” 

“I’m a firm believer that we heal together. Even if we do it on an individual level, it has a ripple effect on everybody you come in contact with.”  

“The preparation, the journey, and the integration are almost of equal importance. In fact, I have seen people have huge transformations in the preparation process that [were] exceeding their expectations of what they were going to get out of the entire thing, and then the medicine just became a springboard to it. This has not been proven in research, but I believe that when you are intentionally moving in the direction of doing this work, that it’s almost like part of your being starts to know it’s [being] given an invitation to be seen, and those things come to the surface and you can really start addressing them.”  

Links

Journeyintopsychedelics.com

Psychedelics Today: PT244 – Mark Haberstroh – Mushrooms, Retreat Centers, and Safety

Mycorisingfungi.com

Lightning in a Bottle Festival

Psychedelics Today: PT265 – Jessica Cadoch, MA – Cooperation, Drug Exceptionalism, and 12-step Programs

Goodreads.com: Alan Watts’ “Hang up the phone” quote

Hegelian Dialectics

Wikipedia.org: Realty Tunnels

Heroicheartsproject.org

Psychedelics Today: PT322 – Kimberly Juroviesky, Capt., USAF, Retired – Ketamine and Complex Regional Pain Syndrome

Psychedelics Today: PT275 – James Fadiman, Ph.D. – Transpersonal Psychology, Microdosing, and Your Symphony of Selves

Guildofguides.nl

Posted on

PT348 – Cannabis and Psychedelics: Industry, Consciousness, Justice, and Joy

In this episode, David interviews globally-recognized cannabis activist, author, entrepreneur, speaker, podcaster, and “father of the legal cannabis industry,” Steve DeAngelo. 

DeAngelo has been there through it all (read his extensive bio) and was integral in the beginning of cannabis legalization in California, playing a role in the passage of Prop 64 (their adult-use law), and co-founding Harborside; one of the first six dispensaries licensed in the US. He looks back and remembers some big wins and losses, and discusses the beginnings of the ideological judgment of drugs and the launching of the drug war; noting his concerns for psychedelics taking the same path cannabis did when it was legalized – where quality products and the people whose work was motivated by love were squeezed out in favor of investor profits. 

He talks about why the DEA is the way that it is; how cannabis feels to many like a (much needed) female energy; the default mode network and the endocannabinoid system; the concept of “the stoner epiphany”; decriminalization; how we’ve removed the divine from everything; and how the lessons psychedelics and cannabis are telling us are slowly changing society into one that cares about the environment and is more open, loving, and empathetic. 

DeAngelo is currently in Jamaica, working to get people (specifically Rastafarians – cannabis pioneers and a massive inspiration to him) involved in the legal cannabis industry, and heading up The Last Prisoner Project, which fights for the release of people in prison for cannabis offenses. While he fully supports the movement of cannabis and psychedelics being used for therapeutic purposes, he envisions a world where they are used as tools for bringing about joy, ecstasy, wonder, and connection – where these amazing gifts aren’t just attributed to “being high,” but are instead a part of normal, every day human experience.

Notable Quotes

“We didn’t know the science and the history. We didn’t even know about María Sabina. We didn’t know about Albert Hofmann. We didn’t know about the industrial uses or the medical uses of cannabis. All that we really knew was that when we ingested cannabis, it helped us be more like the people we really wanted to be, and we figured that if it did that for us, that it would probably do it for other people too. And we had enough faith (and I still do have enough faith) in the heart of human beings to believe that if we’re all really, really trying to be the people that we really, in our innermost hearts want to be; that we’re going to be moving towards that better world that we all really want to live in together.”

“Joy, ecstasy, wonder: these are all necessary and important parts of the human experience and we’ve removed a lot of that. A lot of people think about those parts of the experience as ‘just getting high’ or being recreational, but they’re not really. I mean, what are we here for on this planet if not for those moments of joy and ecstasy and love and connection, where you just feel like everything comes together in a magic, magic moment where you feel alive in a way that you don’t usually feel? How could we deny ourselves those moments or relegate them to the idea of ‘just being high’?” 

“If we recognize the divinity in each other, if we recognize the divinity in all living creatures, if we recognize the divinity in all natural objects in the world; in the rocks, in the water, in the air, in the trees; then we start cultivating the kind of consciousness that we need to really create a new kind of world where those moments of ecstasy and joy and connection aren’t just little things that happen like little blips on the radar screen, but they’re like a constant state for us. I think that’s where we all want to live.”

Links

Stevedeangelo.com

Lastprisonerproject.org

The Unified Legacy Operators Council (UNLOC INC.)

Radio Free Cannabis podcast

Harborside Cannabis Dispensary

Businessinsider.com: Top Nixon adviser reveals the racist reason he started the ‘war on drugs’ decades ago

Psychedelics Today: PT314 – Daniel McQueen, MA – Vital Psychedelic Conversations

Huffpost.com: Remembering Coral Gardens: Rastas Wanted Dead or Alive

Posted on

PT347 – Rescheduling Psilocybin, Patents and IP, and The Entourage Effect

In this episode, Joe interviews Christopher Koddermann: Co-Founder and Chair of the Board of Directors of the International Therapeutic Psilocybin Rescheduling Initiative (ITPRI).

Under the 1971 Convention on Psychotropic Substances, 184 participating countries have to regulate medical and scientific access to drugs by a scheduling system, and although some countries (Jamaica) have sidestepped these regulations by their interpretation of the convention, these provisions have generally made attempts at academic research and clinical trials very time-consuming, overly complicated, and expensive – especially for psilocybin, which clearly should not be a Schedule I drug. Koddermann helped create ITPRI to assist countries in pursuing and securing the rescheduling of psilocybin, first by initiating reviews of its status. He talks about what steps need to be taken to enable easier access to psilocybin, which countries are part of ITPRI and why, and why the US is not a likely candidate.

He discusses patents, IP, and “Psychedelics 2.0,” where companies are patenting new molecules, using IP to create investment interest, and patent-hopping: What should companies be allowed to patent? What is truly novel? He also talks about market exclusivity and patents; ketamine, esketamine, and the case of China attempting to schedule ketamine; Ken Kesey; consumer preferences around natural products vs. synthetic; the early investment hype in psychedelics; and the entourage effect and baeocystin, a compound present in many mushrooms.

Notable Quotes

“It just gets very complicated to do research, and in some cases, the research just doesn’t happen because you have researchers who may be minded to undertake research and look at the requirements and say, ‘Forget it. I don’t have the time or the expertise to deal with the administrative burden. I don’t have the financing to deal with the costs.’ So they go and do something else. …It really gums up the system and slows down the research, and obviously; when you’re slowing down the research, you’re ultimately slowing down the development of therapies for patients.”

“I think the patent system isn’t perfect and probably needs to be looked at in terms of what is really novel and nonobvious and useful (which are the three criteria for awarding patents), because [in] some cases, patents are stifling as opposed to promoting innovation, which is the purpose of the patent system.”

“The science is so early on and when it comes to these analogs, so little is known. Some of these have only been discovered in the last five years, so we’re really at [the] foundation when it comes to understanding what these analogs are doing, and what else is in the mushrooms – there may be other compounds that simply have not been discovered, especially when considering that dry weight is, in best case, 2% of the mass.”

Links

Reschedulepsilocybin.org

The Electric Kool-Aid Acid Test, by Tom Wolfe

Wikipedia.org: Convention on Psychotropic Substances

Psychedelicmedicinecoalition.org

Drugscience.org.uk

Psychedelicinvest.com: Australian Government pledges to donate $14.8 Million for Psychedelic Medicine Research

Drugsinc.eu: Canadian government grants $3 million for psilocybin research

Academic.oup.com: ‘Hitting Highs at Rock Bottom’: LSD Treatment for Alcoholism, 1950–1970

Apollopact.org

Reason-for-hope.org

Mapscanada.org

Therapsil.ca

Psychedelics Today: PT277 – Ryan Zurrer – Venture Capital, Reciprocity, and the Regenerative Financing Vine

Vine.vc

Psychsymposium.com

Meetfieldtrip.com: Field Trip Receives Notice of Allowance for US Patent Application Covering FT-104 (Isoprocin Glutarate), its Novel Psychedelic Molecule in Development

Cybin.com: Development Pipeline

Vice.com: New Filing Challenges Compass Pathways’ Infamous Patent on Synthetic Psilocybin

Maps.org

Usonainstitute.org

Academic.oup.com: Consumers Prefer “Natural” More for Preventatives Than for Curatives

Filament.health

Wikipedia.org: Baeocystin

Psychedelicreview.com: Studying the Effects of Baeocystin

Posted on

PT346 – Horizons Northwest, The Psilocybin Services Act, and the Magic in Gathering Together

In this episode, David interviews Kevin Balktick: Founder and Director of Horizons; one of the world’s longest-running psychedelic media, education, and communities – who we all know for their yearly Horizons conference in New York City. 

Fifteen years in, Horizons is making its way West with their first conference outside of NYC; September 15-18 at the Portland Art Museum in Oregon. Balktick talks about what led to the creation of Horizons in 2007, why he seeks out old buildings with history, and why it’s become necessary to have a second conference in Oregon now that the state is about to forever be changed by the Oregon Psilocybin Services Act (aka Measure 109). Onlookers may think it’s about expansion and combating the government, but to him, it’s really about responsibility towards making sure that the community works together (and addresses what needs addressing) to get this pivotal moment right. 

He also talks about Horizons New York (October 12-13 at The New York Academy of Medicine and The Great Hall at The Cooper Union); The Oregon Health Authority; why psilocybin is making the biggest waves in psychedelics; David Nutt’s paper on “Equasy”; Horizons’ scholarship system; how conferences don’t reflect the real demographic of their surrounding communities; and the importance (and life-changing possibilities) of gathering together in three dimensions.

And reminder that we are able to offer discounts on Horizons to ether event! For Horizons Northwest, use code PSYCHEDELICSTODAY-NW-17 at checkout for 17% off, and for Horizons New York, use PSYCHEDELICSTODAY-NY-15 at checkout for 15% off. Joe and Kyle will be at Horizons Northwest and hope to see you!

Notable Quotes

“The venue is kind of part of the message that you can’t necessarily escape, so the selection of venues and the messages they communicate are a big part of the set and setting. Although it would be a lot easier in many ways, I’ve just never desired to have Horizons be at a hotel with the carpet and acoustic tile ceilings and so on and so forth. I’ve always wanted to be in somewhere that has history and has its own kind of character and dignity.”

“I have heard this again and again from people who were not sure whether they really wanted to risk their career by becoming publicly associated with psychedelics and then they went to Horizons or another similar conference and they could suddenly feel the strength and the confidence to do so. …All of those were people who had read journal articles, magazine articles, [and] watched videos galore. It is doing the fundamental human thing and being in a place with other human beings – that’s what really created change in people’s lives, and it was important that those things happened publicly and not at some private event with only a handful of people who are allowed to be there.”

“When someone wants to bring someone to Horizons that is not already a part of this community and may harbor some skepticism; that’s a real relationship of trust, especially when it’s a family member, and someone is kind of implicitly saying, ‘I believe in this and the way you present it so well that I trust my family relationships with this community and with this event and with what’s being said on stage’ – that is the compliment I really, really am deeply honored and humbled to receive.”

Links

Horizonspbc.com

Horizons Northwest: September 15-18, 2022, Portland Oregon (Use code PSYCHEDELICSTODAY-NW-17 at checkout for 17% off)

Horizons New York: October 12-16, 2022, New York City (Use code PSYCHEDELICSTODAY-NY-15 at checkout to receive 15% off)

Meowwolf.com

Judson Memorial Church

The Portland Art Museum

The New York Academy of Medicine

The Great Hall at The Cooper Union

The Sheri Eckert Foundation

Naturalmedicinecolorado.org: The Natural Medicine Health Act

Journals.sagepub.com: Equasy – An overlooked addiction with implications for the current debate on drug harms

Horizonspbc.com: Scholarships

Atableofourown.org

Psychedelics Today: PT278 – Ayize Jama-Everett, Courtney Watson, Leticia Brown, and Kufikiri Imara – A Table of Our Own

Vimeo.com: “Covid-19, Black Lives, and Psychedelics”

Posted on

PT345 – Vital Psychedelic Conversations

In this episode, Kyle returns with another edition of Vital Psychedelic Conversations – this time with past guest Steve Thayer: clinical psychologist, Clinical Director of Education & Training at Novamind, and co-host (with Dr. Reid Robison) of the Psychedelic Therapy Frontiers podcast.

He talks a lot about integration and what psychedelic-assisted therapy really means, pointing out that much of integration work is just general good mental hygiene. He talks about how clients need to be open to where the experience takes them, but remember why they sought it out in the first place: What change are they looking for? He gives advice for people looking to enter the field, and points out the difficulties in comparing the efficacy of different types of therapy (as most studies focus on the drug itself). 

He also discusses the main pillars of therapy and the essential domains of psychedelic-assisted psychotherapy; his theoretical orientations (parts work, emotion-focused therapy, and acceptance and commitment therapy); the importance of trusting the inner healer (but with some structure); the unique communal aspects of group work; integration challenges he’s run into; mindful awareness; cognitive fusion; the importance of helpers getting help; and how psychedelics make us comfortable with not knowing. 

Notable Quotes

“Everyone gets really excited, in my experience, about the medicine: ‘Can psilocybin cure my depression?’ ‘Can ketamine cure my trauma?’ ‘Can MDMA make me whole again?’ …People come to the doctor for the cure, and they just sort of expect the medicine to do the work. The medicine does a lot of work, but it doesn’t do all the work.”

“We don’t really know what’s going on when you’re in a psychedelic experience. We’ve got our predecessors who worked with this medicine a lot, and we’ve got the ancient traditions that have been using plant medicines and altered states for thousands of years that we can learn from, and then we have a little bit of empirical research here in the modern era; but to say that that gives us the authority to say, ‘Well, we know exactly what’s going on when you take this much of psilocybin or this much of LSD, and this is exactly what you should do to navigate that experience’ would be unbridled hubris.” 

“If you know you want to become a psychedelic-assisted therapist, become a good therapist first. You can get training on the psychedelic medicine later. For me, I’m biased because I am a psychotherapist, [but] I think becoming a really skilled, competent therapist is really going to be the harder thing to do than it is to learn how to work with these medicines.” 

“I’m also well aware that just because I’ve been trained in a Western modern psychotherapeutic approach, that I don’t have any kind of monopoly on the wisdom it takes to heal. …There are plenty of guides who work outside this paradigm that I’ve been licensed within who I would be more than happy to send a loved one to – that I would go to myself because I want to learn from their wisdom. We haven’t cornered the market on that.” 

Links

Drstevethayer.com

Psychedelic Therapy Frontiers podcast

Novamind.ca

Cedarpsychiatry.com

Cedarclinicalresearch.com

Psychedelics Today: PT323 – Dr. Reid Robison & Steve Thayer, Ph.D. – Ketamine-Assisted Psychotherapy, Therapist Burnout, and LSD for Anxiety

Holotropic Breathwork: A New Approach to Self-Exploration and Therapy, by Stanislav Grof & Christina Grof

Psychedelics Today: PT300 – Dr. Richard C. Schwartz – Vital Psychedelic Conversations

The Tim Ferriss Show: #492: Richard Schwartz — IFS, Psychedelic Experiences Without Drugs, and Finding Inner Peace for Our Many Parts

Rickstrassman.com

Psychedelicgrad.com

Prnewswire.com: Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research

Novamind.ca: Frontline KAP

Zendoproject.org

Thecut.com: You Won’t Feel High After Watching This Video

Vitalpsychedelictraining.com

Fluencetraining.com

Polarisinsight.com

Psychedelic.support

Cedarpsychiatry.com/edu: Foundations of KAP course coming soon

Posted on

PT344 – Epigenetics, Resilience, and Remembering

In this episode, David interviews Susan Beaulieu: Anishinaabe citizen of the Red Lake Nation, Ph.D. student, podcaster, and Extension Educator at the University of Minnesota Extension. She works with Indigenous communities primarily around intergenerational trauma and strengthening community resilience. 

She gives some history of the Red Lake Nation, discussing the impact of boarding schools on their community and how the government attempted to assimilate children to a Western way of life, and how an ayahuasca session made her realize the power (and prevalence) of intergenerational trauma. She talks about how language shapes reality and the risk of losing Indigenous language, how psychedelics could help her community remember its traditions, and the need to insert important aspects of their culture into the healing process and integration work. She wonders: How do they create pathways beyond what is being explored in our current Western model that tribal leaders would be on board with? Does tribal sovereignty mean they have a legal right to try these new medicines? And how do they best keep tradition alive while embracing a whole new paradigm?

She also discusses mind-body medicine and soft belly breathing; the interconnectedness of all of our parts; the importance of truly feeling your “bad” emotions and embracing the flow of energy; how feeling someone else’s healing can be invigorating; and how culture is not just what you do, but how (and why) you do it.

Notable Quotes

“When we think about epigenetics, it’s not just the trauma that gets passed on. Epigenetics is about survival, so it’s also the resilience and the knowledge of our ancestors that gets passed on. So how do we, as Indigenous people, really tap into that again? I think the more that we’re able to heal, the more we’re going to be able to.”

“It’s one thing if a trauma befalls a family within a community that has all of those supports, because the rest of the community is able to come around and help support that family or individual. But when the attack is happening across the entire community and those practices are made illegal and the children are taken, who holds the space?”

“To me, culture isn’t just the activities you do, but it’s how you do the activities that you do.” 

“As sovereign nations, we should have the ability to choose how we heal, when we heal, all of those pieces. And that should not be determined by anybody outside of our community, especially the governments that inflicted the harm in the first place. That really should be up to our communities to decide when and how and all of that, and, resources should be coming to our communities to help us do that. As many resources as went into our communities to try and dismantle and tear our communities apart; just as many resources should go back into helping our communities to be able to access healing in the ways that we see appropriate.”

Links

Pharmacy.umn.edu: Susan Beaulieu

Remembering Resilience Podcast

Fromresearchtoreality.com

The Center For Mind-Body Medicine

NPS.gov: The Dawes Act

Redlakenation.org

Bushfoundation.org

Historymatters.gmu.edu: “Kill the Indian, and Save the Man”: Capt. Richard H. Pratt on the Education of Native Americans

Psychedelics Today: PT286 – Joe Tafur, MD – Vital Psychedelic Conversations

Modernspirit.org

Posted on

PT343 – Kratom and Anti-Prohibition: Lessons Learned and Applied

In this episode, Joe interviews Soren Shade: passionate anti-prohibitionist, producer of the third season of “Hamilton’s Pharmacopeia” and his new podcast, and Co-Founder of Top Tree Herbs, a kratom tea company dedicated to educating people about kratom, normalizing its use, and defeating the prohibitionists who want to ban it. 

He tells his story of learning from Dr. Carl Hart at Columbia, discovering kratom, and meeting Hamilton Morris, and tells us all about kratom: how to pronounce it; its legal history (which is also summed up nicely in a blog he wrote for us); its ties to opium overuse and why it’s still political; how people typically use it today vs. how it was consumed traditionally; why people use it; caffeine and kratom as a coffee substitute; and what he and Joe like most about it. 

And he talks about the lessons we can learn from kratom’s path to legality, which came into play recently when the DEA attempted to schedule 4-HO-DiPT, 5-MeO-aMT, 5-MeO-MiPT, DOI, and DOC. This episode was recorded as a lot of attention was being paid to this attempt, after Hamilton Morris had previously sounded the alarm and people were beginning to prepare for a fight. But after only a few months of public comments, the DEA backed down last week, proving that what happened with kratom may not have been a fluke, and we should all be taking notes and applying the lessons learned to future DEA battles.

Notable Quotes

“That’s kind of the bat signal for: ‘Whoa, maybe there’s something interesting here; maybe there’s something that’s not being said’ – when something is getting (without debate) solely bad attention through the typical media-sphere, through news outlets. It’s just: ‘Alright, here’s a plant, everyone’s hating on it. Hmmm… seen that before…’”

“Kratom has the roadmap for how to stop prohibition of a substance that’s announced, and I think that it should have more attention – that people should take more lessons from the one successful instance of overturning a ban and apply it to the bans that are currently ongoing now in regards to psychedelics.”

“I think normalizing drug use and use of traditional plant compounds and trying things in curiosity and talking about something despite there being a possible social stigma are all hard, but things that have to be done in order to get us into a post-prohibitionist paradigm.”

“Many millions of others count on this plant every day, and we’re just trying to keep it out there, keep it available for people and have people not afraid to use it; not lose their job, not lose their kids, not lose their freedom for using it. That’s our mission. And as soon as kratom seems like it’s in a safe position from that, it’s on to the next one until prohibition is just a reprehensible chapter in our history that we look back on and go, ‘Wow, glad we’re not dealing with that anymore.’”

Links

Toptreeherbs.com

Psychedelics Today: The Intertwined Prohibitionist Histories of Psychedelics and Kratom, by Soren Shade

Kratom Science podcast: 30. Dr. Darshan Singh, University of Science in Malaysia

Psychedelics Today: PT236 – Dr. Carl Hart – Drugs: Honesty, Responsibility, and Logic

Pulitzer.org: Eric Eyre of Charleston Gazette-Mail, Charleston, WV

NPR.org: Drug Distributors Shipped 20.8 Million Painkillers To West Virginia Town Of 3,000

Pgorman.com (Peter Gorman)

Drcarlhart.com: The Rational Choices of Crack Addicts

Vicetv.com: Hamilton’s Pharmacopeia – “Kratom: The Forbidden Leaf”

NYtimes.com: NEGRO COCAINE “FIENDS” ARE A NEW SOUTHERN MENACE; Murder and Insanity Increasing Among Lower Class Blacks Because They Have Taken to “Sniffing” Since Deprived of Whisky by Prohibition (1914)

ABCnews.go.com: Thailand legalizes kratom, popular plant-based painkiller

Menshealth.com: This Healthy 27-Year-Old Bodybuilder Died After Using a Common Supplement

Caffeineinformer.com: The Half Life of Caffeine

Hamilton Morris’ tweet about 4-HO-DiPT, 5-MeO-aMT, and 5-MeO-MiPT

Hamilton Morris’ tweet about DOI & DOC

Federal Register comments: Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I

Federal Register comments: Schedules of Controlled Substances: Placement of 4-hydroxy-N,N

Hamilton Morris’ tweet after the DEA backed down

Psychscenehub.com: David Nutt’s drug harm ranking chart

Patreon.com: Hamilton Morris

Apple Podcasts: The Hamilton Morris Podcast

How to Change Your Mind: What the New Science of Psychedelics Teaches Us about Consciousness, Dying, Addiction, Depression, and Transcendence, by Michael Pollan

Psychedelics Today: PT281 – Oliver Grundmann, Ph.D. – A Thorough Exploration of Kratom

Posted on

PT342 – The Right to Psilocybin in Canada: TheraPsil’s Charter Challenge

In this episode, we introduce a new voice at Psychedelics Today: Director of Corporate Communications, Victoria Dekker, in her first PT podcast; breaking some big news with Spencer Hawkswell, CEO of TheraPsil. 

Nearly two years ago, TheraPsil helped four Canadians suffering from end-of-life distress access legal psilocybin under a Section 56 exemption. But due to these exemptions expiring and the new Co-Ministers of Health (Jean-Yves Duclos and Carolyn Bennett) having other priorities, these patients and other hopeful patients have lost access to their medicine. So just this week, TheraPsil has backed a charter challenge effectively suing the Canadian government, stating that closing these exemptions violates Canadians’ Section 7 charter rights to “life, liberty and security of person,” and launched a fundraiser to help with this upcoming battle. You can read more and donate at Therapsil.ca. 

Hawkswell discusses the creation of TheraPsil and how they help patients through this process; the current (and complicated) ways patients access psilocybin; how Canada’s Special Access Program works; how mirroring cannabis legislation is the best place to start with psilocybin; and TheraPsil’s just-launched Project Solace, where people who have received SAP (or Section 56) access can report back on their experience with both the medicine and the process. 

And he tells the story of Thomas Hartle, the first patient to be granted legal access to psilocybin through TheraPsil’s efforts, and how he has once again begun the battle to gain access to the medicine that changed his life. Hawkswell believes that through this charter challenge (of which Hartle is the main plaintiff), politicians are going to show their true colors. Will they waste millions in taxpayer dollars fighting against the citizens they’re supposed to represent, or will they do the right thing?

Notable Quotes

“I’ve been trying to get a doctor for the last probably six months here in Vancouver. So now we’ve got end-of-life patients looking for a new doctor who’s trained with psilocybin and/or willing to support those exemptions. It becomes an absolute nightmare. And the unfortunate truth is that for many patients, they will die before they find a doctor who’s able to support them.”

“It is a right in Canada to have that access, whether patients are going to grow it [on] their own or whether we’re going to make regulations so that companies can produce it. …The only people in the way of that medicine getting into the hands of the patients who need it are our policymakers and the bureaucrats in Health Canada. So they can do the right thing, or they can be told to do the right thing by the courts.”

“The CAMH; that is an amazing grant [and] I’m so happy It’s been approved by the government, but it’s to see whether or not we can remove the psychedelic effects of psilocybin. It’s to see whether or not there’s something in psilocybin that is just this miracle kind of fix-the-depression [compound]. And to me, as a psychonaut, someone who’s spoken with (at this point) hundreds of patients who have been through therapy legally with psilocybin; the journey is the good part. It is the journey. It is the mind-altering psychedelic experience which makes you do the work that you need to do in order to heal. It is the fear; it is the bad trip; it is the dragon you encounter; it’s the deep, dark basement that you don’t want to go into; it’s the tears that you have to experience. It is the journey, and it just feels so right in my soul that that should be the case.”

“Thomas is someone who was given psilocybin in 2020. The exemption is only good for a year, and the Minister took that away from him. And it’s why he is going to be the lead plaintiff on the charter challenge. This is a person in Canada – a Canadian hero – who legalized psilocybin for himself and other Canadians, who is now being told: ‘You do not have the right to your medicine. You do not get it again.’ …It’s amazing to see that side of him come out again – the fighter wanting to change the laws in Canada, because he’s back on the case. He’s still fighting his cancer, and he’s now fighting the Minister of Health, and he’s going to legalize psilocybin for everybody in Canada and change so many lives. It’s a beautiful thing.”

Links

Therapsil.ca

Therapsil.ca: Dr. Bruce Tobin

Therapsil.ca: 4 palliative Canadians approved for end of life psilocybin therapy through section 56(1)- first legal medical exemptions for psilocybin in Canada since 1970s

Canada.ca: Subsection 56(1) class exemption for patients, practitioners and pharmacists prescribing and providing controlled substances in Canada

Psychedelics Today: Canada’s SAP Expansion Signals a Step Forward for Psychedelics

Healthing.ca: Health Canada denies health care practitioners access to psilocybin for training purposes

Apexlabs.com

Psygen.ca

Theintercept.com: Biden Administration Plans For Legal Psychedelic Therapies With Two Years

Cbc.ca: Toronto’s CAMH gets 1st federal grant to study magic mushrooms as treatment for depression

Drugsinc.eu: Canadian government grants $3 million for psilocybin research

Therapsil.ca: Project Solace

Havn Life Sciences

Filament.health

Quoteinvestigator.com: “Never Doubt That a Small Group…” quote

Canada.ca: The Honourable Patty Hajdu, MP

Canada.ca: The Honourable Jean-Yves Duclos, MP

Canada.ca: The Honourable Carolyn Bennett, MP

Drugscience.org.uk

Mapscanada.org

Canada.ca: Health Canada’s special access programs: Request a drug

Posted on

PT341 – Racism, Trauma, Research, and Psychedelics

In this episode, David interviews Monnica Williams, Ph.D.: licensed clinical psychologist, Associate Professor at the School of Psychology at the University of Ottawa, Clinical Director of the Behavioral Wellness Clinic in Connecticut, and fairly regular conference speaker. 

In this in-person conversation recorded at the From Research to Reality conference (which she co-founded), she discusses her primary focus: the mental health impact communities of color face as a result of racism (both active and intergenerational); and what therapists, clinicians, and especially researchers need to do to make mental healthcare more accessible and more attractive to them. Between triggering language in informed consent paperwork, the fact that the tools for measuring trauma weren’t developed with racism in mind, and the personal biases of therapists (and defensive walls they often erect around racial issues), there is a lot of work to be done – and it all starts with education and open conversation.

Williams talks about why she moved to Canada; the differences in race relations she’s noticed between Canada and the US; why therapists need to be extra careful when dealing with race and psychedelics; internalized racism; the drug war and its intentions; and courses and readings she recommends for learning about anti-racism and for building up the stamina necessary for dealing with the inevitable backlash that comes from trying to help people. She is currently working towards a study on microsoding and racial trauma, a study on MDMA for PTSD due to traumatic immigration experiences, and she’s seeking expanded access to psychedelic-assisted psychotherapy for people dealing with racial trauma.

Notable Quotes

“For some strange reason, when it comes to racism, it’s almost like this automatic defense system comes up and it’s almost like the weapons come out and the therapists are like, ‘Well, how do you know that was racism?’ and “Well, could they have meant something else?’ Or they’re like, ‘Well, what does this really mean about you?’ This is not the direction the conversation should be going if you want the person to feel understood and if you want the person to feel safe, but it’s almost like an automatic reaction that people have that’s counter-therapeutic.” 

“You can’t do good therapy with Black and Brown people in America if you don’t have some rudimentary understanding and appreciation of the traumatic history that we’ve experienced. And that’s doubly so, doing psychedelic-assisted psychotherapy.” 

“I think that the fact that so many people of color feel a little reluctant to get mental healthcare is because most of us kind of know that most therapists don’t really understand [us] and the process may be counter-therapeutic. And I think oftentimes, people of color are often looked down upon, and there may be this idea that ‘Well, they just don’t really understand.’ Well, no, I think they do understand, and that’s why they don’t want to come for therapy, because they’ve already had bad experiences in other aspects of healthcare and they don’t see any reason why it would be any different in mental health.” 

Links

Monnicawilliams.com

BewellCT.com

Psychologytoday.com blog: Culturally Speaking: Challenging assumptions about culture, race, and mental health

Ocdtypes.com: New England OCD Institute

Psychedelics Today: Exploring Race-Based Traumatic Stress and MDMA-Assisted Psychotherapy – Dr. Monnica Williams and Dr. Will Siu

Psycnet.apa.org: A clinical scale for the assessment of racial trauma

Fromresearchtoreality.com

Psychedelics Today: Natalie Ginsberg – Psychedelic Policy and Advocacy

Sciencedirect.com: Tuskegee Syphilis Experiment

Chacruna.net: Course: Diversity, Culture and Social Justice in Psychedelics

The Cognitive Behaviour Therapist: Being an anti-racist clinician

Psycnet.apa.org: Racial justice allyship requires civil courage: A behavioral prescription for moral growth and change